Thoracic Magnetic Resonance Imaging by Ciet, P. (Pierluigi)
506596-L-sub01-os-Ciet Processed on: 16-11-2016
Thoracic
Magnetic Resonance Imaging
Pierluigi Ciet
Th
oracic M
agnetic Resonance Im
aging                                       Pierluigi C
iet
INVITATION/
UITNODIGING 
To attend the public defense of the 
PhD thesis/Voor het bijwonen van 
de openbare verdediging van het 
proefschrift
THORACIC 
MAGNETIC RESONANCE 
IMAGING
By
Pierluigi Ciet 
p.ciet@erasmusmc.nl
On Wednesday 14th December 2016  
at 13.30 hours
Op woensdag 14e December  
om 13.30 uur
Location/Locatie
Prof. Dr. Andries Querido Auditorium
Education center,  
Erasmus MC University
Prof. Dr. Andries Querido zaal
Onderwijscentrum (Eg370),  
Erasmus MC Universitait
Dr Molewaterplein 50,  
3015 GE Rotterdam
A reception will be held after  
the public defense
Receptie na afloop van de promotie
Paranimfen:
Mauro Lo Rito   
(mauro.lorito@gmail.com)
Mario Silva   
(mariosilvamed@gmail.com)
oracic
agnetic esonance I aging
Pierluigi iet
Th
oracic M
agnetic Resonance Im
aging                                       Pierluigi C
iet
INVITATION/
UITNODIGING 
To attend the public defense of the 
PhD the is/V or het bijwonen van 
de openbare verdediging van het 
proefschrift
THORACIC 
MAGNETIC RESONANCE 
IMAGING
By
Pierluigi Ciet 
p.ciet@erasmusmc.nl
On Wednesday 14th December 2016  
at 13.30 hours
Op woensdag 14e December  
om 13.30 ur
Location/Locatie
Prof. Dr. Andries Querido Auditorium
Education center,  
Erasmus MC University
Prof. Dr. Andries Querido z al
Onderwijscentrum (Eg370),  
Erasmus MC Universitait
Dr Molewaterplein 50,  
3015 GE Rotterdam
A reception will be held after  
the public defense
Receptie na afl op van de promotie
Paranimfen:
Mauro Lo Rito   
(mauro.lorito@gmail.com)
Mario Silva   
(mariosilvamed@gmail.com)
Th
oracic M
agnetic Resonance Im
aging                                       Pierluigi C
iet
 a te  t e lic efe se f t e 
 t esis/ r et ij e  a  
e e are er e i i  a  et 
r efsc rift
 
  
i l i i i t 
.ciet eras s c. l
 e es a  th ece er   
at .  rs
 e s a  e ece er  
 .  r
cati / catie
r f. r. ries eri  it ri
cati  ce ter,  
ras s  i ersit
r f. r. ries eri  z al
er ijsce tr  ( ),  
ras s  i ersitait
r le ater lei  ,  
  ter a
 rece ti  ill e el  after  
t e lic efe se
ece tie a afl  a  e r tie
ara i fe :
a r   it    
( a r .l rit ail.c )
ari  il a   
( ari sil a e ail.c )

Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Thoracic
Magnetic Resonance Imaging
Pierluigi Ciet
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Acknowledgements
The work presented in this thesis was conducted at the Department of Pediatrics, Division Pediatric 
Respiratory Medicine and Allergology of the Sophia Children’s Hospital, department of Radiology of 
the Erasmsus Medical Center in Rotterdam, Netherlands, Department of Radiology of the Ca’Foncello 
General Hospital in Treviso, Italy; and department of Radiology of the Beth Israel Deaconess Medical 
Center in Boston, USA.
All studies represented in this thesis where in toto or partially funded by the Sophia Children’s Hospital 
Fund (SSWO) through the 2011 Sporten voor Sophia funds raising campaign. Studies represented 
in chapter 3-5 and were supported in part by the Italian Cystic Fibrosis League (Lega Italiana Fibrosi 
Cistica, LIFC) and by the Italian Cystic Fibrosis Foundation (Fondazione Fibrosi Cistica, FFC).
 
The printing of this thesis has been financially supported by the Erasmus University Rotterdam, the 
Radiology Department of the Erasmus Medical Center and by the foundation Imago.
Cover design: cover was designed by Bob Marongiu (www.bobart.it).
Layout: Legatron Electronic Publishing, Rotterdam
Printed by: Ipskamp Drukkers, Enschede
ISBN/EAN: 978-94-028-0432-4
© 2016 Pierluigi Ciet
All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any 
means, electronic or mechanical, including photocopying, recording, or any information storage and 
retrieval system, without prior written permission from the copyright owner. For all articles published 
or accepted the copyright has been transferred to the respective publisher.
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Thoracic Magnetic Resonance Imaging
Thesis
To obtaining the degree of Doctor from the Erasmus University Rotterdam
by command of the rector magnificus
Prof. dr. Huibert A.P. Pols 
and in accordance with the decision of the Doctorate Board,  
The public defence shall be held on
Wednesday 14th December 2016 at 13.30 hours
By
Pierluigi Ciet
Born in Asolo, Italy
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Doctoral Committee/Promotiecomissie
Promotors:  Prof. Dr. H. A. W. M. Tiddens 
 Prof. Dr. G. P. Krestin
Other members: Prof. Dr. W.M. Prokop
 Prof. Dr. I.K.M. Reiss
 Prof. Dr. E.H.H.M. Rings
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
To my beloved wife Laura and my children Agata and Carlo
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Contents
Chapter 1 General Introduction 9
Part 1 Cystic Fibrosis (CF) lung monitoring using MRI
Chapter 2 Magnetic Resonance Imaging in Children: Common Problems and 19
Possible Solutions for Lung and Airways Imaging
Chapter 3 The Comparison of CT and MRI for Pulmonary Imaging Assessment 61
of CF Lung Disease Using Motion Corrected PROPELLER MRI: 
a Comparison with CT
Chapter 4 Diffusion-weighted MRI (DW-MRI) as New Technique to Assess 75
Inflammation in CF Lung Disease Diffusion Weighted Imaging in Cystic 
Fibrosis Disease: Beyond Morphological Imaging
Chapter 5 Quantification of Lung Inflammation in Cystic Fibrosis during 93
Respiratory Tract Exacerbation using Diffusion-Weighted Magnetic 
Resonance Imaging
Chapter 6 Mosaic Pattern in Cystic Fibrosis Lung Disease: Trapped Air or 115
Hypoperfusion?
Chapter 7 Three-dimensional Fourier Decomposition Ventilation Magnetic 133
Resonance Lung Imaging
Part 2 Airways imaging using MRI
Chapter 8 Spirometer-controlled Cine Magnetic Resonance Imaging Used to 149
Diagnose Tracheobronchomalacia in Paediatric Patients
Chapter 9 Technical Innovation: Cine-MRI of Tracheal Dynamics in Healthy 163
Volunteers and Patients with Tracheomalacia
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Part 3 Diaphragm mechanics using MRI
Chapter 10 Lung MRI and Impairment of Diaphragmatic Function in 193
Pompe Disease
Chapter 11 Discussion 209
Chapter 12 Summary 223
Chapter 13 Samenvatting 227
List of Publications 231
Acknowledgments/Dankwoord 235
Summary of PhD training and related activities 241
About the Author 243
Abbreviations 245
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
Chapter 1
General Introduction 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
10
Chapter 1
Thoracic Imaging: from X-RAY to MRI 
Chest-x ray (CXR) and computed tomography (CT) [1] are today the most important techniques 
used for thoracic imaging. Chest CT is fast and offers great anatomical detail. The major limitation of 
chest CT is related to the use of ionizing radiation [2]. Although, the last generation of CT scanners 
can perform low or ultra-low dose chest CT protocols [3], the long term risk of developing radiation-
related cancer cannot be ignored [4]. This risk is greater in pediatric patients, who are more sensitive 
to radiation than adults [4]. To reduce radiation exposure in medical imaging, the American College 
of Radiology has promoted two campaigns both in children (Image Gently) and in adults (Image 
Wisely) [5,6]. 
Magnetic Resonance Imaging (MRI) which development has started in the same period as CT in late 
1970 is an ionizing radiation free technique based on magnetic fields and radio waves to image the 
body [7]. MRI has become the most important image modality for high proton density structures 
such as the brain, liver, and musculoskeletal system. Unfortunately, the lung is not well suited for MRI 
being a spongious structure with low proton density that results in a low MRI signal [8]. In addition, 
tissue air interfaces result in proton dephasing with extreme shortening of lung T2* relaxation time 
and consequent rapid signal loss [8]. Related to the relatively long acquisition times needed for lung 
MRI the images are sensitive to breathing and heart motions, which further decrease image quality [8]. 
For these reasons, relatively little research efforts was directed towards the development of lung MRI 
and CT has remained the preferred method for thoracic imaging [9]. Only in the last two decades lung 
MRI has regained interest as a radiation free alternative for thoracic imaging [10-12]. This new interest 
in pulmonary MRI has been mostly driven by the development of fast and high-resolution sequences, 
which now allows to overcome the challenges related to lung MRI [10]. Further development of MRI 
as a radiation free alternative for thoracic imaging is highly relevant, especially in children with chronic 
lung disease [13]. These patients require repeated imaging, so MRI being a radiation free alternative for 
chest CT could be a very efficient strategy to reduce cumulative radiation exposure [8].
Chronic lung disease and follow-up imaging: the CF model
Cystic Fibrosis (CF) is a typical example of a congenital chronic lung disease that potentially could 
benefit greatly from further development of lung MRI [14]. CF is characterized by a defect of the cystic 
fibrosis transmembrane conductance regulator (CFTR) protein that results in chronic inflammation 
and progressive structural lung changes that starts in infancy [15]. Regular follow-up of CF lung 
disease is mandatory to timely detecting progressive lung changes and in order to adjust therapy 
[16]. Monitoring of CF lung disease can be performed both indirectly with lung function techniques 
and directly with imaging [17,18]. The former detects the effect of structural lung changes on lung 
physiology and can include several techniques, which are grouped as pulmonary function tests (PFT). 
PFT have the advantage of wide availability and low costs, but they suffer from limited sensitivity for 
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regional structural changes [17]. Patients with CF can have severe localized structural lung changes 
despite normal spirometry parameters [19]. For this reason imaging techniques are needed to detect 
structural lung changes. The imaging of CF lung disease has changed considerably in the last two 
decades, following the technological developments both in chest CT and chest MRI [18]. Although 
chest x-ray (CXR) is still the most used radiology modality, thanks its large availability and low cost, 
CT has shown to be the most sensitive technique to detect and monitor CF lung disease [20]. Concerns 
related to cumulative dose are at the basis for the development of low and ultra-low dose CT protocols 
and the introduction of pulmonary MRI in clinical practice [14]. To date however, a large number 
of studies have been conducted to develop and validate chest CT as outcome measure for CF lung 
disease. For chest MRI these developments have been started only recently. 
Pro and cons of chest MRI
MRI has several advantages over CT for thoracic imaging [11]. The most important one is the absence 
or ionizing radiation, which makes MRI especially suitable for pediatric and repeated lung imaging. 
Another advantage of MRI over CT is its higher tissue characterization deriving from multi-parametric 
(T1, T2, proton density) imaging [8]. Different tissue weighting can provide different information 
about the target tissue. For example T2 sequences are better suited to detect water, for example in the 
case of pleural effusion, while T1 sequence are instead preferred for vascular imaging, especially after 
contrast administration [21]. 
MRI also has the ability to provide functional information, which are not readily available with CT, 
except at the expenses of high radiation exposure [11]. For instance, MRI can provide ventilation 
imaging using hyperpolarized gases or Fourier Decomposition techniques [22,23]. Moreover, MRI 
can be used to assess pulmonary inflammation using Diffusion Weighted Imaging (DWI). Contrast 
administration can be used to assess pulmonary vasculature and parenchymal perfusion [24]. Finally, 
MRI has the advantage to perform dynamic studies to assess “moving” thoracic structures, like central 
airways and diaphragm[13].
Therefore, chest MRI has the potential to provide in a single scan session information about Ventilation, 
Inflammation, Perfusion and Structure, which can be summarized by the acronym we coined: VIPS 
[25]. VIPS information can provide new insight not only in CF lung disease, but also in other chronic 
lung diseases where structure-function relationship has not been fully unfolded. However, before 
introducing VIPS techniques in clinical practice, they need to be validated against other established 
outcome measures. 
The studies in this thesis aimed to contribute to the development of chest MRI for pediatric and adult 
lung diseases. 
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Chapter 1
Thesis topics
This thesis describes first in a review the challenges, solutions and possible applications of MRI in 
thoracic imaging. Furthermore it addresses the use of chest MRI for three areas: CF lung disease 
monitoring (five studies), central airways assessment (two studies) and diaphragm mechanics (one 
study). 
Chest MRI in CF lung disease monitoring
To further validate chest MRI as outcome measure in CF lung disease we:
 – Compared chest MRI to chest CT to assess CF lung disease in a group of stable patients with CF 
(chapter 3)
 – Investigated diffusion-weighted MRI (DW-MRI) as new technique to assess inflammation in CF 
lung disease (chapter 4)
 – Validated DW-MRI as new tool to quantify pulmonary inflammation during CF lung exacerbation 
(chapter 5)
 – Studied the relationship between trapped air and hypoperfusion in CF lung disease using CEMRI 
(chapter 6)
 – Investigated a newly developed three-dimensional (3D) Fourier Decomposition ventilation MRI 
protocol for patients with CF (chapter 7)
To validate chest MRI as new tools to assess central airways dynamics we: 
 – Developed a new chest MRI protocol to assess central airways in static and dynamic conditions and 
tested this protocol in a group of pediatric patients with a clinical suspicion of tracheobronchomalacia 
(chapter 8)
 – Tested the central airways protocol in a group of healthy volunteers and adult patients with a 
clinical suspicion of saber-sheath tracheomalacia (chapter 9)
To validate chest MRI as new method to assess diaphragm mechanics we:
 – Developed a chest MRI protocol to assess diaphragmatic function in patients with Pompe disease 
(chapter 10).
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Thesis outline
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Magnetic Resonance Imaging in Children: 
Common Problems and Possible Solutions 
for Lung and Airways Imaging
Ciet P, Tiddens HA, Wielopolski PA, Wild JM, Lee EY, Morana G, Lequin MH
Based upon Pediatric Radiology. 2015 Dec;45(13):1901-15. (Extended version)
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Abstract
Pediatric chest MRI faces many challenges. High resolution scans of the lungs and airways are 
compromised by long imaging times, low lung proton density signal and cardiac and respiratory 
motion. A low lung signal is problematic in imaging relatively normal lung tissue, but less so for 
diseased lung tissue. Indeed, various pathologic conditions often result in an increased signal from 
lung parenchyma that can render chest MRI more informative. 
One of the most important criteria for successful chest MRI is proper patient cooperation. In fact, 
relatively long acquisition times of MRI makes patient preparation crucial. Children usually have 
problems with long breath holds or the concept of quiet breathing. The acquisition of chest MRI in 
young children is even more challenging because of higher cardiac and respiratory rates, which result 
in motion and imaging blurring. For these reasons, to date computed tomography (CT) has been 
preferred over MRI for chest pediatric imaging. 
Despite its drawbacks, MRI also has advantages over CT, which justifies its further development and 
clinical use. The most important advantage is the absence of ionizing radiation, which allows frequent 
scanning for short and long term follow-up studies of chronic diseases. Moreover, MRI allows the 
assessment of functional aspects of the chest, such as lung perfusion and ventilation, or airways and 
diaphragm mechanics. In this review, we describe the most common MRI acquisition techniques on 
the verge of clinical translation, their problems and the possible solutions to make chest MRI feasible 
in children.
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
21
State-of-the art review on chest MRI
2
Introduction
Lung Magnetic resonance imaging (MRI) is challenging because of the magnetic heterogeneous 
environment in this region [1]. Lung parenchyma is a spongious structure with a low proton density 
per voxel and hence a reduced signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) [2]. 
In addition, the numerous air-tissue interfaces within a voxel induce strong localised microscopic 
magnetic field gradients, which produce extensive MRI signal dephasing leading to extremely short 
T2-star (T2*, between 1 and 2 ms at 1.5 Tesla) and geometric distortions. These field inhomogeneity 
effects become stronger at higher magnetic field strengths, such as 3.0 Tesla, which is increasingly 
used in clinical setting [3]. However, in cases of lung pathology like pneumonia, edema, tumors and 
atelectasis, the SNR of these diseased regions is higher due to increased proton density of the fluid 
and/or tissue, so resulting in an improved visualization [4]. Another important reason for the relatively 
poor spatial resolution of MRI compared to computed tomography (CT) is the relatively long scan 
times required, which result in artifacts related to respiratory and cardiac motion. Hence, many well 
established MRI and magnetic resonance angiographic (MRA) techniques used in routine studies of 
the brain, neck and peripheral vasculature cannot be easily implemented in the lung region due to 
inconsistent image quality. 
To optimize lung MRI protocols the target structure, and the patient’s cooperation in following 
breathing instructions have to be taken into account [5]. 
The target structure influences the contrast weighting needed, such as that T1 weighting is normally 
used for vessel visualization, T2 weighting for bronchi, and PD weighting for lung parenchyma [4]. 
Breath-hold is usually preferred for lung MRI and MRA sequences, because it supplies the best image 
quality [5]. Unfortunately, many lung diseases result in increased respiratory rates and maintaining 
breath holds of several seconds may not be possible for patients[5]. This problem is even more 
prominent for young children, who have a higher respiratory rate compared to adults [5] and where 
cooperation is poor. To address this problem a MR sequence with high temporal resolution and good 
SNR is required. MR physicists have worked hard to develop MR acquisition techniques [6] that meet 
these challenging criteria [7,8]. Breathing instruction has been improved by introducing dedicated 
patient’s training before the examination. Also MRI compatible spirometers have been developed and 
used for MRI lung imaging [9,10]. 
The driving force to develop sophisticated MR sequences for lung MRI is that this technique is free 
of ionizing radiation, which is especially important for pediatric patients or in case of serial imaging. 
Pediatric patients are more sensitive to ionizing radiation than adults, therefore is crucial to reduce 
cumulative dose according to the ALARA principle [11]. Similarly adult patients, who need repeated 
imaging to assess clinical deterioration or response to therapy, might end up with high cumulative 
radiation dose [12]. For these reasons, dose reduction campaigns were promoted by the American 
College of Radiology both in pediatric and adult populations [13,14].
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Lung MRI fits the aim of these campaigns because it makes it possible to monitor chronic pediatric 
diseases (i.e. cystic fibrosis, CF) or oncology patients [15] without increasing the lifelong cumulative 
radiation dose [3]. Moreover, MRI has the advantage of integrating anatomical and physiologic 
information in a single examination, a possibility not as readily available with other imaging modalities. 
In fact, MRI can provide information regarding lung perfusion [16] using gadolinium contrast, 
lung mechanics using dynamic acquisitions [10], and ventilation and gas exchange using inhaled 
hyperpolarized gases [17], oxygen enhancement or dynamic motion based methods [18]. Furthermore, 
MRI has shown advantages over CT for imaging the following lung related disorders: 1) Identification 
of tumor infiltration into the mediastinum or the chest wall [19,20]; 2) differentiation between solid 
lesions and vascular structures in the hila without intravenous contrast medium injection [21], 3) 
representation of pathologies of the diaphragm, in particular evidence of tumor penetration of the 
thorax into the abdomen [22]; 4) evaluation of the mediastinum in patients with treated lymphoma 
[23].
For all the aforementioned reasons, MRI has been introduced in clinical practice, although use on a 
large-scale base is still far off. In this introduction, we will review the challenges faced in lung MRI and 
the most common MRI techniques used for imaging lung and airways diseases.
Patient preparation
Image quality in thoracic imaging is highly dependent of patient cooperation, which in turn is related 
to patient age, mental status and disease status [5]. Patients with dyspnea, younger than 6 years old, 
mentally impaired or with hearing problems have problems following breathing instructions. In patient 
with dyspnea, fast imaging or respiratory gated options should be chosen to reduce scan time. These 
techniques will be discussed in the following chapters. In pediatric patients younger than 6 years old, 
as some adult subjects, may need sedation for MR imaging because of claustrophobia or other anxiety. 
In young children, the need of sedation can be reduced by making the child more comfortable during 
the examination. For instance, the parents can stay in the examination room with the child or it can be 
used some distraction methods, such as movies or music [24]. When these methods fail, it is frequently 
necessary to use deep sedation, with airways intubation in collaboration with anesthesiologists [25]. 
The use of deep anesthesia is anyway controversy, and it should be weighed against the potential risks 
and benefits of other faster imaging options, such as CT. There is indeed recent evidence that deep 
sedation in early-developing brain might produce long-term sequelae [26,27].
Sedation in radiology departments can be performed with different anesthetic agents, such as fentanyl, 
midazolam, pentobarbital, propofol, chlorpromazine, and sevoflurane chloral hydrate [28]. The 
selection of the most appropriate anesthetic agent should be performed by a dedicated anesthesia team 
and according to patient’s age, duration of examination, comorbidities [29]. During sedation, the 
anesthesiologist can monitor patient’s vital signs and respiration and coordinate with the MR imaging 
technologist the acquisition of images. For lung MRI, the anesthesiologist can recreate breath-hold 
conditions in inspiration (25 cm H2O) and at end-expiration (0 cm H2O) in a controlled environment, 
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while the radiologist and the MR radiographer minimize the imaging time and ensure diagnostic MRI 
sequences [24]. Finally, lung MRI should be performed in short scan sessions to avoid the development 
of atelectasis, which can hamper assessment of the underlying disease and be secondary to patient 
ventilation. After anesthesia, patient should be monitored and evaluated before discharge, being the 
radiologist responsible for any adverse outcomes that result from the use of sedation, even after the 
patient leaves the facility [29].
In children of 6 years and above, cooperation can be increased substantially with adequate patient 
training in a mock scanner and the use of MR-compatible spirometers [9]. Patient training consists 
of a set of training instructions to rehearse a specific breathing maneuver, ideally before the scan is 
performed. Training can be performed in the supine position adopted in the MRI scanner on a bed 
using a MRI-compatible spirometer (Figure 1). 
Figure 1. MRI compatible spirometer set-up. CF patient in a 1.5 T MRI with MR compatible spirometer setting. 
(1a) A plastic adjustable tripod holds the mouthpiece that is connected through a plastic black corrugated tube to the 
control computer at the scanner operator’s side. (1b) Mock MRI scanner is used to train the pediatric patient before 
the actual MRI scan. The mock MRI scanner can reproduce the noises that the patient will hear inside the real MRI 
environment. The mock scanner also contributes to reduce the anxiety level of the patient before the real examination.
The purpose of the training is: 1) to obtain inspiratory and expiratory capacity in supine position 
as a point of reference for the actual scanning; 2) to train the subject executing specified breathing 
maneuvers by using the spirometer during the MRI; 3) to reduce anxiety related to MRI investigations; 
and 4) to increase the number of successful MRI investigations [9,10]. Commonly used breathing 
maneuvers are: a breath-hold at maximal inspiration or maximal expiration; quiet free breathing; 
quiet deep inspiration-expiration; forced expiration after a maximal deep inspiration; or coughing 
maneuvers. These maneuvers allow the study of anatomical detail of airway and parenchyma or to 
study the response of the airways to respiratory motion and different air flow situations [10]. 
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Breath-hold acquisitions are the cornerstone of chest MRI and can be acquired comfortably in most 
pediatric patients without extensive MRI scanning sessions [5]. These acquisitions are in general 
preferred over free-breathing acquisitions for thoracic imaging as resolution and SNR are lower when 
compared to gated MRI scans (Figure 2). 
Figure 2. Breath-hold versus free-breathing acquisition. Breath-hold (a) versus free-breathing (b) 3D SPGR axial 
reformats (TR/TE/FA=1.4/0.6/2). Note the motion artifact in the free-breathing acquisition (arrows).
MR system and coil selection
Selection of the appropriate MR system is of key importance as it strongly influences image quality in 
lung MRI. Theoretically one could enhance SNR, like in other imaging regions [4], by using higher 
magnetic field strengths, but in lung MRI higher field strength does not necessarily equate to higher 
SNR due to the increase in T2* dephasing and susceptibility artifacts. For this reason, lower magnetic 
field systems (i.e. 1.5 Tesla) are currently more suitable for routine clinical lung MRI than 3 T systems, 
(Figure 3). Given the requirements for higher spatial resolution in children, MR scanners with strong 
and fast imaging gradients are needed, with values typically between 40-50 mT/m (milliTesla/meter), 
and slew rates in excess of 200 T/m/s (Tesla/meter/second).
Making the correct coil selection for a given exam is also a critical factor for image quality. For lung 
MRI close fitting receiver array coils are optimum, which have multiple small coils combined (coil 
elements in phased array) to record the signal simultaneously [30]. Array coils provide higher SNR by 
virtue of the closer proximity to the lungs but also allow for shorter acquisition time [30] through the 
use of parallel imaging [6]. Optimal coil designs differ depending on the anatomy, for thoracic MRI 
the coils most frequently used are arrays with 4 to 32 channels. Ideally a tailored closely fitting receiver 
coil suited to the size of the thorax of the child should be used, for enhanced sensitivity and patient 
comfort. For instance, an 8 channels head-neck-spine coil can provide better SNR than a 32 channels 
torso coil for dedicated central airways imaging, because of the closer fitting to chest anatomy.
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Figure 3. SNR at 1.5T and 3T. Same subject scanned with 1.5 T (a) and 3 T (b) systems, and same parameters 
(TR/TE=1.4/0.6 ms, Acceleration=6, 3 seconds scan). Note the signal decay of the lung parenchyma with 3T system 
(arrow). Windowing setting is kept constant in both images.
Lung Morphology and image quality
Multiple problems related to lung structure affect image quality in lung MRI: a) extremely low 
proton density of normal lung tissue; b) relative large body volume; c) presence of extensive air-tissue 
interfaces; and motion related signal alterations from breathing and cardiovascular pulsations during 
data collection. In the sections below, these points are clarified in more detail.
Low proton density of the lung and optimal SNR selection
Lung MRI has an intrinsic low SNR, for which reason lung MRI images are often compared to a “black 
hole” [31]. The air-to-tissue ratio of lung parenchyma is high, which is unfortunate as air does not 
provide any MR signal and the number of water protons present per voxel imaged in lung parenchyma 
is low. This is not the case for central airways or vascular structures, which can be visualized quite easily 
[32]. 
A compromise between spatial resolution, SNR and acquisition time must be found to obtain the 
desired image quality [3]. To obtain a specific SNR several MRI parameters must be taken into 
account. A simplified formula for SNR is
√
SNR αK ×(voxel size)  ×
number of excitations (NEX)
receiver readout bandwidth (BW)
* α proportionality operator
The constant K in the formula includes those factors that are beyond the routine operator’s control, 
such as hardware dependent factors (i.e. coil sensitivity) and tissue dependent parameters (proton 
density, T1, T2, T2*) [33]. The influence of some MRI pulse sequence parameters (repetition time, TR; 
echo time, TE; flip angle, α; specific absorption ratio, SAR; spin echo, SE; or gradient recalled echo, 
GRE readouts), voxel size, NEX and BW on SNR will be described below. 
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Voxel size
Voxel size determines spatial resolution, which is in turn determined by the matrix size, the field of 
view (FOV) and slice thickness (SL) [33]. The matrix size is the number of frequency encoding steps, 
in one direction; and the number of phase encoding steps, in the other direction of the image plane 
[33]. Assuming FOV and SL as constant; increasing the number of frequency encodings or the number 
of phase steps results in improved resolution, at the expenses of scan time. 
When comparing acquisition scenarios in lung MRI, increasing the voxel size proportionally augments 
the SNR [33], due to the greater number of protons per voxel. Therefore to ensure acceptable SNR, the 
voxel size chosen in lung MRI is significantly larger in comparison to CT [3]. Consequently, thicker 
slices are acquired (between 5 to10 mm) and spatial resolution is lowered to shorten acquisition time 
[34]. Depending on the MRI readout scheme used, SNR can selectively be augmented and smaller 
voxels acquired. In the case of 3D readout scans, this can be done by selecting more slices (partitions). 
In the case of 2D readouts, a multi-slice interleaved mode can be selected. 
The FOV is the maximum diameter of the area of the scanned object that is represented in the 
reconstructed image [33]. Dividing the FOV by the matrix size provides the pixel size for a specific 
SL. When acquisition matrix is kept constant to retain the same acquisition time, increasing the FOV 
augments SNR, because it translates into larger voxel sizes [33] (Figure 4). Typically FOV is selected 
according to patient size and in lung MRI is usually large in order to get good SNR. For pediatric 
patients care must be taken not to select too small FOV and voxel size so as not to run out of SNR. 
Figure 4. Effect of voxel size on SNR. SPGR with 3x3x3 mm3 (a) and 1.5x1.5x1.5 mm3 (b) isotropic voxels. Note 
that by halving each dimension by half there is a reduced signal-to-noise ratio (SNR) of a factor of 8 as shown by the 
increased image noise in (4b). Scan time for (4a) was 3 sec while for (4b) was 14 sec. In image 4b spatial resolution 
increases, with sharper contours of the lung structures; though at the expense of a slightly longer TR and TE.
Number of excitations
A number of excitations (NEX) or number of signal averages (NSA) represents how many times a 
signal from a given slice is measured [33]. NEX is dependent on many factors, such as the number of 
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signal averages performed, matrix size selected, imaging speed selected (when selecting partial Fourier 
or parallel imaging readout schemes) and on whether two-dimensional (2D) or three-dimensional 
(3D) encoding is used. As described in the formula, the SNR improves proportional to the square root 
of the NEX, but unfortunately scan time also increases linearly with the NEX. Therefore, when MRI 
data are acquired during a breath-hold, acquisition time and SNR have to be balanced in such a way 
to allow data collection in a reasonable time.
Bandwidth
The receiver readout bandwidth (BW) is the range of frequencies collected by an MR system during 
frequency encoding [33]. The MR data acquisition can take more or less time, depending on the 
receiver bandwidth. A broad BW corresponds to faster data acquisition and minimizes chemical shift 
artifacts, but also reduces SNR as more noise is included [33]. Halving BW improves SNR by √2 . 
With a narrow BW, on the other hand, there will be more chemical shift and motion artifacts and 
the number of slices that can be acquired for a given TR will be limited (Figure 5). Narrow BW will 
create blurring and geometrical signal distortions around structures [32]. Therefore, a narrow BW 
setting may not be beneficial for lung imaging, especially for GRE pulse sequences, where narrow BW 
increases breath-hold times and enhances the sensitivity to motion and field inhomogeneity artifacts. 
This therefore results in SNR loss or decreasing spatial resolution [33].
Figure 5. Effect of Bandwidth to SNR. 3D SPGR axial reformat with bandwidth (BW) of 142 (5a), 62.5 (b) and 
31.25 (c) kHz. Note that longer BW influences appearance of lung parenchyma, which for small BW (longer 
acquisition) appears darker (c).
Other factors affecting SNR
Half-Fourier Imaging
SNR loss is also factored if partial Fourier scanning or parallel imaging are used [35,6]. Partial Fourier 
imaging (partial NEX) is used in many instances to reduce scan time in lung imaging. Partial Fourier 
scanning takes advantage of the symmetry of k-space to reduce scan time, where just over half of 
the data (~60% k-space) is acquired and used to reconstruct the missing part [35]. When selecting a 
partial NEX of 0.5 cuts acquisition time by almost the same factor with a consequent loss of SNR of 
approximately √2  [35]. Scan time reduction achieved through parallel imaging techniques can suffer 
from SNR performance. Although SNR is reduced, in some sequences (i.e. gradient-echo) this can be 
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counterbalanced by a reduction in TE. Scans collected using parallel imaging can reduce breath holds 
substantially (5 to 10 seconds) with complete thoracic coverage with both 2D or 3D acquisitions and 
with higher spatial resolution [34]. 
Parallel Imaging
In parallel imaging, scan time reduction is achieved by scanning less phase encoding lines in k-space 
(2D or 3D acquisitions) and uses the different coil sensitivities of a phased array coil to reconstruct a 
full dataset [6]. All parallel imaging techniques reduce acquisition time according to the acceleration 
factor selected by the operator, and acquisition time is shortened by the same factor. For instance, 
when the acceleration factor is two, only half of the k-space is sampled and the acquisition time is 
halved. Although theoretically the acceleration factor can assume values up to the number of phased-
array-coil, in practice most MRI vendors allow values ranging between 2 and 6 [36]. According to 
the numbers of coils and how the coils are distributed in the phased array receiver, the acceleration 
factor can range between 2 and 3 times for 2D and from 2 to 6 times for 3D acquisition techniques. 
Acceleration factors higher than 2 for 2D imaging are seldom used for lung parenchyma imaging [34]. 
The higher the parallel imaging factor or “acceleration” utilized, the higher the penalty in SNR (Figure 
6). As the acceleration factor increases the greater the degree of noise induced magnification [36].
Different parallel imaging methods are available among the MRI vendors, such as Array coil Spatial 
Sensitivity Encoding (ASSET, SENSE, etc.) or Autocalibrating Reconstruction for Cartesian imaging 
(ARC, GRAPPA, etc.) [37]. While ASSET requires a separate calibration scan used to map the 
spatial sensitivity of the coil, in ARC the calibration acquisition is included in the parallel imaging 
acquisition. ASSET is usually preferred to achieve high temporal resolution, because it results in 
shorter acquisitions times than ARC. Moreover ASSET tends to provide better image quality than 
ARC for high acceleration factors. However ARC is the best choice for lung MRI, where accurate 
coil sensitivity maps are difficult to achieve [36]. ARC indeed reduces reconstruction artifacts when 
patient cannot execute breath-holding in a reproducible manner, which gives discrepancies between 
the calibration and the parallel imaging acquisitions [36]. Finally, ARC allows selecting FOV smaller 
than the imaged area without significant artifact, which might be important to achieve high spatial 
resolution (i.e. airways imaging). 
In lung MRI, higher acceleration factors can be selected in case of diseased states, such as increased 
T2 from fluids or tumor, or larger and thicker airways (i.e. bronchiectasis) or when contrast agents are 
used to shorten the T1 of lung parenchyma, blood or surrounding structures. When SNR is sufficient, 
the benefits of using partial Fourier and parallel imaging is to freeze motion and eliminate the 
detrimental effects of breathing by using breath-hold acquisitions, which can permit uncompromised 
imaging of lung parenchyma, vasculature and airway structures [4]. The acceleration obtained by these 
techniques can also make possible to freeze cardiac motion by collecting sub-second 2D or 3D scans or 
shortening cardiac gated acquisitions to a short breath-hold time. Finally, the high temporal resolution 
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obtained by combining these two techniques can be useful for applications in cine-mode, such as for 
the dynamic assessment of the central airways and the diaphragm.
Figure 6. Parallel imaging, SNR and Acquisition Time (TA). SPGR acquired without and with parallel imaging 
using auto-calibrating reconstruction for cartesian sampling (ARC, GE, Milwaukee, USA) and increasing acceleration 
factor (AF): (a) no acceleration and TA 15 sec, (b) AF 1.25x1.25 and TA 10 sec, (c) AF 1.5x1.5 and TA 7 sec, (d) AF 
2x2 and TA 5 sec, and (e) AF 2x3 and TA 4 sec. Note that by increasing AF the TA reduces from 15 sec to 4 sec, but 
at the same time SNR reduces, with the last image (e) appearing noisier than the first image (a).
Coping with large magnetic susceptibility gradients 
The choice of MR pulse sequences based on SE or GRE readouts can dramatically impact SNR and 
on how lung parenchyma and surrounding structures will appear. In lung MRI, an increase of TE can 
dramatically decrease SNR of lung parenchyma depending on T2*. Imaging of the lung parenchyma 
is best performed with SE based techniques as these techniques can in most of the cases circumvent 
the need to acquire scans with short TEs [38]. Differently, irreversible dephasing of the MR signal 
due to short T2* is critical with GRE techniques, whereas signal can be completely lost for most 
structures with slices thicker than 7 mm and TEs longer than 4 ms at mid and higher magnetic field 
strengths. This SNR loss appears as signal voids in the pulmonary vasculature and airways, especially 
in regions distally from the central large bronchial structures and the heart [39]. Nonetheless, GRE 
scans can be effectively used for imaging lung parenchyma, when the selected TE is below 1 ms 
(millisecond) for 3.0 Tesla scanners and 2 ms at 1.5 Tesla scanners. The most sophisticated MR GRE 
pulse sequences, which secure less signal loss and acquisition speed for lung parenchymal imaging, are 
based on projection reconstruction techniques with TEs on the order of microseconds (ultra-short TE, 
UTE), therefore mitigating signal dephasing due to the short T2*s [40,41]. Similar sequence is also the 
zero TE (ZTE) gradient-echo, which combines high resolution images to a noiseless MRI acquisition 
and that might be especially suitable for pediatric lung imaging [42,43].
Independently of the choice made, scanning lungs in inspiration will result in more problems 
than scanning during expiration, when lung density is higher (Figure 7). However, for the correct 
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assessment of lung diseases, MRI should be performed in inspiration (Figure 8). On the other hand, 
MR acquisition at end expiration allows a better definition of trapped air (Figure 9).
Figure 7. Inspiratory level and SNR with 3D SSFP/TrueFISP. 3D SSFP/TrueFISP coronal at end-inspiration 
(a), half-expiration (b) and forced expiration (c). Note the progressive increased SNR of the lung parenchyma from 
a to c.
Figure 8. Bronchiectasis. CT (a) versus 2D SSFP MRI (b) in 14 year old cystic fibrosis boy with bronchiectasis 
(white arrows) in the left upper lobe.
Respiratory and cardiac motion 
A. Respiratory monitored acquisitions: When patients cannot execute breath holds, respiratory monitored 
acquisitions during free breathing can be considered using navigator echoes or pneumobelts. Navigator 
echoes in the form of a pencil excitation are placed over the diaphragmatic dome and can be created 
in two different ways: 1) with an intersection of a SE generated signal from two overlapping slices 
excited with a 90°-180° RF excitation pair or 2), a beam or pencil like excitation generated using a 2D 
RF pulse with a GRE readout [44]. When using navigator echoes the diaphragm position is detected 
in real time, and can trigger the image acquisition prospectively based on a predetermined range of 
motion mostly selecting the diaphragm during expiration. The position in expiration is based on a 
short observation period at the beginning of the acquisition, during which a respiratory waveform is 
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reconstructed from a number of seconds of numerous breathing cycles during which pencil excitations 
are recorded [44] (Figure 10). To obtain better data acceptance during scanning, the data processed 
from the pencil excitation can be used to appropriately shift the slice or slab acquired in the region of 
interest. Navigator echo based techniques usually dramatically improves the image quality without the 
need for patient cooperation but at the expense of longer acquisition times (on average 5-9 minutes 
per acquisition). Acquisition time highly depends on the regularity of the breathing pattern, when 
using a prospective data acquisition scheme [44]. This technique has been used in children as young 
as 4 years old [45].
Figure 9. Trapped air and MRI. Trapped air assessment with MRI. (a) Free-breathing BLADE MRI, (b) CT at 
end expiration, performed the same day, (c) 3D SPGR MRI coronal reformat breath-hold at end-inspiration and 
(d) end-expiration. Note areas trapped air in the left lower lobe (thick arrow) and area of air trapping in the left upper 
lobe (thin arrow).
Respiratory gating can also be obtained using pneumobelts or with the use of other external respiratory 
devices to trigger the scan prospectively [46]. A pneumobelt consists of a flexible corrugated tube placed 
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around the rib cage or the abdomen, the positioning selected depends on the maximum distention 
of the tube possible during the respiratory cycle. A predefined threshold is automatically selected by 
the patient monitoring unit dependent on the maximum excursion of the signal recorded from the 
pneumobelt. Similar to the navigator echo system, image acquisition is mostly performed during 
expiration, because it is more reproducible compared to inspiration. 
Figure 10. Navigator technique. (a) excitation pencil to determine diaphragmatic dome position at end expiration 
(white box), (b) respiratory waveform reconstructed. 
B. Non-monitored respiratory acquisitions: Another established method to overcome breathing motion, 
is by averaging multiple acquisitions during free breathing. This method leads to image blurring, 
but reduces image ghosting [47]. In general this technique increases the acquisition time but mostly 
without increasing total MRI scanning time. Some special encoding techniques can even reduce 
scanning time, if the phase encoding lines collected are ordered depending on the signal acquired from 
the respiratory monitoring device [48]. Projection-like scanning techniques can also be used effectively 
without respiratory monitoring in order to better suppress the effect or motion and appearance of 
image artifacts. In many cases, when using this acquisition strategy, respiratory and cardiac waveforms 
may be extracted from the data collected and used to further reduce the detrimental effects from 
motion by correcting or eliminating data that may corrupt the acquisition (Figure 11). 
C. Cardiac monitored acquisitions: To avoid blurring and ghosting artifacts from cardiac motion, ECG 
gating can be additionally incorporated [49]. ECG gating is not important for the upper portion of 
the lung, such as the apices, but it becomes more important for the diagnosis of pathologies involving 
the right middle lobe, lingula and the left lower lobe. The use of ECG and respiratory triggering 
together may increase scan time dramatically as imaging data is only accepted if both respiratory (at 
expiration) and cardiac triggering (at diastole) coincide [50]. Scans can be collected using retrospective 
or prospective schemes and may come in many different types as to reduce scanning time. MRI pulse 
sequences incorporating the projection reconstruction k-space encoding techniques can monitor both 
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types of motion and can reorder the data acquired as to produce datasets of the respiratory and cardiac 
cycles [7,8].
Figure 11. Non-monitored respiratory acquisitions. 3D SPGR free-breathing using parallel imaging (ARC 6) 
multiphase (20 phases in 1min, ~3sec/phase). Note that sequence is fast enough not being affected by lung motion. 
The only visible ghosting is due to cardiac and vessels pulsation (white arrows).
MRI pulse sequences for lung MRI
Sequences for lung MRI must be selected based on the type of contrast required (T1, T2 or proton 
density), SNR, CNR, spatial and temporal resolution, and the sensitivity to motion and magnetic 
field inhomogeneity. Here, we summarize SE or GRE based MR pulse sequences for different vendors, 
which may collect 2D and 3D images during breath-hold conditions, because these are usually 
preferred for thoracic MRI and MRA [3] (Table 1). 
Turbo spin-echo sequence:
Turbo spin-echo (TSE) sequences are fast variants of conventional SE scans, which have the same low 
sensitivity to magnetic susceptibility artifacts and magnetic field inhomogeneities as SE and can be also 
used with sub-second acquisition times (i.e. single shot TSE scans) [38]. A typically robust sequence 
is the 2D T2-weighted single shot TSE scan, known under different acronyms as HASTE (Siemens) 
or SSFSE (GE) depending on the MRI scan manufacturer [51]. Single shot TSE techniques have 
high sensitivity and high SNR for fluid detection. TEs in the order of the T2 of the lung parenchyma 
(~40 ms at 1.5 Tesla) are preferred for lung imaging with TSE [4]. 
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One factor to consider with single shot TSE is the echo train length and the blurring introduced 
by the T2 decay during acquisition. In fact when longer echo times are used, the T2 decay in the 
phase encoding direction produces a filtering effect in the k-space, which manifests as blurring in the 
images [4]. This can be reduced in the lungs by using a rectangular FOV and orienting the phase-
encode direction along the shortest axis e.g. anterior-posterior in an axial scan. Additionally parallel 
imaging and half-Fourier imaging option can help reduce this effect by reduction in the echo train 
length and the number of k-space line acquired [4]. Another problem of TSE readouts is that fat 
signal can be much brighter when compared to conventional SE scans due to J coupling refocusing 
of the coupled lipid spins [33]. Fat suppression schemes (FS) can be used to reduce this effect using 
chemically selective fat saturation techniques as fat resonates at a different frequency, or using short 
tau inversion recovery (STIR) preparations, because of the short T1 of fat relative to many surrounding 
tissues in the thorax [52]. Although the FS is faster, it is less reliable than STIR, because of magnetic 
field inhomogeneities over such large FOVs, hence the effectiveness of the chemical fat suppression 
is compromised substantially when longer echo trains are used in a single-shot acquisitions. On the 
other hand, the inversion radiofrequency pulse used in STIR to cancel fat signal affects the signal in 
all the tissues contained in the slice acquired, leading to a generalized loss of SNR [52]. In general, the 
lung parenchyma and all tissues with longer T2s, are best visualized when using these fat suppression 
techniques in combination with TSE readouts. Parallel imaging can dramatically reduce the effect 
of brighter fat, because fewer 180° refocusing pulses may be required when acquiring a particular 
slice per sequence TR at fixed resolution, so acquiring less phase encoding lines. Finally, Dixon-based 
fat separation techniques (i.e. DIXON, Siemens, or IDEAL, GE) can provide a more homogeneous 
removal of lipid signals than conventional frequency selective chemical saturation techniques [53] 
(Figure 12).
The clinical utility of single shot TSE scans for imaging the lung has been shown in different studies 
for the detection of lung pathologies, such as pneumonia in immune compromised patients [54,55]. 
In a study at low magnetic field strengths, TSE was the preferred sequence for the visualization of 
mediastinum and lung consolidations [56]. HASTE has been used to assess not only consolidations due 
to pneumonia, but also its complications, such as abscess, necrosis and empyema. These T2-weighted 
sequences are also indicated in those cystic diseases with increased water-content, such congenital lung 
airway malformations (CPAMs), and CF [5]. In CF, HASTE sequence delineates easily bronchiectasis 
and mucus plugs, which have both high signal in T2-weighted imaging [57] (Figure 13). 
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Figure 12. Fat saturation. Fat signal suppression techniques, DIXON (a and c) versus Fat Sat (b and d). Note more 
homogenous fat signal suppression in DIXON (arrow head) than Fat Sat technique. Note also the generalized loss of 
signal with Fat Sat technique (arrow). Image windowing and resolution are constant between the images.
Figure 13. a and b SSFSE/HASTE in CF. CF patient, CT image (a) and SSFSE (b) at end-inspiration. Note the 
consolidation in the right middle lobe (white arrow) and the adjacent bronchi filled of mucus (white circle).
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Gradient recalled echo sequences 
All variations of 2D and 3D short and ultra-short TE (UTE) GRE readouts are typically considered as 
the most robust sequence for lung parenchyma and lung MR imaging [4]. Short and UTE GRE scans 
can overcome the short T2* of lung parenchyma and minimize the signal loss created by the extensive 
air-tissue interfaces found around vascular and airway structures. GRE sequences are usually collected 
with very short TRs, when compared to single shot or slower gated TSE scans. A short TR is critical for 
patients, who are unable to accomplish long breath-holds (>10 seconds) [3]. Likewise, GRE scans have 
much lower specific absorption ratios values, when compared to TSE readouts, although this usually 
comes with a penalty on SNR. The specific absorption ratio is a direct indicator of the potential tissue 
heating that can happen due to the application of the RF during scanning [33].
In general, 3D GRE acquisitions are the preferred scanning methodology as they provide better SNR 
and are less sensitive to susceptibility artifacts than 2D scans. Nonetheless, 3D may not be as robust 
regarding to the detrimental effects of motion as compared to 2D scans, which can freeze cardiac and 
respiratory motion even in non- cooperative patients. Overall, 3D GRE acquisitions can acquire the 
entire thorax with adequate resolution with isotropic voxels (≥3 mm3) and SNR in less than 15 seconds 
[10]. When isotropic voxels are collected, multi-planar reformats can be performed in any orientation 
which is crucial in the evaluation of vascular and airways structures [4] (Figure 14). 
There are two types of GRE readouts: those MR pulse sequences that eliminate the transverse 
magnetization prior to the application of each RF pulse on each TR and those that do not. The first 
type includes the most typical scans performed and fall under the acronyms of FLASH (Siemens), 
SPGR (GE), etc. The second type is usually known under the steady state free precession (SSFP) family 
with acronyms such as TrueFISP (Siemens), FIESTA (GE), etc. 
For a fixed repetition time TR, the first type (FLASH, SPGR) provides contrast ranging from proton-
density weighting (low flip angle), mostly used to investigate lung parenchyma and airways without the 
use of contrast agents, to T1 weighting (high flip angle), used to better characterize vascular structures 
and to map lung parenchymal perfusion after contrast administration. A limitation of GRE sequences 
is that they cannot readily provide T2 weighting, because the TE can never be chosen long enough 
and the T2* effects dominate signal behavior. Another limitation in GRE imaging is due to the strong 
tissue-air boundaries in the lung parenchyma that create substantial susceptibility artifacts. The net 
result is bright and dark areas with spatial distortion of surrounding anatomy.
The FLASH/SPGR sequences has been used in several clinical studies, for example volume interpolated 
3D GRE (i.e. LAVA) was rated as the best sequence for lung nodule detection in vivo [56] (Figure 15). 
In another comparative study in porcine chest phantom, 3D GRE had similar diagnostic accuracy as 
CT in depicting lung nodules larger than 8 mm, and sensitivity between 80 and 90% for lesions larger 
than 4 mm [58]. Lesion smaller than 4 mm were difficult to detect with MRI [58]. 2D/3D SPGR is 
also the preferred sequence for contrast enhanced studies, where contrast enhancing lesions, vessels 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
38
Chapter 2
and lymph nodes can better delineated after Gadolinium injection [3] and in MR angiography and 
dynamic contrast enhanced perfusion imaging of the lungs.
Figure 14. SPGR (FLASH) 3 D. 3D SPGR sagittal acquisition with axial and coronal reformats at end-inspiration 
(a-c) and end-expiration (d-f ). Isotropic voxel 3 mm3 with 6 seconds acquisition time. Note area of air trapping (thin 
arrow) in the left lower lobe with excessive collapse of trachea (thick arrow) in the expiratory image (lower row).
The second group of sequences (SSFP) generate a T2/T1 weighted contrast with medium to high 
flip angle settings (>30º) and very short TRs, so enhancing tissues in the lung with more water-like 
behavior, such as mucus plugs in the airways [33]. 2D SSFP scans are frequently used due to the 
inherent high SNR, which is mostly due to the use of higher flip angles than SPGR. 2D SSFP allows 
fast acquisition of the entire thorax in a single breath-hold with good SNR. At the same time, SSFP 
type can be quite sensitive to magnetic field inhomogeneities producing unwanted local variations 
in contrast behavior, which become quite problematic at higher magnetic field strengths, i.e. 3.0T. 
These inhomogeneities are usually described as off-resonance banding artifacts, which are seen with 
SSFP in regions of regional magnetic inhomogeneity, such as the area above the diaphragm [33]. This 
artifact tends to alter the lung signal intensity, so signal from nodules and vessels are subsequently 
cancelled [59]. This artifact can be reduced by substantially shortening TR [59]. Another limitation of 
SSFP imaging is that it has an intensive specific absorption ratio, especially when used with high flip 
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angles at higher field strengths. Repeated imaging with SSFP sequence can exceed the maximal specific 
absorption ratios level allowed in MRI.
Figure 15. SPGR. 3D SPGR coronal (a) and axial (b) acquired with a 1.5 T system in a patient with flu symptoms. 
Note areas of air trapping (thin arrow) and left lower lobe subpleural nodule (thick arrow).
SSFP is commonly used in cardiac imaging, but it can also be used for lung MRI. In a comparative 
single center study between different MRI sequences, SSFP was the preferred sequence to visualize 
lung parenchyma in volunteers, and also the sequence that had the fewest motion artifacts [56]. In CF 
patients, SSFP showed to be sensitive in the detection of clinically relevant structural abnormalities, 
such as bronchiectasis, mucus plugging, and atelectasis [39] (Figure 16). In children with possible 
pneumonia SSFP was compared to chest radiograph [60], showing really good correlation between 
MRI and chest radiograph for all pathological findings [60]. More recently SSFP has been proposed as 
best sequence to assess lung fibrosis [59]. Finally, 3D SSFP provides an effective means of generating a 
lung MR angiogram without the need for contrast.
Projection acquisition and reconstruction techniques
PROPELLER is a particular TSE non-breath hold readout that has been used more extensively 
for lung MRI. PROPELLER collects imaging data using rotating k-space bands or blades, which 
is thought to be more robust to respiratory movements [61]. The collection of blades oversamples 
the center of k-space, so producing better SNR and reducing rotational and translational in-plane 
motion occurred between the images collected on each blade [62]. This sequence is more suitable 
for non-cooperative subjects, such as pediatric patients younger than 5 years old or adults unable to 
breath-holding. PROPELLER can also be combined with respiratory-gated techniques (i.e. navigators 
or pneumobelts), so further reducing the effects of motion. This combined approach allows full chest 
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coverage in 4-7 minutes, depending on the breathing pattern of the patient, with good in-plane spatial 
resolution (1-1.5 mm) [3]. However, studies have shown that PROPELLER frequently produces streak 
artifacts [5]. As result lines are projected in the lung parenchyma creating false signals resembling 
bronchial walls and bronchiectasis (Figure 17). To reduce this artifact, the blade width (k-space 
coverage acquired per blade), should be increased or a finer angular sampling used [62]. 
Figure 16. Aspergillomas infection in CF. CT (a) versus SSFP MRI (b) in 16 years old boy with end stage CF lung 
disease. Note widely dilated bronchi filled with thick mucus and aspergillomas (white arrow).
Figure 17. PROPELLER/BLADE artifact. 2D PROPELLER/BLADE free-breathing in CF patient. Note linear 
ghosting surrounding the heart and the external portion of the chest (white arrows) due to the helicoidal k-space 
reconstruction.
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Figure 18. PROPELLER/BLADE in CF. 
2D PROPELLER/BLADE coronal in CF 
patient. Note areas of mucus plug (arrows) and 
bronchiectasis (arrowhead).
In a multicenter study in CF patients comparing CT and MRI, PROPELLER showed good intra- 
and inter-observer agreement to assess CF-related lung abnormalities [63] (Figure 18). In another 
comparative study with chest radiography, PROPELLER was superior to detect lung abnormalities 
in patient with middle lobe syndrome [45]. In patients with common variable immunodeficiency, 
who are prone to suffer repeated lung infection, PROPELLER was proposed as alternative method to 
reduce cumulative dose due to repeated CT imaging [64].
Functional Imaging
MRI offers different techniques to study different functional aspects of lung and airways. Gadolinium 
contrast has been used to assess the pulmonary vasculature, and lung perfusion [65,66]. The high 
temporal resolution of MRI has proven to be useful to assess lung- and central airways mechanics [10]. 
Hyperpolarized gases, such as helium (3He) and Xenon (129Xe) have been developed to produce high-
contrast images of lung ventilation [5,17]. Finally Fourier Decomposition (FD), a recent developed 
MR technique, has been used to assess lung perfusion and lung ventilation without the use of contrast 
media [67]. These techniques will be briefly described starting with the clinical available to the most 
experimental technique.
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
42
Chapter 2
Lung Magnetic Resonance Angiography 
Magnetic resonance angiography (MRA) of the lung can be obtained without and with the intravenous 
administration of contrast. In both cases, the low proton density of the lungs is ideal for generating 
high angiographic contrast with all sequence types (SPGR and SSFP). 
Non-contrast MRA acquisitions 
The main advantage of these techniques is that they can be repeated without concerns related to the 
use of contrast, especially in patients with impaired renal function [5]. When using SPGR scans, 
MRAs can be obtained using a proton-density weighted contrast or employing the time-of-flight 
(TOF) enhancement phenomenon by choosing higher flip angles and the correct orientation for 2D 
slices or 3D volumes. TOF angiography is based on the phenomenon of flow-related enhancement of 
fully-magnetized blood spins entering into an imaged slice [33]. As a result of being unsaturated, these 
blood spins give more signal than surrounding saturated stationary spins, thus generating bright blood 
images. 3D angiograms can be generated using techniques, such as maximum intensity projection or 
volume rendering, making vessels appear similar to conventional X-ray angiography [33] (Figure 19). 
TOF always allows good depiction of vascular morphology whenever inflow effects are adequate (high 
flow velocities). Different acquisition strategies can be used to perform TOF 2D and 3D (Table 2).
Non-contrast MRA can also be obtained with 2D and 3D SSFP based sequences, which supply bright 
blood vessels images. Thin 3D slab SSFP scans (i.e. 3 mm) can be collected in a single breath-hold 
with reasonable resolution. Nevertheless, this sequence has been adapted for longer scanning scenarios, 
using respiratory navigators and higher resolution settings with larger slice coverage and smaller voxel 
sizes. With these improved settings, SSFP has been used for non-contrast MRA evaluation of the 
thoracic vasculature and pulmonary embolism [68,69] (Figure 20).
Table 2. Time of Flight (TOF) 2D and 3D
Breath-hold TOF 2D/3D SPGR scans
2D slice/3D thin slab 
sequential acquisitions
Short TR (5-10ms), short TE (1-3ms), flip angle >45o. Tracking saturation bands for selective 
imaging of pulmonary arteries or veins (mostly for sagittal acquisitions) can be used.
2D Interleaved Long TR (100-280ms), short TE (1-3ms), intermediate flip angles (25o-45o). No tracking 
saturation bands. Inflow effects on the arterial side can provide higher signal than veins.
2D Segmented k-space 
& cardiac triggering
Short TR (5-10 ms), short TE (1-3ms). Optimal inflow effect at peak systole allows higher 
SNR and distinction against veins. Can be performed in a cine loop. Usually one thick slice per 
breath-hold is acquired.
Thick slab 3D Short TR (5-10ms), short TE (1-3ms).
Sagittal slab, one lung.
Low flip angles or spatially variable RF (TONE, VUSE). Arteries can be seen with higher 
intensity as compared to veins.
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Figure 19. Time of flight angiography. 3D Time-of-
Flight (TOF) SPGR with increasing flip angle (FA): 
(a) FA=2, (b) FA=6, (c) FA=8, and (d) FA=12. Note 
that by increasing the FA the weighting is shifting 
from PD to T1, as denoted by signal intensity of the 
fat in the anterior chest wall (white arrow). Echo-
time is also increasing, thus SNR decay as denoted by 
vessel signal. Finally at the highest FA, (d) the signal 
from the vein disappears, but new ghosting artifact 
from artery pulsation is visible (thick arrow).
To detect pulmonary embolism, typically 2D or small slab 3D sequential SPGR TOF sequences have 
the best chance to show pulmonary embolism, because they maximize the TOF effect using higher 
angle imaging and thin slices/volumes. Other combinations of 2D and 3D scans are inadequate to 
demonstrate pulmonary embolism properly, especially in patients with compromised cardiac function 
because of poor inflow effects. 
For pulmonary embolism detection, SSFP sequence showed a sensitivity ranging from 90 to 100% for 
central pulmonary embolism (main pulmonary arteries) and 68 to 80% for peripheral subsegmental 
pulmonary embolism [70,71]. It is important to underline how with SSFP, pulmonary embolism 
appearance depends on the age of the clot. In case the pulmonary embolism is chronic it appears 
as darker regions against brighter vessels. In case of acute pulmonary embolism, the signal can vary 
largely according the methaemoglobin content. 
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Figure 20. Scimitar syndrome. 2D SSFP/TrueFISP coronal in patient with anomalous partial pulmonary venous 
return (scimitar syndrome). Note the aberrant pulmonary vein connected to inferior vena cava (arrows).
Dark blood angiography 
ECG-gated black blood SSFSE with double inversion recovery has also been proposed as a non-contrast 
sequence that provides dark vessel images and provides better anatomical images of the diseased lung 
or thoracic abnormalities. Dark blood SSFSE acquisitions are frequently used to study the anatomy 
of the heart, great vessels and mediastinum [72]. Dark blood SSFSE has several advantages, including 
good SNR, minimal motion blurring, little artifact from field inhomogeneities and superb contrast 
characteristics. Pulmonary emboli can be well seen using this sequence at short TE [72] (Figure 21).
Figure 21. a and b. Black blood SSFSE. Sagittal (a) and axial (b) cardiac triggered fast spin echo with black blood 
preparation and fat suppression in patient with parietal thrombus in the aortic arch (arrowheads). Note clear depiction 
of right lower lobe infiltrate (thin arrow) and small pleural effusion (thick arrow).
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Arterial Spin labeling
Arterial Spin Labeling (ASL) is a technique based on “labeling” of blood protons in the supplying 
vessels outside the volume of interest (VOI) by using a selective radiofrequency pulse excitation [73]. 
The VOI is imaged after a period of time known as the post labeling delay (PLD), which is needed 
for the labeled blood to reach the targeted organ parenchyma. Images are obtained both in the labeled 
and control (i.e. unlabeled) state to perform subtraction imaging. ASL technique can be performed 
both with SSFP or SSFSE sequences, because both techniques allow short scan times and the use of 
various pre-pulses (fat-suppression, inversion and/or ASL pulses) [74]. While SSFSE is limited by 
flow characteristics (i.e. velocity and vessel orientation), SSFP is more flow independent and enables 
imaging of fast flow vessels [74]. For this reason SSFP is usually the preferred method for lung MRI 
[73]. 
The major advantage of ASL is the absence of contrast and the repeatability of the exam. These two 
characteristics make ASL suitable for patients with impaired renal function, where repeated contrast 
administration is limited or for young children where noninvasive techniques are preferred. However 
ASL is technically challenging to implement in clinical practice, because it is a single slice technique 
with limited voxel resolution that requires a regular cardiac cycle [73]. Moreover the SNR of ASL 
images is low, especially in the anterior portion of the lung, which in supine position is less perfused 
than the posterior portion. To increase sensitivity of ASL to perfusion defects, it is recommended 
positioning the patient so that the area of interest is down-gravity (i.e. prone position for upper lobes) 
[73]. Moreover, SNR can also be enhanced by performing ASL during end-expiratory breath-hold 
condition [75]. These technical challenges explain the limited number of works describing the clinical 
application of ASL [76,77].
Contrast-enhanced MRA acquisitions 
Despite non-contrast studies are feasible for lung MRA, contrast-enhanced MRA (CEMRA) studies 
using the intravenous injection of contrast media are the preferred method. CEMRA supplies high 
SNR and CNR using T1-weighted scans, and hence supplying images with higher temporal and 
spatial resolution [5]. Likewise, CEMRA is reliable; the injection of contrast agents, mostly based 
on gadolinium chelates, renders angiographic images virtually acquired in any orientation (sagittal, 
coronal or axial) and is completely independent from inflow effects. CEMRA allows to identify even 
down to sixth order subsegmental pulmonary arteries of a normal lung [78]. Timing of contrast bolus 
is crucial to optimize image contrast, so k-space is acquired during contrast peak, and to limit venous 
contamination of MRA [79]. CEMRA usually collects data using a very short TR 2D/3D heavily 
T1-weighted GRE acquisition. With scanning strategies using parallel imaging, volumetric CEMRA 
scans can be acquired even with sub-second time resolution using powerful imaging gradient systems. 
Typical breath-hold CEMRA settings consider very short TR (1.3-3 ms), short TE (0.5-1.3ms), 
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and flip angles ranging between 10-30o depending on contrast dosage, concentration and speed of 
administration. Resolution and coverage are usually adjusted to suit a comfortable breath-hold [3]. In 
adults CEMRA has used to study pulmonary emboli, especially when iodinated contrast agent and CT 
imaging is contraindicated [80]. In pediatric patients, CEMRA is frequently used to study congenital 
vascular anomalies, such as transposition of great vessel, tetralogy of Fallot, anomalous pulmonary 
venous return, pulmonary sequestration, thromboembolism, etc. [5,24,81] (Figure 22).
Figure 22. MRA. Contrast enhanced Magnetic Resonance Angiography (CEMRA) of aorta in patient with bicuspid 
aortic valve, moderate stenosis, complicated by mild insufficiency and ascending aorta dilatation. (a) 3D GRE after 
gadolinium injection (TR/TE/FA=3.2 ms/1.15 ms/17°) and (b-c) maximum intensity projection reconstructions 
(MIP).
Magnetic Resonance Lung Perfusion 
Different lung diseases alter lung perfusion through the physiologic mechanism of hypoxic lung 
vasoconstriction, also known as Euler-Liljestrand mechanism [82]. This mechanism determines 
constriction of the pulmonary arteries in poorly ventilated lung areas, redirecting blood flow to normally 
ventilated alveoli. These perfusion defects can be assessed by MRI sequences using gadolinium, such as 
dynamic contrast-enhanced (DCE) imaging, or without, such as Fourier Decomposition (FD), which 
is described in the following chapter. Despite DCE has a broader use in clinical practice than FD, both 
techniques are still used in experimental setting. 
DCE is obtained by fast imaging of the first pass of contrast agent through the lungs after an intravenous 
bolus injection [5]. 3D gradient echo sequences are usually preferred over 2D techniques due to the 
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higher spatial resolution and anatomic coverage [73]. Different k-space acquisition strategies have been 
developed to improve temporal and spatial resolution of DCE, such as TREAT, TWIST (Siemens) 
and TRICKS (GE) [83,73] (Table 1). These techniques use key-hole and view sharing methods, which 
oversamples the center of the k-space (image contrast) compared to the periphery (image edge detail). 
This improves the temporal resolution, because only part of the k-space is collected, and provides the 
high CNR needed for perfusion MRI [84]. Key-hole and view sharing methods can also be combined 
with spiral or radial k-space readout trajectories (i.e. vastly undersampled isotropic projection, 
VIPR) that allow both central and peripheral k-space sampling, thus providing both high CNR and 
spatial resolution [84]. Further evolution of this technique is the highly constrained back-projection 
reconstruction (HYPR), which is a mask-based reconstruction technique capable of acceleration 
factors as large as 1000, with minimal tradeoff between spatial and temporal resolution [84]. Finally 
compress sensing (CS), a technique that allows to reconstruct images from fewer signal measurements, 
can be combined with the aforementioned k-space undersampling techniques [85]. CS is a promising 
technique for 3D lung perfusion imaging by enabling higher acceleration factors with reduced motion 
artifacts [86]. 
Figure 23. Perfusion. MR Perfusion study. Non-subtracted (a) and subtracted (b) coronal views of Time-resolved 
Angiography With Interleaved Stochastic Trajectories (TWIST@SIEMENS) after gadolinium injection in CF 
patients. Note multiple areas of mosaic perfusion likely representing areas of hypoperfusion (arrows).
DCE has mostly been tested in adults to assess pulmonary embolism, chronic thromboembolic 
pulmonary hypertension and chronic obstructive lung disease [87-89]. In these diseases, MRI showed 
similar sensitivity to nuclear medicine and CT studies to assess lung perfusion impairment, but with 
the advantage of higher spatial resolution and no radiation exposure [90,91]. DCE has also shown 
high reliability to quantify regional pulmonary microvascular perfusion [92]. Perfusion MRI showed 
higher potential than CT to distinguish controls from mild COPD patients and was more sensitive 
in identifying abnormalities amongst smokers with normal lung function [93]. In pediatric patients, 
DCE has also proved to be a very sensitive technique to assess early vascular functional impairment 
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and therapy control in CF [16,94] (Figure 23) and congenital diaphragmatic hernia [95]. In a study 
regarding childhood constrictive bronchiolitis obliterans, DCE showed to be more sensitive than Tc99m 
perfusion scintigraphy to detect perfusion defect and determine prognosis [96]. 
Contrast agents for CEMRA
MRA and Perfusion MRI can be performed either with intravascular or extravascular Gadolinium 
based contrast agents (GBCA) [97]. Extravascular agents permit high-contrast first-passing imaging 
[79] but the rapid decline of contrast enhancement make the appropriate timing challenging. Different 
techniques exist to optimize contrast bolus timing with extravascular agent. The dual bolus technique 
relies in a small “test bolus” (1 to 2 ml) to compute the bolus arrival time in the main pulmonary artery. 
This small bolus is also used to compute the arterial input function (AIF), which is needed to obtain 
quantitative parameters (i.e. pulmonary blood flow) [79]. The single bolus technique uses a dose of 
0.1-0.2 ml/kg GBCA followed by 20-30 ml saline solution at high flow injection (4-5 ml/sec). Single 
bolus technique is frequently combined with bolus tracking method, where contrast bolus is monitored 
in real time and injection is triggered when contrast reach pulmonary artery. Extravascular agents can 
be used both for MRA and Perfusion MRI [79]. In a recent comparison between extravascular agents 
and injections techniques, Gd-BOPTA (Multihance, Bracco, Italy) with single bolus showed the best 
SNR in the lung parenchyma [98]. 
Differently the intravascular (aka “blood pool”) GBCA are used for steady state imaging (i.e. 
gadofosveset trisodium@Ablavar, Lantheus Medical Imaging, or @Vasovist, Bayern Schering Pharma). 
Blood pool GBCA have gained popularity in vascular imaging, especially in those patients where 
distinction between arteries and veins is not necessary [99]. Blood pool GBCA has a prolonged half-
life, which allows high-resolution imaging at lower Gadolinium dose compared to extravascular agents 
[99]. In fact, the longer intravascular permanence of gadofosveset facilitates longer acquisition sessions 
of sub-millimetric isotropic voxels, frequently needed in pediatric patients [99]. Despite the good 
safety profile of this blood pool agents, its use in pediatric patients remains an off-label use [99,100]. 
Independently from the type of contrast and the administration technique used, GBCA administration 
should carefully considered according patient’s renal function and after an appropriate risk-to-benefit 
assessment [97]. Guidelines for GBCA administration varies between United States and Europe [101-
105]. In general, GBCA administration depends on patient’s renal function, age, comorbidities, history 
of allergic reactions and specific gender-related conditions, such as pregnancy or lactation [97,106]. In 
these situations, the GBCA should be chosen according its safety profile, which varies according the 
chemical structure. In general, the macrocyclic nonionic GBCA (Gd-DOTA@Dotarem, Guerbet, Gd-
HP-DO3A@Prohance, Bracco, Gd-BT-DO3A@GADOVIST, Bayer) have the safest administration 
profile, and are usually preferred in pediatric patients or those with impaired renal function [5,97,102]. 
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Fourier Decomposition
Fourier decomposition is a new technique of non-contrast-enhanced functional lung MRI that supplies 
perfusion and ventilation maps not dependent on intravenous or gaseous contrast agents [107]. This 
new technique is based on a 2D SSFP sequence with high temporal resolution of 3.33 images/s 
acquired in coronal and sagittal view without cardiac or respiratory gating. After data collection, first 
a non-rigid image registration algorithm is applied to compensate for respiratory motion. Then using 
the Fourier transformation, the signal intensity changes of the lung parenchyma related to the cardiac 
and respiratory cycle are decomposed to obtain the perfusion- and ventilation-weighted images [107]. 
Although this technique is currently only commercially available in Siemens scanner, preliminary 
results are promising (Figure 24). For example Fourier decomposition has shown high sensitivity and 
specificity to diagnose chronic pulmonary embolism [108]. Fourier decomposition has been recently 
applied in a group of pediatric CF patients [18], and it was able to provide equivalent diagnostic 
information to dynamic contrast enhanced MR imaging in CF patients. 
Figure 24. Fourier Decomposition. PROPELLER/ BLADE MRI (a) and FOURIER DECOMPOSITION MRI 
ventilation (b) and perfusion (c) maps, in patient with common variable immunodeficiency (CVID). Note in the 
morphological image darker area in the left lower lobe (black arrow), which consists of area of trapped air. In the 
correspondent ventilation map that area appears not ventilated (white thin arrow). The same area in the perfusion 
map shows reduced perfusion (thick white arrow), according the physiologic reflex of hypoxic vasoconstriction. 
Courtesy of Giovanni Morana, Ca’Foncello Treviso Hospital.
Oxygen-enhanced MRI
Oxygen-enhanced MRI (OE-MRI) is a non-invasive method that supplies information on lung 
ventilation and tissue oxygenation. OE-MRI takes advantage on the concentration-dependent 
paramagnetic effect of oxygen on T1 relaxation time, which shortens at high O2 concentration levels 
[109]. Gradient-echo readouts are used to perform T1-mapping at variable oxygen concentration 
and to compute the oxygen transfer function. Although inversion recovery single shot fast spin echo 
(IR-SSFSE) technique have been used in OE-MRI, the best results have been achieved with 3D 
radial UTE [109]. 3D radial UTE provides robust correction of cardiac motion and high CNR by 
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oversampling of the k-space center. Low cost and high accessibility of oxygen are the main advantages 
of OE-MRI technique, which is still hampered by different technical challenges. OE-MRI requires 
indeed long imaging acquisitions sessions (5-30 min), breath-hold imaging is not feasible and SNR is 
usually low when compared to other ventilation techniques, such as hyperpolarized gases MRI [109]. 
Despite these limitations OE-MRI has been used in different chronic lung diseases, such as COPD, 
asthma and CF. In patient with emphysema OE-MRI has been used to map the diffusing capacity of 
the lung [110] and to classify COPD patients accordingly to the pulmonary function loss [111]. In 
asthma patients, OE-MRI has been used to assess clinical stage and to evaluate response to treatment 
[112]. In CF, OE-MRI showed inhomogeneous ventilation compared to healthy volunteers (Figure 
25), with patchy ventilation/perfusion defects [113]. 
Figure 25. Oxygen-enhanced MRI. Coronal Oxygen-enhanced MRI in healthy volunteer at room air (a) and during 
oxygen administration (b). Note signal increase during oxygen administration for T1 shortening effect.
Hyperpolarized Gases
Hyperpolarized gas MRI (HP MRI) allows regional measures of emphysema, gas trapping and airflow 
obstruction [109]. With 3D GRE and SSFP sequences high-resolution images of lung ventilation can 
be obtained which have the sensitivity to assess regional changes in lung intervention with therapy 
[114]. With rapid 2D imaging inspiratory gas flow can be monitored and multi-breath imaging 
gas washout time constants can be mapped [115,116]. Diffusion weighted imaging with HP MRI 
measures the restriction of gas diffusivity in lung microstructure, and supply an indirect measurement 
of airspaces dimension [109]. Despite the exquisite sensitivity of HP MRI to early signs of structure-
function change in lung disease, the added complexity of the technology has so far limited its use in 
clinical practice to date. A well-known limit of HP MRI is the need of gas polarizer and multinuclear 
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technology that are not widely available [109]. Hyperpolarized gases MRI requires custom polarization 
systems for preparation of the gases and dedicated transmit/receive radiofrequency coils tuned to the 
He3 or Xe129 resonance frequency and as such is still primarily used for clinical research. Moreover 
the limited availability of 3He has also meant that clinical uptake has been limited, but 129Xe provides 
a cheaper alternative for clinical lung imaging in years to come and is now ready for evaluation 
pediatrics. Some concerns remain for the anesthetic effect of xenon, which remain to be studied in 
pediatric patients [109].
HP MRI has demonstrated the ability to detect changes in ventilation, and lung microstructure in 
different lung diseases, including COPD [117,118], asthma [119], CF [120], congenital diaphragmatic 
hernia and bronchopulmonary dysplasia [121] (Figure 26).
Figure 26. He3 MRI. Hyperpolarized helium (He3) ventilation image from a cystic fibrosis (CF) child with normal 
spirometry and normal looking computed tomography (CT). Note areas of inhomogeneous ventilation (white 
arrows). Courtesy of Jim Wild, University of Sheffield.
Fluorinated gases MRI
Fluorine-19 lung MRI (19F MRI) using inert fluorinated gases is the most recent technique for 
ventilation MRI [122]. This technique has been developed as cheaper alternative to HP MRI, but 
it can supply similar information. 19F MRI uses safe inert fluorinated gases which are abundant 
and do not need the hyperpolarization technology [122]. The two most used fluorinated gases are 
sulfur hexafluoride (SF6) and hexafluoroethane (C2F6) gases [109]. Full 3D ventilation imaging with 
reasonable breath-holding time (~ 15 sec) can be achieved with 3D radial UTE sequences [123]. The 
short T1 relaxation time of these fluorinated gases also allows repeated imaging over short temporal 
windows, so it is suited for dynamic imaging of ventilation [109]. 19F MRI has shown ventilation maps 
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comparable to HP MRI in subjects with COPD and emphysema [124]. Although these preliminary 
results showed that 19F MRI is a promising and well-tolerated technique that can be used for several 
lung diseases, a true validation with a direct comparison to HP MRI is still lacking [122]. Future works 
might eventually prove 19F MRI as a cheaper alternative to HP MRI.
Cine Studies
The high temporal resolution and the lack of radiation have made MRI suitable for studying lung 
mechanics in cine mode (cine-MRI). Fast 2D GRE and SSFP sequences with parallel imaging options 
can achieve temporal resolution ranging between 3-10 images per seconds, which are used for single 
slab dynamic assessment [125]. With the introduction of non-cartesians k-space acquisitions strategies, 
3D coverage of the entire chest in dynamic condition is now feasible [126]. In general temporal and 
spatial resolution of 3D cine-MRI is lower than 2D, but it has the advantage to account for chest 
changes in all spatial direction [126]. 3D cine-MRI allows recording the continuous lung volume 
variation during the breathing cycle, which influences chest and airways mechanics. In fact 3D cine 
MRI has recently been used as conjunct to pulmonary function test to assess airways and diaphragm 
mechanics [10,127]. Cine MRI can supply regional information not readily available with pulmonary 
function. Despite pulmonary function test is a fast and economic method routinely used in clinical 
practice, which gives functional information representing the overall respiratory system, it does not 
supply any structural or regional information [15]. MRI can supply this regional information that 
can be also correlated to pulmonary function tests data. In a comparative study, good agreement was 
found between lung volumes as measured by pulmonary function tests and MR [128]. In a different 
study, fast temporal resolution techniques, such as 3D GRE FLASH, have been used to delineate 
the diaphragmatic domes and chest wall during active breathing [129]. These techniques have been 
proven to be useful for surgical and radiotherapy planning in patients with lung cancer [130,131]. 
Cine-MRI represents a simple non-invasive method to differentiate mobility of tumors with different 
diameters and its influence on the surrounding tissue. Cine-MRI has also been proposed to assess and 
monitor pediatric patients after spinal surgery for scoliosis [132,133]. In these patients, MRI might be 
useful to understand the complex biomechanical relation between reduced vital capacity and scoliosis, 
visualizing the functional deficit of both diaphragm and rib cage expansion of the lungs during tidal 
breathing respiration and efforts [132]. In COPD and emphysema patients, cine-MRI was used to 
assess the altered chest mechanics due to hyperinflation [134,135].
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Finally, cine-MRI has also been used to assess tracheobronchomalacia in a group of pediatric patients 
[10]. This study has shown that Cine-MRI is a feasible technique, which might be an alternative to 
bronchoscopy and cine-CT for tracheobronchomalacia [10] (Figure 27). 
Figure 27. Tracheomalacia assessment with cine-MRI. 3D SPGR axial at end-inspiration (a), SPGR with Time 
Resolved Imaging of Contrast KineticS (TRICKS) dynamic during forced expiration (b), and coughing maneuver 
(c); 3 D SPGR axial at end expiration (d). Note increased collapse during breathing maneuvers compared to end 
expiration scan. 
Conclusion
MRI of the lung has reached a point that it can be used in routine clinical practice. Although MRI 
cannot yet be compared to CT in anatomical detail, new sequences allow acquisition of lung images 
with high diagnostic quality in less than 15 seconds, which makes MRI use in clinical practice feasible. 
MRI can be considered as an alternative imaging technique for CT to monitor lung diseases and 
response to the treatment. Moreover in some diseases, which require long-term follow-up, such as CF, 
MRI can play in important role to reduce lifelong radiation exposure related to repeated CT scans. 
More importantly, MRI has the ability to offer functional information, which can only be obtained 
by CT at the expense of high radiation exposure. Information about lung mechanics, perfusion and 
ventilation can give a new insight in different lung diseases. This functional information not only can 
improve our understanding about the pathophysiology of lung diseases, but also open new diagnostic 
and therapeutic options.
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Motion Corrected PROPELLER MRI:
a Comparison with CT
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Abstract
Objectives: to date, PROPELLER MRI, a breathing-motion-insensitive technique, has not been 
assessed for cystic fibrosis (CF) lung disease. We compared this technique to CT for assessing CF lung 
disease in children and adults.
Methods: thirty-eight stable CF patients (median 21 years, range 6-51 years, 22 female) underwent 
MRI and CT on the same day. Study protocol included respiratory-triggered PROPELLER MRI and 
volumetric CT end-inspiratory and -expiratory acquisitions. Two observers scored the images using 
the CF-MRI and CF-CT systems. Scores were compared with intra-class correlation coefficient (ICC) 
and Bland-Altman plots. The sensitivity and specificity of MRI versus CT were calculated.
Results: MRI sensitivity for detecting severe CF bronchiectasis was 0.33 (CI 0.09-0.57), while 
specificity was 100% (CI 0.88-1). ICCs for bronchiectasis and trapped air were as follows: MRI-
bronchiectasis (0.79); CT-bronchiectasis (0.85); MRI-trapped air (0.51); CT-trapped air (0.87). 
Bland-Altman plots showed an MRI tendency to overestimate the severity of bronchiectasis in mild 
CF disease and underestimate bronchiectasis in severe disease.
Conclusions: motion correction in PROPELLER MRI does not improve assessment of CF lung 
disease compared to CT. However, the good inter- and intra-observer agreement and the high 
specificity suggest that MRI might play a role in the short-term follow-up of CF lung disease (i.e. 
pulmonary exacerbations).
Key points: 
 – PROPELLER MRI does not match CT sensitivity to assess CF lung disease
 – PROPELLER MRI has lower sensitivity than CT to detect severe bronchiectasis
 – PROPELLER MRI has good to very good intra- and inter-observer variability
 – PROPELLER MRI can be used for short-term follow-up studies in CF
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Introduction
Cystic fibrosis (CF) is the most common genetic disease, with a reduced life expectancy in Caucasians 
[1]. Life expectancy is reduced due to progressive lung disease, characterized by several structural lung 
changes, most importantly bronchiectasis and trapped air [2,3]. To guide therapy to prevent or reduce 
bronchiectasis and trapped air, it is crucial to monitor CF lung disease at regular intervals. 
CF lung disease monitoring has changed in the last decade [4,5]. Nowadays, computed tomography 
(CT) is considered the most sensitive method to monitor CF lung disease in early and advanced stages 
[6] and is usually preferred over chest x-rays. The main disadvantage of CT is that it exposes patients 
to ionizing radiation. Therefore, CT protocols for CF are usually low or ultra-low dose [7,8]. Despite 
this relatively low radiation dose, it restricts the use of chest CT, especially in children, who are more 
sensitive to radiation exposure than adults [9]. Furthermore, ionizing radiation limits the frequency 
with which chest CT can be repeated for short and long-term monitoring of CF lung disease [10]. 
Magnetic resonance imaging (MRI), as radiation free technique, has been introduced as an alternative 
to CT [11,12]. To date, MRI has been directly compared to CT in only a few studies, using various 
MRI sequences [13-15], but none of those included motion correction free-breathing sequences, 
such as PROPELLER. The PROPELLER sequence has been designed to be relatively insensitive to 
respiratory movements, as it enables correction of in-plane motion, rotation and translation [16,17]. 
Moreover, PROPELLER is applied and increasingly proposed as a respiratory triggered sequence in 
non-compliant patients, such as patients not able to perform breath-hold maneuvers (i.e. CF children) 
[18]. Finally, to date PROPELLER has not been compared to CT for CF. Therefore, our study aims to 
assess if the breathing motion correction of PROPELLER-MRI improves diagnostic performance of 
MRI versus CT to assess CF lung disease in a group of stable CF patients, who had both examinations 
performed on the same day.
Material and Methods
Stable CF patients were consecutively recruited in two CF centers by their treating clinicians. A CF 
patient was defined stable, when no signs or symptoms of acute or recent pulmonary exacerbations 
were present as defined in the exclusion criteria. Inclusion and exclusion criteria were as follows: 
Inclusion criteria: CF proven by a positive sweat test, genotyping and clinical symptoms; willing 
and able to participate in the study; scheduled for biennial routine chest-CT scan requested by the 
attending physician; ability to comply with instructions during MRI and CT examinations; informed 
consent. 
Exclusion criteria: minimum age of 6 years old; chronic oxygen therapy; present or recent (two weeks) 
pulmonary exacerbation defined as treatment with intravenous antibiotics (non-stable); history of 
lung transplantation; participation in other trials; contraindications for MRI; possible pregnancy. 
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On the same day, prior to MRI and CT, each patient underwent a clinical examination and spirometry 
(Masterscope, Jaeger-Care Fusion, Germany). Spirometry was performed according to “ATS/
ERS guidelines” [19]. Approval for this multicenter prospective cohort study was obtained by the 
institutional review boards of both participating centers.
MRI and CT Protocol
The MRI protocol was performed in 1.5 T scanners (Avanto, Siemens, Enlargen Germany) as follows: 
16 channels torso superficial coil; PROPELLER (BLADE@Siemens) sequence proton density (PD) 
weighted with respiratory triggering (Navigator@Siemens) at end-expiration; (TR/TE/alpha/TA: 
2000/27 ms/150º/18s, Ø=5 mm) axial and coronal. Average time per acquisition was 7 to 10 minutes. 
The complete MRI protocol lasted on average 35 minutes (range 20-45 minutes).
The CT protocol was performed in 16-row or 64-row scanners (Sensation, Siemens, Enlargen, Germany) 
as follows: volumetric end-inspiratory and end-expiratory optimized-dose scans, 100 kV for children 
<35kg and 120kV for children ≥35 kg, mAs 15-40, scan range lung apices to bases, slice collimation 
1 mm, slice thickness (Ø) 1 mm, reconstruction increment 0.8 mm, pitch 1. For comparison with 
MRI, multiplanar reconstructions (axial, coronal) with slice thickness of 5mm, kernels B31f, B60f 
and B70f were obtained. Both MRI and CT protocols did not include the administration of contrast 
agent. 
Image analysis – CT and MRI 
All MRI and CT images were anonymized and scored in random order by two independent radiologists 
(G.S. and P.C.), who were experienced in scoring and with 2 and 4 years of experience in thoracic CT 
and MR imaging respectively. Both radiologists were blinded to any clinical information.
To score CTs, we used the CF-CT scoring system (CF-CT) [20]. The total CF-CT score is the sum 
of the following sub-scores: bronchiectasis; mucous plugging; peribronchial thickening; parenchymal 
score; and trapped air. Each of the 5 sub-scores is rated according to presence and severity, in each of 
the six lobes, with the lingula as a separate lobe. All score and sub-scores are expressed as a percentage 
of the maximum possible score, ranging from 0 (no pathological findings) to 100 (maximum severity). 
To score MRI images, we used a CF-MRI scoring system, equivalent of the CF-CT scoring system and 
used in previous studies [13,14]. To train both observers, MRI images of 16 patients excluded from 
final analysis due to an incomplete CT dataset (absence of end-expiratory scan) were used. Consensus 
meetings were held during and at the end of scoring all MRIs of the training set. To determine intra-
observer agreement, observer 1 (P. C.) scored all CT and MRI images twice, separated by two months 
to avoid recall bias.
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Statistical Analysis 
Inter and intra-observer agreement
Intraclass correlation coefficients (ICC) were used to evaluate inter- and intra-observer agreement 
for both MRI and CT scores. ICC values between 0.4 and 0.6, 0.6 and 0.8 or ≥0.8 are considered to 
indicate moderate, good and very good agreement, respectively [21].
To assess pairwise inter- and intra-observer agreement between MRI and CT scores Bland-Altman 
plots and identity plots were created for: 1) MRIobs1 vs. MRIobs2; 2) CTobs1 vs. CTobs2 and 3) MRIobs1 vs. 
MRIobs1 and CTobs1 vs. CTobs1. To compare MRI scores with CT scores, we evaluated MRImean obs 1+2 vs. 
CTmean obs 1+2. All statistical analyses were performed using SPSS 16.0 (SPSS, Chicago, IL), and STATA 
12.0 (STATA, College Station, TX).
Sensitivity, specificity, PPV and NPV of MRI versus CT
CF-CT bronchiectasis sub-score was used as main indicator of CF lung disease severity in order 
to determine sensitivity, specificity, positive predictive values (PPV) and negative predictive values 
(NPV) of MRI versus CT. Bronchiectasis has been recognized as a well-validated and clinically relevant 
outcome measure in CF [2]. Using chest-CT as the reference test, a cut-off value of 26% or higher, 
representing severe bronchiectasis, was defined as true-positive finding for MRI-bronchiectasis sub-
score. 26% represents the percentage of maximum possible score for bronchiectasis which is according 
to CF-CT 12 per each lobe and 72 in totals. This cut-off of 26% was based on the median value 
of bronchiectasis severity observed in 2 cohort studies, either with mild or severe CF lung disease 
[3,22], using receiver operating characteristic analysis to determine different cut-off values. Sensitivity, 
specificity, PPV and NPV, were calculated for each observer (obs1 and obs2), in addition to the mean 
of the bronchiectasis scores of both observers (mean obs1+2). 
Descriptive statistics were used to characterize the patients at the time of their MRI and CT scans. All 
scoring data are numerical with results expressed as median (range) and scores expressed as percentage 
of the maximum possible score.
Results
In this study, we enrolled 54 patients. 16 patients were excluded for the analysis because of missing the 
end-expiratory CT scans. MRIs of these 16 patients were used for training of the observers. Hence, 38 
patients with stable CF (median 21 years, range 6-51 years, 22 female), were eligible for the comparison 
of CTs and MRIs. Baseline characteristics are shown in Table 1. Prevalence of bronchiectasis, trapped 
air, total CF scores with MRI and CT represented as first and third quartiles is shown in Table 2. 
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Table 1. Baseline patients’ characteristics.
Demographic data Value
No. patients 38
Female sex 22 (56 %)
Age, years 21 (6-51)
Morphofunctional data Value 
FEV1 % predicted 75 (51.1-109.9)
Total CF-CT 25.9 (1.4-49.1)
Total CF-MRI 20.5 (0-39.6)
CT-bronchiectasis 22.7 (1.4-45.9)
MRI-bronchiectasis 18 (0-35)
CT-trapped air 46.3 (0-67)
MRI-trapped air 37 (0-66)
FEV1%=Forced expiratory volume in one second % predicted. CF-CT=Cystic Fibrosis Computed Tomography total score, CF-
MRI=Cystic Fibrosis Magnetic Resonance Imaging total score, CT-bronchiectasis=Computed tomography bronchiectasis sub-score, 
MRI-bronchiectasis=Magnetic Resonance Imaging bronchiectasis sub-score, CT-trapped air=Computed tomography trapped air 
sub-score, MRI-trapped air=Magnetic Resonance Imaging trapped air sub-score. The maximum absolute score for CF-CT/CF-MRI, 
bronchiectasis and trapped air sub-scores is 243, 72 and 27 respectively. Data are presented as median percentage of the maximum 
score and range.
Table 2. Prevalence of total MRI, total CT, bronchiectasis MRI, bronchiectasis CT, trapped air MRI and trapped air 
CT scores expressed in quartiles.
Quartiles CF-CT CT 
bronchiectasis
CT  
trapped air
CF-MRI MRI 
bronchiectasis
MRI  
trapped air
First (25%) 17 15 25.9 15.8 13 27.8
Third (75%) 36 28.9 60 29 22.7 44
CF-CT=Cystic Fibrosis Computed Tomography total score, CF-MRI=Cystic Fibrosis Magnetic Resonance Imaging total score, CT-
bronchiectasis=Computed tomography bronchiectasis sub-score, MRI-bronchiectasis=Magnetic Resonance Imaging bronchiectasis 
sub-score, CT-trapped air=Computed tomography trapped air sub-score, MRI-trapped air=Magnetic Resonance Imaging trapped air 
sub-score. Data are presented as percentage of the maximum score No. (%). For instance a CF-CT of 17 for the first quartile means 
that 25 % of the patients had a total CF-CT score to 17% of the maximum bronchiectasis score.
Inter- and intra-observer agreement MRI versus CT
Inter- and intra-observer agreement, expressed as ICCs, for MRIobs1 vs. MRIobs2, CTobs1 vs. CTobs2, 
MRImean obs 1+2 vs. CTmean obs 1+2, CTobs1 vs. CTobs1, and MRIobs1 vs. MRIobs1 are summarized in Table 3. 
In summary, the inter- and intra-observer agreement for MRI was good or very good, although lower 
than for CT. The ICCs for CF-CT sub-scores were higher compared to CF-MRI sub-scores, especially 
for peribronchial thickening and trapped air. Trapped air measurement by MRI did not match with 
CT as showed by the ICCs values: CT-trapped air (0.87); MRI-trapped air (0.51) and MRI/CT-
trapped air (0.46). 
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Finally, the intra-observer agreement for the observer 1, who repeated the score twice, was overall very 
good, but lower for MRI than for CT.
Bland-Altman and identity plots showed that PROPELLER MRI, for almost all sub-scores, tends to 
overestimate mild CF cases and underestimate severe CF cases (Figures 1, 2). 
Figure 1. Bland-Altman plot of MRImean obs 1+2 vs. CTmean obs 1+2. All scoring data are numerical and 
scores are expressed as percentage of the maximal possible score. Horizontal axis: Average bronchiectasis sub-score 
[(MRImean + CTmean)/2]; Vertical axis=Difference bronchiectasis sub-score (MRImean – CTmean). Red and green 
lines represent mean and ±2 Standard deviations (SD) respectively
Figure 2. Identity plot MRI-bronchiectasis versus CT-bronchiectasis sub-scores (mean score observer 1+ observer 2). 
Green line identity line Y=1 * X+0. Note that MRI tends to overestimate mild CF cases and underestimate severe 
CF cases (red line).
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Table 3. ICCs values of inter- and intra-observer agreement between observers for all sub-scores, CF-MRI total score 
and CF-CT total score.
CF lung alterations MRIobs1 vs.  
MRIobs2
CTobs1 vs.  
CTobs2
MRImean obs 1+2 vs.  
CTmean obs 1+2
MRIobs1 vs.  
MRIobs1
CTobs1 vs.  
CTobs1
Bronchiectasis 0.79 0.85 0.78 0.83 0.92
Air Wall Thickening 0.60 0.74 0.79 0.81 0.95
Mucus 0.79 0.91 0.76 0.90 0.94
Parenchyma 0.85 0.91 0.84 0.92 0.88
Trapped Air 0.51 0.87 0.46 0.81 0.91
Total Score 0.80 0.93 0.82 0.91 0.96
Note that Trapped Air assessment shows the lowest ICC values, indicating poor agreement of MRI with CT. Moreover Bronchiectasis 
score agreement tends to decrease between observers from CT vs. CT to MRI vs. MRI and MRI vs. CT comparison.
Sensitivity, Specificity, PPV and NPV
Sensitivity of MRI to detect severe bronchiectasis was low. Using the cut-off value of 26%, MRI 
identified six (16%) and CT fourteen (38%) patients with severe bronchiectasis. This was true for 
both observers (obs1=25%; obs2=50%) and also when the mean of both observers was used for analysis 
(mean obs1+2 = 33%). Specificity for MRI to detect severe bronchiectasis was very high: obs1=95%; 
obs2=100% and average of obs1+2 = 100%. Similarly PPV of MRI was high, while NPV was low, using 
either observer scores or the average. Sensitivity, specificity, PPV and NPV values for each observer and 
as an average of both observers are shown in Table 4.
Table 4. Differentiation of mild versus severe CF lung disease using chest-MRI.
Parameter Value C.I (95%)
Sensitivityobs1 0.25 (4/15) 0.11-0.49
Sensitivityobs2 0.50 (9/18) 0.24-0.76
Sensitivityobs1+2 0.33 (5/15) 0.09-0.57
Specificityobs1 0.95 (19/20) 0.86-1
Specificityobs2 1 (20/20) 0.90-1
Specificityobs1+2 1 (23/23) 0.88-1
PPVobs1 0.8 (3/4) 0.24-1
PPVobs2 1 (8/8) 0.8-1
PPVobs1+2 1 (6/6) 0.55-1
NPVobs1 0.64 (21/34) 0.46-0.81
NPVobs2 0.69 (20/30) 0.51-0.87
NPVobs1+2 0.63 (20/32) 0.45-0.80
PPV=Positive Predictive Value; NPV=Negative Predictive Value. Data are presented as ratio, with absolute values in brackets.
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Discussion
In this prospective two centers study, we compared a motion insensitive MRI sequence, PROPELLER, 
to CT to assess lung disease in a group of stable CF patients. This study showed that PROPELLER 
MRI is not as good as CT to assess CF lung disease. Moreover, our study confirmed low sensitivity of 
MRI compared to CT to detect trapped air. 
Firstly, we showed that despite MRI had good or very good inter and intra-observer agreement, this 
was lower than for CT. Moreover, the inter-observer agreement for MRI was lower than for CT, 
indicating that it was more difficult for the observers to score MRIs compared to scoring CTs. In 
previous studies the inter-observer agreement between MRI and CT scores ranged from moderate to 
very good, while intra-observer agreement was not assessed [13,14]. In our study, the intra-observer 
agreement was very good, thus suggesting that the technique is robust, although less sensitive than CT.
Secondly, we confirmed that trapped air could not be reliably visualized with MRI, as previously 
demonstrated by Failo et al and more recently by Rajaram et al [14,15]. Trapped air is an early change 
associated with small airways disease [3,23]. Unfortunately our MRI protocol was not sensitive enough 
to differentiate trapped air from surrounding normal lung parenchyma. However, we believe that 
innovative sequences can be added to the MR examination that might be more sensitive to detect 
trapped air, such as the recently developed Fourier decomposition [24]. 
Figure 3. Example of underestimation by chest MRI relative to chest CT. On the left the CT image during 
inspiration and on the right the correspondent PROPELLER MRI image. Note the peripheral bronchiectasis depicted 
by CT in right upper lobe tend to disappear in the correspondent MRI image (white dotted ovals). Similarly the 
small areas of tree-in bud in the left lower lobe are blurred and therefore less visible in the correspondent MRI image.
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Thirdly, in our study with PROPELLER, MRI tended to overestimate mild CF lung disease and 
underestimate severe CF lung disease compared to CT. CT appears to have superior sensitivity 
especially for changes in the periphery of the lung, where small abnormalities, such as bronchiolectasis 
and mucus plugs can be easily missed by MRI (Figure 3). To overcome this problem, it is important 
to further increase the spatial resolution of our routine MRI protocol. This is likely possible with new 
techniques, such as 3D T1 GRE sequences with radial acquisition in free breathing or in breath-hold 
condition and highly accelerated parallel imaging [25]. 
Finally, we found a low sensitivity and NPV for MRI to detect severe bronchiectasis compared to CT. 
This finding partially matches the study of Puderbach et al, where the lowest level of concordance 
between MRI and CT was for the severity of bronchiectasis [13]. Similarly, Failo et al demonstrated the 
lower spatial resolution of MRI relative to CT, especially at the periphery of the lung [14]. Conversely, 
we found a high specificity and PPV for MRI, which indicates that in case a structural abnormality is 
observed on MRI it is also visible on CT. Thus, such an abnormality on MRI can be further followed 
by MRI avoiding CT. The high specificity with the very good intra and inter-observer agreement 
of PROPELLER might result highly advantageous for short-term follow-up of CF patient with 
pulmonary exacerbation. The use of PROPELLER could allow assessing efficacy of antibiotic therapy 
without exposing patient to ionizing radiation. Moreover, PROPELLER might be even suitable for 
really young patient, who are not capable of breath-hold acquisition, or in those sick CF patients with 
reduced compliance. 
There are some limitations might have reduced agreement between MRI and CT in our study. 
The main limitation is that we evaluated a single sequence, which may have influenced the sensitivity 
of MRI to detect CF lung disease. We used a single sequence study design as in prior publications 
[13,14], because we want to assess if the motion correction technique of PROPELLER would have 
resulted in improved image quality in chest MRI by reducing the impact of respiratory movements 
[26]. However, a potential limitation of the use of PROPELLER is that this sequence can produce 
streak artifacts related to the K-space reconstruction [16,17]. To reduce this artifact we increased the 
blade width and the k-space coverage [27]. However, despite this adaptation, streak artifacts were still 
observed in about 20% of patients (Figure 4). Hence the occurrence of streak artifacts might have 
reduced the sensitivity of MRI in our study.
The second limitation, which might have affected our MRI-CT comparison, is that the image quality 
of the MRI images were partially impaired by motion artifacts related to pulsation of the heart and 
great vessels (Figure 5). We did not attempt to reduce these artifacts by using cardiac-gating since this 
would have added 5-10 minutes scan time to an already lengthy MRI protocol of 35 minutes (average 
20-45 minutes). Purposely, PROPELLER sequence was applied with NAVIGATOR technique, which 
reduced problems related to patient cooperation, especially in younger patients, since the acquisition 
was automatically triggered at the end of the expiration, independently by the respiratory pattern. A 
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disadvantage of the NAVIGATOR technique was that in children with irregular breathing it prolonged 
acquisition time.
Figure 4. Streak artifacts of propeller sequence. On the left the CT image during inspiration and on the right the 
corresponding MRI image acquired using the PROPELLER sequence. Note that streaks artifacts are visible not only 
inside the parenchyma (arrow heads), but also outside (white arrows).
Figure 5. Motion Artifacts of MRI PROPELLER (BLADE@Siemens). Note the motion artifacts around the heart 
(white arrows)
The third limitation of our study is that images were acquired using different breathing conditions for 
the CT and MRI protocols. As discussed, MRI images were acquired near functional residual volume 
level (FRC) using free breathing acquisition, while for CT bronchiectasis were assessed after a deep 
inspiration at a lung volume close to total lung capacity while trapped air was assessed at a lung volume 
close to residual volume during a breath hold maneuver at end-expiration. However, it has been shown 
that CT scans acquired near FRC overestimate trapped air relative to scans acquired near residual 
volume [28]. Therefore, our MRI protocol should have shown larger amount of trapped air compared 
to CT, but this was not the case.
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Finally, the reduced sensitivity of chest MRI relative to CT might be related to the use of our CF-MRI 
semi-quantitative scoring system. We decided to use a similar scoring strategy for MRI as for CT, to 
allow a fair comparison between sub-scores. The CF-MRI scoring system was used by our group with 
success in previous studies [13,14]. As shown by the good intra and inter observer variability both the 
CF-CT and CF-MRI scoring system can be trained reliable. It is possible that the development of 
more sophisticated scoring methods for MRI might improve the sensitivity of MRI. 
Conclusions
In conclusion, this comparison showed that motion corrected MR images acquisition with 
PROPELLER does not show a good sensitivity to assess CF lung disease, and is still not able to assess 
severity of CF lung disease with the same precision of CT. However, the good or very good inter- and 
intra-observer agreement and the high specificity suggest that MRI can be applied in the follow-up 
of CF lung disease. MRI may be used for short term follow-up of major lung abnormalities, such as 
evaluating the efficacy of intravenous treatment for a pulmonary exacerbation, and, avoiding ionizing 
radiation which is an inherent limitation of CT. Likely in future, further protocol optimization and 
alternative more sensitive image analysis techniques will allow chest MRI to playing a more important 
role in the follow-up of CF lung disease.
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Diffusion-weighted MRI (DW-MRI) as 
New Technique to Assess Inflammation in 
CF Lung Disease
Diffusion Weighted Imaging in Cystic Fibrosis 
Disease: Beyond Morphological Imaging
Ciet P, Serra G, Andrinopoulou ER, Bertolo S, Ros M, Catalano C, Colagrande S, Tiddens HAWM, 
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Abstract
Objectives: To explore the feasibility of diffusion weighted imaging (DWI) to assess inflammatory 
lung changes in patients with Cystic Fibrosis (CF)
Methods: CF patients referred for their annual check-up had spirometry, chest-CT and MRI on 
the same day. MRI was performed in a 1.5T scanner with BLADE and EPI-DWI sequences 
(b=0-600 s/mm2). End-inspiratory and end-expiratory scans were acquired in multi-row scanners. 
DWI was scored with an established semi-quantitative scoring system. DWI score was correlated to 
CT sub-scores for bronchiectasis (CF-CTBE), mucus (CF-CTmucus), total score (CF-CTtotal-score), FEV1, 
and BMI. T-test was used to assess differences between patients with and without DWI-hotspots. 
Results: 33 CF patients were enrolled (mean 21 years, range 6-51, 19 female). 4% (SD 2.6, range 
1.5-12.9) of total CF-CT alterations presented DWI-hotspots. DWI-hotspots coincided with mucus 
plugging (60%), consolidation (30%) and bronchiectasis (10%). DWItotal-score correlated (all p<0.0001) 
positively to CF-CTBE (r=0.757), CF-CTmucus (r=0.759) and CF-CTtotal-score (r=0.790); and negatively 
to FEV1 (r=0.688). FEV1 was significantly higher (p<0.0001) in patients without DWI-hotspots. 
Conclusions: DWI-hotspots strongly correlated with radiological and clinical parameters of lung 
disease severity. Future validation studies are needed to establish the exact nature of DWI-hotspots in 
CF patients.
Key points 
 – DWI hotspots only partly overlapped structural abnormalities on morphological imaging
 – DWI strongly correlated with radiological and clinical indicators of CF-disease severity 
 – Patients with more DWI hotspots had lower lung function values 
 – Mucus score best predicted the presence of DWI-hotspots with restricted diffusion. 
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Introduction
Cystic Fibrosis (CF) lung disease is characterized by chronic airways infection, inflammation and 
progressive lung damage starting in early childhood [1]. Exacerbations, acute episodes of infection and 
inflammation, eventually lead to end-stage lung disease, the main cause of death in patients with CF 
[2]. Regular monitoring that include a physical examination, spirometry, quality-of-life questionnaires 
and imaging [3], is used to detect lung changes, that require timely treatment [4]. 
To date, imaging techniques such chest x-ray (CXR) and chest-CT (CT) have been the preferred 
methods for CF monitoring, however both techniques have limitations [5]. CXR only allows detection 
of gross lung changes, such as consolidation, atelectasis and pleural effusion [5]. CT is far more sensitive 
to localize and quantify structural changes [6], however short-term follow-up with CT, for example 
during an exacerbation, is restricted by radiation exposure [7]. The latter limitation was the driving force 
to introduce MRI in CF lung monitoring [8]. Unfortunately, MRI has inferior sensitivity compared 
to CT to detect structural changes in the CF lung [9,10] due to a lower spatial resolution. However 
more recently the resolution has improved by using newly developed sequences, such as ultrashort [11] 
or zero echo time [12]. Furthermore, the interest to use MRI in CF has expanded towards functional 
imaging [13]. Multi-parametric MRI, such as Fourier Decomposition [14], hyperpolarized-gases MRI 
and oxygen-enhanced MRI [15,16], provide information not readily available with CT [17]. Diffusion-
weighted imaging (DWI) is another MRI technique that might have great potential in CF lung 
monitoring [18]. To date, DWI has been primarily used to assess malignancies in thoracic imaging 
[19]. Interestingly, DWI has proved to be accurate in the identification of inflammation in various 
organs, such as brain, spine, muscle and intestines [20-23]. Based on these studies, we investigated 
whether DWI has potential to detect inflammatory changes in CF lung disease. 
The main aims of our study were: (1) to explore the feasibility of DWI to detect lung inflammatory 
changes in CF patients, and (2) to correlate DWI with radiological and clinical indicators of CF lung 
disease severity.
Material and Methods
In this multicenter prospective cross-sectional study, patients with CF scheduled for their routine 
annual evaluation were consecutively recruited in two Italian CF centers (Treviso and Rome) by their 
treating physicians. At the clinical evaluation, each patient was informed about the study and asked 
to participate. When willing to participate, the subject was planned for the study protocol within two 
weeks from the visit. The study was approved by the institutional review board in all participating 
centers (n. 292/AULSS9 and n. 419/09). All patients underwent a physical examination, spirometry, 
chest-CT and chest-MRI on the same day. Inclusion and exclusion criteria are described in Table 1.
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
78
Chapter 4
Table 1. Inclusion / Exclusion criteria for patient selection.
Inclusion criteria Exclusion Criteria
 – Proven CF as evidenced by positive sweat test or two  
CF gene mutations
 – Scheduled for biennial routine chest-CT scan  
requested by the attending physician
 – Ability to perform reproducible maneuvers for 
spirometry
 – Ability to comply with instructions during CT and  
MRI examinations
 – Age below 6-years
 – Chronic oxygen therapy
 – Present or recent (two weeks) pulmonary exacerbation
 – History of lung transplantation
 – Participation in other trial
 – Contraindications for MRI 
 – Proved or possible pregnancy 
 – Not able or not willing to give informed consent
Physical examination and spirometry
Informed consent was obtained, and each patient underwent a clinical examination, pulse oximetry, 
and spirometry, prior to imaging. As part of the clinical exam, heart and respiratory rate, weight and 
height were recorded. Spirometry was performed according to the ATS/ERS guidelines [24].
CT and MRI Protocol
The routine biennial CT protocol consisted of volumetric end-inspiratory and end-expiratory low-
dose scans in a 16- or 64-row scanner (SOMATOM Sensation, Siemens, Erlangen, Germany) using 
the following parameters: 120kV for patients ≥35 kg,100 kV for patients <35kg, mAs 15-40, no 
contrast agent, 1 mm collimation, slice thickness 1 mm, reconstruction increment 0.8 mm, pitch 1. 
Five mm axial and coronal reformats with kernels B31f, B60f and B70f were obtained to match the 
slice thickness of MR images. 
In addition to the routine CT protocol a chest MRI was performed on the same day. The MRI protocol 
consisted of respiratory-triggered scans using a 16 channel torso coil in a clinical 1.5 T scanner, with 
the following parameters: axial and coronal BLADE sequence proton-density (PD)-weighted with 
navigator (TR/TE/alpha/: ∞/28 ms/90º, in plane resolution 1.2x1.2 mm and slice thickness 5 mm) 
and T2-weighted axial BLADE sequence (TR/TE/alpha=2000ms/27ms/150°, in plane resolution 
3.2x2.5 mm and slice thickness 5 mm). DWI was acquired using a single-shot echo-planar imaging 
sequence (EPI) in the axial plane, with gradients equal in all directions (readout, phase and slice-section 
orientations). DWI was obtained with b values of 0 and 600 s/mm2 (TR/TE/alpha=5632ms/83ms/90°, 
slice thickness 5 mm, gap 0 mm, 2 average). All sequences were acquired at end-expiration during 
free-breathing using navigator echoes respiratory triggering. The MRI protocol was identical in both 
CF centers, which had the same MRI scanner (MAGNETOM Avanto, Siemens Healthcare, Erlangen, 
Germany).
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Image analysis
All CT and MRI images were anonymized and evaluated in random order by two radiologists (P.C. 
and G.S.), with 4 years and 1 year of experience in thoracic CT and MRI scoring, respectively. Both 
radiologists were blinded to any clinical information and to each other’s CT and MRI assessment. 
Prior to this study, both radiologists were trained in the CF center of Erasmus MC (Rotterdam, the 
Netherlands) to the CF-CT and CF-MRI scoring systems [25], which were used to score the CT 
and BLADE MR images [26].The total score is the sum of the individual sub-scores per lobe of the 
following parameters: bronchiectasis (CF-CTBE); mucus plugging (CF-CTmucus); air wall thickening 
(CF-CTAWT); trapped air (CF-CTTA) and parenchyma (CF-CTPAR) [26]. Sub-scores and total scores are 
expressed as % of the maximal possible score. 
DWI images were scored in random order using a semi-quantitative scoring approach which has been 
used in previous studies [27-29]. This qualitatively analyzes the signal intensity of lung lesions with 
altered signal intensity (hotspots). Each hotspot was visually graded on a three-point score scale by 
signal intensity: score 0, no signal; score 1, weak signal and score 2, strong signal. Signal intensity 
was judged using the highest b-value (b=600 s/mm2) images, compared to the signal of the spinal 
cord. Spinal cord was used as the reference structure as it has constant high signal intensity on high b 
values as a result of the anatomical organization of the sagittal nerve fascicles, and it is alongside the 
entire chest. When the DWI signal of lung parenchymal hotspots was lower than that of the cord, it 
was graded as “weak” (DWIweak score, score=1), whereas if the signal was greater than or equal to that of 
the cord it was graded as “strong” (DWIstrong score, score=2). The total DWI score (DWItotal score) is the 
sum of all weak and strong hotspots for each of the 6 lung lobes, with lingula considered a separate 
lobe. A quantitative analysis was not performed based on the poor reliability of the apparent diffusion 
coefficient (ADC) maps due to residual motion and susceptibility-induced distortions. Following 
DWI scoring, using fusion technique (Image Fusion, Siemens Healthcare, Erlangen, Germany) 
between DWI and correlated morphological image (axial BLADE), the anatomical substrate and the 
distribution of the DWI hotspots was identified. In uncertain cases, the CT was used as reference 
image. The percentage of structural CT changes presenting hotspots in DWI images was computed as 
a ratio between the DWItotal score and the CF-CTtotal score. Anatomical substrates with DWI signal were 
categorized in a similar fashion to the CF-CT and CF-MRI scoring system (Online supplement digital 
content 1).
Statistical analysis
For each patient, the mean DWI score of the two observers was used to assess frequency and 
distribution of the anatomical substrates with DWI signal. Inter-observer agreement for the CF-CT, 
CF-MRI and DWI scoring methods was assessed using the intraclass correlation coefficient (ICC) and 
Bland-Altman plots. ICC values between 0.40-0.60; 0.60-0.80; and ≥0.80 are considered to represent 
moderate, good and very good agreement, respectively.
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Pearson’s correlation was used to measure the strength of the association between DWI score and clinical 
and radiological parameters reflecting disease severity. These parameters included: forced expiratory 
volume in one second (FEV1 % predicted); Body Mass Index (BMI); CF-CTBE; CF-CTmucus; and 
CF-CTtotal score. According to Cohen’s criteria correlations with r between 0.10 and 0.29 are considered 
weak, between 0.30 and 0.49 moderate and above 0.50 strong [30]. Multiple comparisons were 
adjusted using the Bonferroni correction. Differences in continuous variables between patients with 
and without DWI hotspots were examined using a Student t-test. 
Finally, data were analyzed using mixed-effects models to investigate whether there was an association 
between specific covariates and the outcomes of interest, while accounting for the correlation within 
the same patients [31]. The covariates tested in the model were BMI, FEV1, sex, CF-CTBE, CF-CTmucus 
and score of each observer (score observer 1 versus observer 2). The outcome tested for these covariates 
were: DWIweak score, DWIstrong score and DWItotal score. The Akaike information criterion (AIC) was used to 
investigate which model performs better [32]. The lowest AIC coefficient defines the best model for 
the given data, and differences in AIC coefficient greater than 5 points are considered significant [32]. 
Differences were statistically significant if p<0.05. Statistical analysis was performed with SPSS (version 
20.0, SPSS, Chicago, IL, USA) and R (version 3.1.3, the R foundation for statistical computing, 
Vienna, Austria). 
Results
After 12 months of recruitment (April 2011-March 2012) period, thirty-eight consecutively selected 
patients with CF (mean age 24 years, range 6-51 years, 22 females) were enrolled in the study. Five 
subjects were excluded for incomplete study protocol, so eventually thirty-three patients with CF were 
used for data analysis. (mean age 21 years, range 6-51 years, 19 females). Patients’ characteristics, CT 
and DWI scores are summarized in Table 2. 
Distribution and anatomical substrates of DWI signal
A mean number of 6 (SD 5.2, range 0-17.5) weak and 6.9 (SD 8.4, range 0-32) strong DWI hotspots 
were identified. DWI hotspots were distributed in decreasing order in the right upper lobe (mean 
25.4%, SD 8.4, range 0-37.9%), right lower lobe (mean 24.7%, SD 6.8, range 16.3-50%), left 
lower lobe (mean 21.5%, SD 6.9, range 10-36.7%), left upper lobe (mean 13.5%, SD 3.6, range 
6.7-20.6%), right middle lobe (mean 8.2%, SD 5.4, range 0-18.2%) and lingula (mean 6.7%, SD 3.1, 
1.5-13.3%). The most frequent structural lung alterations as examined on axial BLADE with either 
weak or strong DWI signal were mucus plugging (mean 61%, SD 35, range 0-100%), followed by 
consolidation (mean 26.5%, SD 16.8, range 0-54%), and bronchiectasis (mean 12.5%, SD 9.3, 
range 0-37.5%). The DWI hotspots pattern only partially overlapped the structural lung changes on 
morphological MRI or CT, and only 4% (SD 2.6, range 1.5-12.9%) of total CF-CT structural lung 
changes presented DWI hotspots.
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Table 2. Patients’ characteristics.
 Mean Standard deviation Range
Clinical parameters
BMI (kg/m2) 19.1 3.4 12.9-29.9
FEV1 % predicted 71.8 25.2 24-113.4
CT scores
CT-BE (%) 22.4 10.6 3.5-43.8
CT-Mucus (%) 21.7 13.7 0-44.4
CF-CT (%) 25.1 11.6 2.7-45.1
DWI scores
Weak DWI score 6.0 5.2 0-17.5
Strong DWI score 6.9 8.4 0-32
Total DWI score 20.4 14.0 1-54
BMI=Body Mass Index, CT-BE=Computed tomography bronchiectasis sub-score, CF-CT=Cystic Fibrosis Computed Tomography 
score, CT-Mucus=Computed tomography mucus plugs sub-score, DWI=Diffusion Weighted Imaging, FEV1%=Forced expiratory 
volume in one second % predicted. All CT score and sub-scores are expressed as a percentage of the maximum possible score, ranging 
from 0 (no pathological findings) to 100 (maximum severity). The maximum possible scores for CF-CT, CT-BE and CT-mucus 
sub-scores are 243, 72 and 36 respectively. DWI scores are expressed as mean score of the two observers for each patient.
Reliability of DWI score
Overall, inter-observer agreement for CF-CT and CF-MRI sub-scores was good or very good, except 
for the trapped-air sub-score. ICCs for CF-CT and CF-MRI are presented as table in the online 
supplement digital content 2BLINDED. Inter-observer agreements for DWIweak score, DWIstrong score and 
DWItotal score were good: ICC 0.76 (C.I. 95%, 0.55-0.87), 0.74 (C.I. 95%, 0.43-0.87) and 0.7 (C.I. 95%, 
0.04-0.89), respectively. Bland-Altman and identity plots showed that observer 2 had systematically 
higher DWItotal score scores than observer 1 (Figure 1). Bland-Altman and identity plots for total DWI 
hotspots identified by each observer are presented as online supplement digital content 3.
Correlations of DWI signal with clinical and radiological parameters
Total DWI score had strong positive correlation with CF-CTBE (r=0.757 observer 1, r=0.510 observer 
2), CTmucus (r=0.759 observer 1, r=0.584 observer 2) sub-scores, and CF-CTtotal score (r=0.790 observer 
1, r=0.618 observer 2) (Figure 3). DWItotal score had strong negative correlation with FEV1 (r=-0.688 
observer 1, r=-0.611 observer 2) (Figure 2): FEV1 in patients without DWI hotspots (n=11) was 
significantly higher (p<0.0001) than those of patients with DWI hotspots. BMI did not correlate with 
DWItotal score and no significant differences in BMI were found between the groups with or without 
hotspots. 
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Figure 1. (a) Bland-Altman for Total DWI score observer 1 (Obs1) versus observer 2 (Obs2). Thick line is the 
mean, dashed lines are ±2 standard deviations (SD). (b) Identity Plot Total DWI score observer 1 versus observer 
2. The continuous line is the identity line (y=1*x+0), dashed line is the correlations line. Note that observer 2 had 
higher scores than observer 1 (mean difference ~9).
Figure 2. (a) Correlation of total diffusion weighted imaging (DWI) score with total cystic fibrosis computed 
tomography score (CF-CT score). (b) Correlation of total DWI score with forced expiratory volume in 1 second 
(FEV1). Continuous lines are correlation lines, dashed lines are 95% confidence intervals. Note strong positive 
correlation of total DWI score with total CF-CT score (Pearson r=0.717, p<0.0001), and strong negative correlation 
with FEV1 (Pearson r=-0.649, p<0.0001). Mean score of the two observers were used to build the plots.
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Relationship of covariates in DWI scores: mixed-model analysis
For the DWIstrong outcome, the model with the covariate CF-CTmucus (AIC=398.6) was better than 
the model with FEV1 (AIC=406.2). However, there were no significant differences in AIC coefficient 
between the model with FEV1 or CF-CTmucus covariates when tested for the DWIweak and DWItotal score 
outcomes (DWIweak: AIC-FEV1=367.4, AIC-CF-CTmucus=368; DWItotal score:AIC-FEV1=447, AIC-
CF-CTmucus=446.9). Therefore, we considered the best predictive model for all three DWI outcomes 
(weak, strong and total DWI) that including CF-CTmucus but not FEV1. The final model included 
the covariates: BMI, sex, observer score, CF-CTBE, CF-CTmucus. In this model the CF-CTmucus and 
observer score covariates were significant for the DWIstrong, and for DWItotal score. For the DWIweak score 
outcome, the CF-CTBE covariate was significant, while CF-CTmucus tended to be significant (p=0.052). 
Mixed-model analysis results are summarized in Table 3. Figure 3 shows effect plots for each DWI 
score outcome (DWIweak score, DWIstrong score and DWItotal score) based on the mixed-effects model analysis.
Figure 3. Effects plots for diffusion-weighted imaging (DWI) scores outcomes (a) weak, (b) strong, and (c) total 
DWI score; and CF-CTmucus covariate. Each plot has two curves, one for each observer. Y-axis represents DWI scores 
while x-axis the CF-CTmucus sub-score expressed as % of maximum score, which is 36 for mucus. Each plot simulates 
changes in CF-CTmucus sub-score according DWI scores for patients with mean BMI, mean CF-CTBE sub-score and 
male gender. For instance, an increase of about 10% in CF-CTmucus sub-score (c) produces an increase of DWItotal score 
of almost 3 points. Note that, although observer 2 has overall higher total DWI scores (c); the slope of the relation 
between DWItotal score and CF-CTmucus sub-score is the same as for observer 1.
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Discussion
To our knowledge, this is the first study that has used DWI to assess CF lung disease, and several 
observations can be made from these results. 
The most important observation is that DWI hotspots only partially overlapped the structural lung 
changes as seen on morphological CT or MRI (Figure 4). Moreover, the DWI signal for the same 
parenchymal abnormality on MRI in a single patient was very different. For instance, mucous plug 
as observed on MRI in a lobe could show different signal intensities, from no signal to a very intense 
signal (Figure 5). Similar variability was also observed for other structural lung changes, such as 
consolidation and bronchiectasis, which were the most frequent structural lung changes presenting a 
DWI signal. We speculate that the observed differences in DWI signal intensity might be related to 
the severity of local inflammation, based on differences in the cellularity of the structure examined and 
consequently in differences in the restriction of proton movement.
Figure 4. (a) End-inspiratory axial CT, (b) Free-breathing PD-weighted axial BLADE image, and (c) diffusion-
weighted imaging (DWI) free breathing (b=600 s/mm2). Note that DWI signal (hotspot) only partially overlaps 
the left lower lobe consolidation, with the most peripheral portion presenting the highest signal (arrow). This indicates 
that the lesion has non-homogenous DWI characteristics, with the most peripheral portion having more restricted 
diffusion.
Alternative explanations are that increased DWI signal intensity depend on an increased capillary 
perfusion in relation to inflammation, which can be detected by DWI as D* (pseudo-diffusion 
coefficient) associated with blood flow [33]. However, pseudo-diffusion was not assessed in our MRI 
protocol, as intravoxel incoherent motion imaging was not applied [34]. Furthermore, differences 
in DWI signal intensity (weak vs. strong) among the structural lung changes could be related to 
differences in water concentrations caused by T2-shine-through artifact [35]. To overcome this, we 
assessed and scored the DWI images in the highest b-value (b=600 s/mm2), with reduced T2-shine-
through effect (Figure 5). 
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Figure 5. (a) End-inspiratory axial CT, (b) free-breathing PD-weighted axial BLADE image, (c) Diffusion 
Weighted Imaging (DWI) free breathing (b=0 s/mm2) and D) DWI (b=600 s/mm2). A large bronchiectasis filled 
with mucus can be appreciated in the right lower lobe (arrow in b) Note heterogeneous DWI signal decay in highest 
b-value of the mucus-filled bronchiectasis (arrow in c and d), although it persists in the dorsal branch due to persistent 
restricted diffusion (arrowhead in d).
The second important finding is that DWI scores correlated well with radiological and clinical 
indicators of CF lung disease severity. DWI scores had a strong positive correlation with CF-CT score 
and a moderate negative correlation with FEV1. In particular, the higher the DWI score, the higher 
the CF-CT score, or the lower the DWI score, the lower the FEV1. These correlations suggest that 
patients with more severe CF lung disease have a larger number of DWI hotspots. This observation is 
also supported by the findings that there were significant differences in FEV1 between patients with 
and without DWI hotspots. 
The third important observation is from the mixed-model analysis, which shows that for the DWIstrong 
outcome, the best model (lowest AIC coefficient) was the model that included the CF-CTmucus sub-score 
instead of the FEV1 covariate. DWIstrong score represents those hotspots with high DWI signal, which 
suggests a restricted diffusion. Paired with the finding that mucus was also the most frequent alteration 
associated with DWI signal, it suggests that mucus significantly contributes to the “inflammatory” 
DWI hotspots in CF lung disease. This is not unlikely as reduced mucus clearance is considered to be 
the primary cause of chronic airway infection and inflammation in CF [1]. 
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We acknowledge some limitations to this study. First, we used a semi-quantitative scoring system to 
assess DWI signal and did not compute ADC maps. The main reason was that the ADC maps were 
not reliable due to residual motion and susceptibility-induced distortions. Part of these distortion 
artifacts was counterbalanced by doubling the number of averages during image acquisition. More 
than two averages combined with respiratory-triggered acquisition were not feasible, as it would have 
led to unacceptably long acquisition times of the DWI sequence (>10 minutes). For these reasons, 
we used a semi-quantitative approach that has proved to be reliable in previous studies, with high 
sensitivity and specificity [29]. Moreover, this method showed good agreement between the observers. 
Second, there were significantly different scores between the observers as shown by the Bland-Altman 
plots and by the mixed model analysis (observer score covariate). However, correlations using the 
individual scores of each observer instead of taking the mean scores of both observers obtained the 
same significant and concordant results (Table 3). Hence, it is unlikely that the differences in scores 
between the observers had any impact on our most important findings. The development of a fully 
quantitative approach will overcome this inter-observer limitation, by providing objective ADC maps 
that are independent of observer variability. For now, we are improving the image quality of our DWI 
protocol, to facilitate the use of ADC maps for future studies.
Finally, we did not objectively assess the exact nature of these DWI hotspots. However, our study 
had the main aim to investigate the information obtainable with DWI in CF lung disease. Clearly, 
further studies are needed to validate this technique in CF patients suffering from a pulmonary tract 
exacerbation. 
Conclusions
In summary, this study is the initial exploratory phase towards the development of DWI as technique 
to quantify lung inflammation in CF lung disease. We observed that the DWI hotspots pattern 
only partly overlapped structural abnormalities on morphological CT or MRI. In addition, DWI 
scores had a strong correlation with radiological and clinical indicators of CF lung disease severity. 
Significant differences in pulmonary function (FEV1) were found between patients without and with 
DWI hotspots. Finally, we found that the amount of mucus in patients with CF was the best predictor 
of strong DWI hotspots (restricted diffusion).
These compelling results have established the foundations for future validation studies in CF patients 
with pulmonary exacerbation, to establish the exact nature of these DWI hotspots. 
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DWI scoring sheet. DWI signal is assessed in highest b-value images (b = 600 s/mm2). Signal intensity 
(SI) of DWI hotspots is compared to SI of the spine and scored 1 when SI hotspots is lower than SI 
spine, or scored 2 when SI hotspot is equal or greater of SI spine. The number of hotspots is counted 
per lobe, with the lingula considered a separate lobe. Moreover, each hotspot is identified in the same 
categories defined in the CF-CT and CF-MRI scoring system. RUL=Right upper lobe, RML=Right 
middle lobe, RLL=Right lower lobe, LUL=Left upper lobe, Lin=Lingula, LLL=Left lower lobe
Online supplement digital content 3. (a) Bland-Altman for total number of DWI hotspots identified by 
observer 1 (Obs1) and observer 2 (Obs2). Thick line is the mean, dashed lines are ±2 standard deviations (SD). (b) 
Identity Plot total DWI hotspots Obs1 versus Obs2. The continuous line is the identity line (y=1*x+0), dashed line is 
the correlations line. Note that that Obs2 detected more hotspots than Obs1 (mean difference ~3).
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Evidence before the study
Despite there is no clear understanding of respiratory tract exacerbation (RTE) in Cystic Fibrosis 
(CF) lung disease, it is universally accepted that acute infection and inflammation are two important 
components of RTE. Several blood-based inflammatory biomarkers have been proposed to monitor 
RTE, but their clinical usefulness is limited. Other methods to assess inflammation, such as 
bronchoalveolar lavage (BAL) or positron emission tomography (PET) are not feasible as a routine 
clinical tool, mainly because BAL is an invasive procedure and PET exposes patients to relatively high 
doses of radiation. Hence, there are no established, sensitive and safe techniques available to monitor 
lung inflammation over the short time course of a RTE. Recently, diffusion weighted MRI (DW-MRI) 
has been developed as a non-invasive method to assess tissue inflammation, and has been used to 
quantify inflammation in several organs, such as brain, liver, muscle, and intestine. 
Added value of this study
This study demonstrates for the first time that DW-MRI is a sensitive and safe method to monitor 
lung inflammation during RTE. We have shown that DW-MRI is a reliable and accurate biomarker 
to distinguish an RTE from the baseline variability that is part of clinical stability in CF lung disease. 
More importantly, we also showed that DW-MRI is a good test to localize and objectively quantify the 
severity of inflammation during RTE.
Implications of all the available evidence
The most important implication is that DW-MRI may serve to monitor the therapeutic effectiveness 
of antibiotic and anti-inflammatory medications during CF RTE. In children age 6 years and older, 
spirometry remains the preferred method to assess recovery of lung function values to pre-RTE levels. 
However, spirometry only gives an overall assessment of the lung and a wide regional variability can 
be expected, with persistent foci of inflammation despite RTE treatment. Our method represents a 
non-invasive and safe alternative to visualize these foci to guide BAL when needed, and to use as an 
outcome measure for tailored therapies. Furthermore, DW-MRI can improve our understanding of the 
patho-physiology of RTE and explain why one quarter to half of the patients with CF do not achieve 
pre-RTE lung function levels following treatment. This study will be of considerable interest to a broad 
audience, because DW-MRI has potential to be applied in other lung diseases where inflammation is 
a major component. Finally, our method could have important implications for testing effectiveness of 
new anti-inflammatory drugs for early phase clinical trials. 
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Abstract
Background: Currently there are no established, sensitive and safe techniques available to monitor 
lung inflammation during cystic fibrosis (CF) respiratory tract exacerbations (RTE). We investigated 
whether diffusion-weighted magnetic resonance imaging (DW-MRI) detects inflammatory and lung 
function changes over the course of RTE treatment in patients with CF. 
Methods: 29 patients with CF and RTE underwent DW-MRI pre and post antibiotic treatment. A 
control group of 27 stable patients with CF, matched for age and sex, underwent DW-MRI with the 
same time gap as those undergoing RTE treatment. Clinical status and lung function were also assessed 
at each DW-MRI time point. The CF-MRI scoring system was used to assess structural lung changes 
in both CF groups. 
Findings: Significant reduction in the DW-MRI score over the course of antibiotic treatment 
(p<0·0001) was observed in patients with RTE, but not in the control group. DWI score had a strong 
inverse correlation with clinical status (r=-0·504, p<0·0001) and lung function (r=-0·635, p<0·0001) 
in patients with RTE. Interestingly, there were persistent significant differences in the CF-MRI score 
between the RTE and control group at both baseline and follow-up (p<0·001), while the differences 
in DWI score were only observed at baseline (p<0·001). The intra and inter-observer agreement for 
DWI score was excellent (ICC-inter=0·877-0·904; ICC-intra=0·9-0·939).
Interpretation: DW-MRI is a promising imaging biomarker for noninvasive quantification of 
pulmonary inflammation during RTE, and may be used to assess treatment efficacy or to test new 
anti-inflammatory drugs.
Funding: Italian Cystic Fibrosis Foundation (FFC).
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Introduction 
Cystic Fibrosis (CF) lung disease is characterized by chronic airways infection and inflammation, 
respiratory tract exacerbation (RTE), and progressive lung damage, starting in early childhood [1]. 
RTE is defined by acute infections with more severe symptoms, reduced pulmonary function test 
(PFT) parameters, and radiographic changes [2]. During RTE, it is important to localize and monitor 
inflammatory changes to assess the efficacy of treatment [3]. To date, such information cannot be 
obtained accurately by physical exam, laboratory tests or PFT, due to their limited sensitivity to 
regional abnormalities [4]. 
Structural changes related to RTE are assessed mostly by chest x-ray (CXR) or by chest CT (CT), 
depending on the center [5]. CXR is the first imaging method used for RTE because of its low-cost, 
low radiation dose and availability. CXR is not useful however, in determining whether a patient 
with CF is having a RTE [6]. In contrast, chest CT localizes and quantifies early regional structural 
and inflammatory lung changes [7]. However, short-term monitoring with CT for RTE is limited by 
radiation exposure, particularly in children [8]. To date, few techniques have been used to monitor 
inflammatory changes in CF [9]. PET-CT has been proposed, but its’ use is also restricted by high 
radiation exposure and cost [10]. Besides PET-CT, Lung Clearance Index (LCI) and Fraction of Exhaled 
Nitric Oxide (FeNO) have been used to quantify lung inflammation, but like with spirometry, they 
do not provide regional information [11,12]. Consequently, a reliable and radiation-free technique to 
localize and quantify lung inflammatory changes during RTE is still needed.
Magnetic resonance imaging (MRI) [13] can fulfill the requirements of a reliable and safe monitoring 
tool for RTE. MRI does not require ionizing radiation and enables safe short-term monitoring needed 
for RTE [13]. Among the available MRI techniques, diffusion-weighted MRI (DW-MRI) is accurate 
in the identification of inflammation in various organs [14] and can provide functional information 
regarding inflammation [14]. To date, DW-MRI has been mostly used to characterize malignant 
thoracic lesions [15]. Only recently, DW-MRI has been used to discriminate between lung cancer and 
post-obstructive pneumonia [16], and to detect lung alterations in patients with primary antibody 
deficiencies [17].
For these reasons, we conducted a cross-sectional study in a group of stable patients with CF, where 
DW-MRI showed foci of high signal (“hotspots”), which only in part overlapped the structural lung 
changes on morphological CT or MRI [18]. We also observed that DW-MRI scores had a strong 
correlation with radiological and clinical parameters indicators of CF lung disease severity [18]. In 
addition, there were significant differences in PFT parameters between patients with and without 
DW-MRI hotspots [18]. 
Driven by these compelling results, we sought to investigate whether DW-MRI: 1) is able to 
differentiate between stable patients with CF and those with RTE; 2) is able to track changes over the 
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course of RTE treatment; 3) correlates with established clinical parameters of CF lung disease severity 
and 4) shows a relationship with structural lung changes established by CF MRI score during RTE.
Material and Methods
For full details of the methods see the online appendix.
Study design and patient enrolment 
This single-center prospective study was approved by the local ethical committee (protocol n. 314/
AULSS9). Following informed consent, patients with CF admitted for RTE treatment underwent a 
study protocol that included clinical examination, spirometry, and MRI on the same day. For each 
RTE patient enrolled, the next suitable CF subject without RTE in the previous 6 months was selected 
for the control group. Controls were CF subjects recruited during the annual follow-up and matched 
with RTE subjects for age, sex, mean FEV1 in the previous 6 months before the visit. General inclusion 
and exclusion criteria for cases and controls are described in Table 1. 
Table 1. General inclusion and exclusion criteria for both groups.
Inclusion criteria Exclusion criteria
 – Proven CF as evidenced by positive sweat test or gene mutation
 – Ability to perform reproducible maneuvers with spirometry 
 – Ability to comply with MRI procedures 
 – FEV1 (% predicted) ≥40
 – Age ≥8 years old
 – Chronic oxygen therapy
 – Isolation of Burkholderia cepacia
 – Lung transplantation
 – Participation in another trial 
 – Any contraindications to MRI
 – Pregnancy 
 – Not able or not willing to give consent
 – Allergic bronchopulmonary aspergillosis
Patients with RTE repeated the study protocol following completion of a course of intravenous 
antibiotic treatment. Similarly, control subjects repeated the study protocol over the same median 
time gap as the RTE group.
Clinical examination, laboratory and pulmonary function tests
Clinical examination included physical exam, heart and respiratory rate measurements, oxygen 
saturation, weight and height. Spirometry was performed according to “ATS/ERS guidelines” using 
a Masterscope (Jaeger-Carefusion, Hoechberg, Germany) spirometer [19]. The following parameters 
were recorded: forced vital capacity (FVC), Forced expired volume in one second (FEV1) % predicted 
and forced expiratory flow at 25-75% (FEF25-75).
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RTE was defined and scored according to the Rosenfeld criteria for pulmonary exacerbation (PEX 
score) [20]. The criteria and the scoring system are listed in the online supplement (Table E1).
MRI Protocol
Each subject in the RTE group underwent a chest MRI at admission (baseline) and at the end of 
antibiotic treatment (follow-up). The same median time gap (20 days) was used for subjects in the 
control group.
MRI was performed at 1.5 Tesla (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany) 
using morphological and functional sequences. Morphological sequences included axial and coronal 
end-expiratory triggered PROPELLER (BLADE@SIEMENS) with proton density (PD) weighting 
[21], and breath-hold axial and coronal SSFP (TrueFISP@SIEMENS). 
The functional data were acquired in the axial plane using diffusion-weighted DW-MRI. DW-MRI 
measures the random Brownian motion of the extra-cellular water molecules in the body. In biologic 
tissues, this motion is dependent and limited by interactions with cell membranes and macromolecules. 
In dense cellular tissues or in case of cellular swelling this water motion is reduced or “restricted”, 
because of reduced extracellular space and by cell membranes. Tumors, edema and inflammation are 
all characterized by restricted diffusion. 
DW-MRI provides two types of images: the native DW images, which are repeated at least twice, 
varying a parameter in the sequence called “b value”, and the post-processed Apparent Diffusion 
Coefficient (ADC) map. The former allows a qualitative assessment of tissue diffusion, where tissue 
with restricted diffusion appears bright at high b values (b value varies from 0 to >1000 mm/s2). As 
high water content (independently from restriction: e.g. cyst) can also provide high signal intensity 
on native DW images, ADC map are obtained allowing correct characterization. These post-processed 
images derived from the native DW acquisitions integrate the information obtained by different b 
values and allow quantitative measurements of tissue diffusion, where restricted diffusion appears 
dark while non-restricted diffusion appears white. Detailed description of the DW-MRI protocol is 
provided in the online supplement. 
Image analysis
MRI images were anonymized and evaluated in random order by two radiologists (V.T. and S.B.), 
with 4 and 8 years of experience in thoracic MRI scoring respectively. Both radiologists were blinded 
to any clinical information and to each other’s MRI assessment. BLADE and TrueFISP MR images 
were scored with the CF MRI scoring system. DW images were scored in random order using a 
semi-quantitative scoring approach which has been used in previous studies [22,23]. A more detailed 
description of the CF MRI and DWI scoring systems is provided in the online supplement. 
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DW images were also assessed quantitatively with ADC maps [24]. A region of interest (ROI) was 
placed in the largest pulmonary area with restricted diffusion on ADC maps by using a freehand 
tracing tool. Adjacent vessels and areas with susceptibility artifact caused by air-tissue interface were 
excluded from image analysis. ROI of the same size and location was placed on ADC maps from MRI 
at baseline and follow-up in both groups. 
Statistical analysis
Descriptive statistics, Q-Q plots and the Shapiro-Wilk tests were used to test data normality. To assess 
baseline difference between the groups, we used the unrelated t-test and the Mann-U-Whitney test. To 
assess difference between baseline and follow-up MRI, we performed the related t-test and Wilcoxon 
test. 
Inter- and intra-observer agreement for the CF-MRI and DWI scoring methods was assessed using the 
intraclass correlation coefficient (ICC) and Bland-Altman plots.
Pearson’s correlation was used to measure the strength of the association between DWI score and 
clinical, spirometry and radiological parameters reflecting disease severity. These parameters included: 
PEX score, FEV1 % predicted, FVC, FEF25-75, and total CF MRI score (CFMRITOT). Multiple 
comparisons were adjusted using the Bonferroni correction. According to Cohen’s criteria, correlations 
with r between 0·10 and 0·29 are considered weak, between 0·30 and 0·49 moderate, and above 0·50 
strong [25]. 
Receiver operating characteristic (ROC) curve were used to determine accuracy of DW-MRI to 
detect patient with CF and RTE. Accuracy was expressed as area under the curve (AUC). AUC values 
between 0·90-1, 0·80-0·90, 0·70-0·80, 0·60-0·70 correspond to an excellent, good, fair and poor 
accuracy respectively [26].
Finally, using mixed-effects models the outcome total DWI score was tested for the following covariates: 
time (baseline versus follow-up) + group (RTE vs control) + time*group, observer (scores observer 
1 versus scores observer 2) and observer*time. The covariates “time*group” and “observer*time” 
specify the factorial interaction between time points within the group and observers. Differences 
were considered statistically significant if p-value was <0.05. Statistical analysis was performed with 
SPSS (version 20.0, SPSS, Chicago, IL, USA) and R (version 3.1.3, the R foundation for statistical 
computing, Vienna, Austria). 
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Results
Patients’ Characteristics
Fifty-six patients with CF were enrolled in the study (mean age 24 years, range 12-58 years, 35 female). 
Twenty-nine subjects were included in the RTE group (mean age 24 years, range 13-48 years, 20 female) 
and twenty-seven subjects in the control group (mean age 23 years, range 12-58, 15 female). Subjects 
were correctly matched for age and sex between the groups. PEX score (p<0·001), DWI score (p=0·002) 
and ADC (p<0·001) were significantly different between the RTE and control group at baseline, but 
not at follow-up. CF-MRI scores between the groups were significantly different at both time points. 
Patients’ characteristics, spirometry, CF-MRI, DWI scores and ADC are summarized in Table 2.
Table 2. Patients’ characteristic, PFT, CF-MRI,DWI scores and ADC.
Parameters Controls RTE p-value
Age (years) 18.50 (15-31) 21 (17-36) 0.3
Sex (M/F) 12/15 9/20 0.2
FEV1_6M 85.9 (25.4) 69.7 (21.7) 0.011*
FVC_6M 97.3 (14.2) 85.7 (14.9) 0.004*
FEV1_t0 88.2 (17.6) 70.7 (19.5) 0.001*
FVC_t0 98.6 (13.3) 81.9 (21.8) 0.01*
FEF25-75_t0 68.8 (31.8) 44.2 (23.8) 0.002*
FEV1_t1 88.3 (18.9) 77.3 (19.5) 0.036*
FVC_t1 96.7 (14.2) 86.9 (15.6) 0.016*
FEF25-75_t1 68.6 (33.4) 52.6 (27.9) 0.053
PEX_t0 0 4.5 (4.1-5.9) <0.001*
PEX_t1 0 1.2 (0-1.2) 0.1
CF-MRI_t0 16.2 (11-36) 42 (25-61) <0.001*
CF-MRI_t1 16 (1-34.5) 39 (18-56) 0.002*
DWI_t0 7 (0-16.7) 22 (9-26) 0.002*
DWI_t1 9 (0-17.7) 13 (5-19) 0.179
ADC_t0 1.55 (1.49-1.64) 1.26 (1.21-1.46) <0.001*
ADC_t1 1.56 (1.48-1.61) 1.57 (1.35-1.63) 0.9
Parameters are presented as median (25-75 percentiles) or mean (standard deviation) according variable’s distribution. FEV1_6M=forced 
expiratory volume in 1 second % predicted six months before baseline MRI; FVC_6M=functional vital capacity six months before 
baseline MRI; FEV1_t0 and FEV1_t1=FEV1 at baseline MRI (t0) and follow-up MRI (t1); FVC_t0 and FVC_t1=functional vital 
capacity at t0 and at t1; FEF25-75_t0 and FEF25-75_t1=forced expiratory flow 25-75% at t0 and t1; PEX_t0 and PEX_t1=pulmonary 
exacerbation score at t0 and t1; CF-MRI_t0 and CF-MRI_t1=cystic fibrosis magnetic resonance imaging score at t0 and t1; DWI_t0 
and DWI_t1=Diffusion-weighted imaging total score at t0 and t1; ADC_t0 and ADC_t1= Apparent Diffusion Coefficient at t0 and t1. 
Significant differences between the groups are indicated by asterisk (*).
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Differences between baseline and follow-up MRI
The RTE group showed significant differences between baseline and follow-up MRI for spirometry, 
PEX score, CF-MRI score, DWI score and ADC (all p<0·0001). Conversely, no significant differences 
were found in the control group between baseline and follow-up for all parameters. Table 3 summarizes 
differences between baseline and follow-up MRI within the groups. Figure 1 shows changes of PEX 
score, FEV1 and DWI score between the groups in time.
Figure 1. Changes in (a) pulmonary exacerbation score (PEX), (b) forced expiratory volume in 1 second (FEV1) 
and (c) total diffusion-weighted imaging score (DWI) between case (dotted lines) and control (continuous 
lines) groups. X-axis represents baseline (t0) and follow-up (t1) time points, while the y-axis of each plot represents 
unit of measure for each variable. Note that RTE group (dotted lines) has significant changes in PEX score, FEV1 and 
DWI score, while the control group (continuous line) remains stable.
Correlations
The DWI score had a strong inverse correlation with FEV1 and FEF25-75 at baseline (FEV1 r=-0·635; 
FEF25-75 r=-0·611; all p<0.0001) and follow-up (FEV1 r=-0·633; FEF25-75 r=-0·626; all p<0.0001). 
DWI score had a strong positive correlation with PEX score at baseline (r=0·504, p<0.0001), but 
not at follow-up (r=0·364, p=0.005; not significant after Bonferroni). ADC had a strong negative 
correlation with PEX score at baseline (r=-0·634, p<0·0001), but not at follow-up (r=-0·43, p=0·766). 
DWI score had a strong positive correlation with CFMRITOT at baseline (r=0·809, p<0·0001) and 
follow-up (r=0·767, p<0·0001).
ROC curves
Figure 2 shows ROC curves for DWI score and ADC. DWI score had a fair diagnostic accuracy 
(AUC=0·73, C.I. 0·59-0·86, p=0·003). For the DWI score a cut-off of 14 had a sensitivity of 73% 
and a specificity of 68%. ADC maps had a good diagnostic accuracy (AUC=0·818, C.I. 0·69-0.94, 
p<0·0001). For the ADC maps, a cut-off value of 1.45*10-3 mm2/s had a sensitivity of 72% and a 
specificity of 84%. 
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Table 3. Differences in spirometry, clinical and MRI parameters between baseline (t0) and follow-up (t1) MRI.
Parameters Controls RTE
Baseline Follow-up p-value Baseline Follow-up p-value
FEV1 88.2 (17.6) 88.3 (18.9) 0.976 70.7 (19.5) 77.3 (19.5) <0.0001*
FVC 98.6 (13.3) 96.7 (14.2) 0.33 81.9(21.8) 86.9 (15.6) <0.0001*
FEF25-75 68.8 (31.8) 68.6 (33.4) 0.948 44.2 (23.8) 52.6 (27.9) <0.0001*
PEX 0 0 0.805 4.5 (4.1-5.9) 1.2 (0-1.2) <0.0001*
CMFRI 16.2 (11-36) 16 (1-34.5) 0.824 42 (25-61) 39 (18-56) <0.0001*
DWI 7 (0-16.7) 9 (0-17.7) 0.652 22 (9-26) 13 (5-19) <0.0001*
ADC 1.55 (1.49-1.64) 1.56 (1.48-1.61) 0.178 1.26 (1.21-1.46) 1.57 (1.35-1.63) <0.0001*
Parameters are presented as median (25-75 percentiles) or mean (standard deviation) according variable’s distribution. FEV1=forced 
expiratory volume in 1 second % predicted; FVC=functional vital capacity; FEF=forced expiratory flow at 25-75%; PEX=pulmonary 
exacerbation score; CF-MRI=cystic fibrosis magnetic resonance imaging score; DWI=Diffusion-weighted imaging total score; 
ADC=Apparent Diffusion Coefficient. Significant differences are indicated by asterisk.
Figure 2. Receiver operating characteristic (ROC) curve for DWI score (a) and ADC (b). Note higher diagnostic 
accuracy of ADC measurements than DWI score to differentiate patient with CF and respiratory tract exacerbation.
Mixed-model analysis
Mixed-model analysis showed that total DWI score outcome was significantly different between the 
groups (group: value=13·3, Std. Error (SE)=3·1, p=0·0003) and that it significantly reduced between 
baseline and follow-up MRI for the RTE group (group*time: value=-5.2, SE=1.4, p=0.0003). There 
were no significant differences in DWI total score between the observers (observer: value=0·7, SE=1·3, 
p=0·58). Moreover the trend of DWI total score between baseline and follow-up was the same for both 
observers (observer*time: value=0·26, SE=0·8, p=0·74). Figure 3 shows effect plots for total DWI score 
outcome based on the mixed-effects model analysis.
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Figure 3. Effects plots for total diffusion-weighted imaging (DWI) score outcome (Tot_DWI) and “time” 
covariate. Each column represents a different observer (observer 1 versus observer (2), while each row represents 
control (group (1) and RTE (group 2) groups. Y-axis represents total DWI score while x-axis the baseline (t0) and 
follow-up (t1) time points. Each plot simulates changes in total DWI score between the time points and the groups. 
Dotted lines are confidence interval lines.
Reliability of DWI score
Inter-observer agreement at baseline and follow-up MRI was excellent for all sub and total DWI 
scores: sub-score A (ICC baseline=0·918; ICC follow-up=0·904), sub-score B (ICC baseline=0·895; 
ICC follow-up=0·873), and total DWI score (ICC baseline =0·904; ICC follow-up=0·877). Also 
intra-observer agreement was excellent: sub-score A (ICC baseline =0·947; ICC follow-up=0·920), 
sub-score B (ICC baseline=0·936; ICC follow-up=0·894), and total DWI score (ICC baseline=0·939; 
ICC follow-up=0·9). Larger variability for both observers was noted at follow-up MRI as shown by 
lower ICC values compared to baseline. Bland-Altman plots did not show systematic differences 
between the observers. Bland-Altman plots for inter- and intra-observer agreements are presented as 
online supplement materials (Figures E3 and E4). 
Discussion
We showed that DWI score and ADC detected the clinical changes related to RTE as determined by 
the PEX score and spirometry parameters. DWI provides a noninvasive method to quantify pulmonary 
inflammation in CF patients with RTE, supporting its potential as radiation-free imaging biomarker 
for lung inflammation to assess therapy efficacy during RTE.
The most interesting observation is that in patients with RTE, following antibiotic treatment, native 
DWI signal at high b values showed a significant reduction overall (Figure 4). Conversely, in the 
control group without RTE, no significant differences in DWI signal between baseline and follow-up 
were observed. This was confirmed both by the DWI score and by the ADC. More importantly these 
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findings were also confirmed by mixed-model analysis after adjustment of confounders (i.e. observer’s 
score), which showed a different trend of DWI score between baseline and follow-up between groups. 
These observations strongly support the concept that DWI can track inflammatory changes over the 
course of RTE treatment. 
Figure 4. DWI changes pre (a-c) and post (b-d) RTE treatment in CF patient with respiratory tract exacerbation. 
Left column is imaging at baseline and right column is at follow-up. Upper row displays morphological free-breathing 
BLADE (Siemens) images, while lower row DW images at b=800 mm/s2. Note that left lower consolidation (open 
arrow in a) with high DWI signal (open arrow in c) became smaller after RTE treatment (close arrow in b) and DWI 
signal also reduced (close arrow in d).
The second interesting finding is the relationship between CF-MRI and DWI scores. In the RTE 
group, CF-MRI score was significantly different between baseline and follow-up at the end of 
treatment. The CF-MRI scores between the RTE and control groups were significantly different at 
baseline and follow-up. This confirms the findings of prior studies that CF patients with more severe 
lung disease are at greater risk of developing an RTE [27,28]. Interestingly, DWI score and ADC were 
significantly different at baseline, but not at follow-up. This difference in DWI can be important to 
assess the acute changes of RTE. Prior studies have shown limited correlation between inflammatory 
biomarkers and reversible structural components assessed by chest x-ray and CT [6,29]. For example, 
a consolidation or mucus plug could remain following antibiotic treatment, while the severity of local 
inflammation was reduced, or vice versa (Figure 5). The ability of DWI to track acute changes related 
to RTE could be of value to assess treatment efficacy of RTE and to develop new treatment strategies 
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for RTE. The sensitivity of the DWI technique may allow such studies to proceed using relatively small 
number of patients.
Figure 5. Relation between morphological and functional lung changes during respiratory tract exacerbations 
in CF patient. Left column is imaging at baseline and right column is at follow-up. Upper row contains morphological 
free-breathing BLADE (Siemens) images (a-b), while lower row are DW images at b=800 mm/s2 (c-d). Note small 
consolidation in the lingula (open arrow in a) with high DWI signal (open arrow in c). After RTE treatment this 
consolidation is still present (close arrow in b), but the DWI signal has disappeared (close arrow in d), showing a 
discordant pattern between morphological and functional images.
The third important finding is the strong positive correlation of DWI and ADC with PEX score and 
strong negative correlation with FEV1 and FEF25-75. Moreover, DWI score and ADC did not correlate 
with PEX and CF-MRI score at the follow-up scan at the end of treatment. Additionally, CF-MRI 
score had a stronger correlation with FEV1 than with DWI score. These correlations confirm the 
discrepancy between structural and functional MR lung changes during RTE, where CF-MRI better 
reflects the severity of structural lung disease, while DWI reflects more the acute inflammatory changes 
related to RTE.
The fourth important finding was the fair to good accuracy of DWI score and ADC to differentiate 
patients with CF treated for a RTE. The better diagnostic performance of ADC than DWI score 
confirms the superiority of the quantitative assessment provided by ADC map, compared to the semi-
quantitative DWI score.
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The last noteworthy finding is that both DWI score and ADC are robust parameters with low intra- 
and inter-observer variability. The strength of our DWI score was also confirmed after adjustment of 
confounders with mixed-model analysis. This supports the usefulness of our scoring method in clinical 
trials focused on RTE treatment.
We acknowledge some limitations to this study. Firstly, we did not obtain direct samples of the DWI 
hotspots which we deemed to be inflammatory. This would have required bronchoscopy, an invasive 
procedure not routinely performed during RTE in our institution and not standard clinical of care in 
CF centers. However, the differences between observations in the RTE and control group showed that 
the DWI signal is often dissociated from the structural changes as quantified by the CF-MRI score. We 
indeed proved that only the RTE group had significant difference in DWI score and ADC between the 
baseline and follow-up. Based on our promising results, we aim to perform further validation studies 
that include BAL to investigate difference between lung areas with and without hotspots and/or pre 
and post RTE therapy. Another option would be to perform a comparison of the DWI technique 
with PET-MR. The radiation burden of PET-MR is about 70% lower than PET-CT and will allow a 
simultaneous comparison between DWI and PET hotspots [30]. 
Lastly, we acknowledge that this is a single-center study, therefore for further clinical translation, 
our method needs to be tested in a larger cohort multi-center study. Despite these limitations, this 
study represents the next important phase towards validating DWI as tool to quantify pulmonary 
inflammation. 
Conclusions
Our study demonstrated that DWI score and ADC detected the clinical changes of patients with CF 
treated for a RTE with fair to good accuracy. Moreover, DWI score and ADC were strongly correlated 
with symptom score and spirometry measures in these patients.
DW-MRI is a noninvasive promising imaging biomarker for a radiation-free quantification of 
pulmonary inflammation during RTE in the CF population. DWI has potential to assess treatment 
efficacy during RTE in CF patients and to develop new therapies for RTE treatment.
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Supplementary Material
Methods
This was a cross-sectional observational study of patients with cystic fibrosis (CF) with and without 
respiratory tract exacerbation (RTE). All subjects with RTE attended on a two occasions, whilst 
admitted for RTE (baseline) and after antibiotic therapy (follow-up), and underwent a series of 
clinical, lung function and radiological examinations during the same visit. Similarly, control subjects 
repeated the study protocol over the same median time gap as the RTE group. Visits took place 
between September 2011-September 2013. Parents/guardians signed informed consent and paediatric 
subjects provided assent.
Patient selection
Respiratory tract exacerbation group
No universally accepted definition of a respiratory tract exacerbation (RTE) exists. A general 
definition, described as “clinical need for additional treatment as indicated by acute changes in clinical 
parameters”, has been recently adopted by the Eurocare CF Working Group [1]. These acute changes 
during RTE include: change in sputum; increased cough; increased malaise; fatigue or lethargy; 
anorexia or weight loss; decrease in spirometry outcomes by 10% or more or radiographic changes; 
and increased dyspnea. These changes are also used by the Rosenfeld criteria to score the clinically 
likelihood of RTE in patient with CF (Table E1) [2]. All subjects enrolled in the study were scored 
with the Rosenfeld criteria for RTE both at baseline at follow-up in.
Table E1. Rosenfeld criteria for respiratory tract exacerbations.
Rosenfeld Criteria PEX scoring system
 – Reduced exercise tolerance
 – Increased cough
 – Increased sputum/cough congestion
 – School or work absenteeism
 – Increased adventitial sounds on lung examination
 – Reduced appetite
 – Reduced FEV1 (≥10% predicted)
 – Each criterion is assigned a coefficient
 – PEX score is the sum of the coefficient per each criterion 
when present
 – Threshold value to define RTE is 2.6
PEX=pulmonary exacerbation scoring system, RTE=respiratory tract exacerbation, FEV1=Forced expiratory volume in 1 sec.
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Clinically stable CF patients – Control group
Clinically stable patients with CF were asked to participate to the study at the annual follow-up 
visit. Clinically stability was defined when patient had no signs or symptoms of RTE in the previous 
6 month to the visit. Each control subject was selected after inclusion of an RTE group subject and 
matched for age, sex, and mean of FEV1 in the previous 6 months before the visit.
Study protocol
The study protocol consisted of clinical examination, spirometry and magnetic resonance imaging 
(MRI). Each RTE subject performed the study protocol at admission (baseline) and after antibiotic 
treatment (follow-up). Each control subject performed the study protocol twice with the similar 
median time gap (~20 days) of RTE subjects.
Clinical examination
Clinical examination started with collection of recent patient history, in particular variation on 
coughing, amount and color of sputum, dyspnea, exercise tolerance, and work or school absenteeism. 
Physical exam consisted of heart and respiratory rate measurements, O2 saturation, weight and height 
recording for body mass index measurement, oral and ear inspection, cardiac and lung auscultation. 
During the clinical examination, was also performed the PEX score to define whether the subject with 
CF had or not RTE.
Spirometry
Repeated spirometry efforts were performed until 3 acceptable maximal maneuvers were obtained 
according to “ATS/ERS guidelines” using a Masterscope (Jaeger-Carefusion, Hochberg, Germany) 
spirometer [3]. When spirometry traces showed evidence of incomplete expiration, cough, and air leak 
were repeated. Acceptable repeatability was obtained when the difference between the largest and next 
largest maneuvers was ≤100 ml or 5% depending on which was the larger value. The recorded result for 
Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) was the highest achieved 
across all technically correct efforts, with the ratio calculated from this FEV1/FVC and reduction in 
forced expiratory flow at 25-75% of the FVC (FEF25-75) were expressed as % of predicted value.
MRI
MRI was performed at 1.5 Tesla (MAGNETOM Avanto, Siemens Healthcare, Erlangen, Germany) 
using morphological and functional sequences. 
Morphological sequences included axial and coronal end-expiratory triggered Periodically Rotated 
Overlapping ParallEL Lines with Enhanced Reconstruction (PROPELLER; SIEMENS brand name, 
BLADE) with proton density (PD) weighting (TR/TE/alpha/TA: 710/26 ms/150°/4’ 25’’, voxel size 
1 x 1 x 6 mm3; bandwidth 601 Hz/pixel, slice gap 0 mm, average n=4) [4], and breath-hold spirometry 
gated axial and coronal steady state free precession (SSFP; SIEMENS brand name, TrueFISP) with 
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T2/T1 weighting (TR/TE/alpha/TA: 229/0.99 ms/66°/14’’, voxel size 2.3x2.3x6 mm
3; bandwidth 
1291 Hz/pixel, slice gap 0 mm, average n=1). 
The functional data were acquired in the axial plane using a diffusion-weighted (DW) single shot 
echo-planar imaging (EPI) sequence prototype (TR/TE=4800 ms/54ms, voxel size 2.5x2.5x6 mm3; 
bandwidth 1644 Hz/pixel, slice gap 1.8 mm, average n=3) with end-expiratory triggering. Eleven 
b-values at different time intervals (0, 10, 20, 30, 50, 70, 100, 150, 200, 400, 800 s/mm2) were 
acquired in three orthogonal directions. The entire MRI scan required approximately 25-30 min. 
Image analysis
Image analysis was conducted using the picture archiving and communication system (PACS) 
SYNAPSE (Fujifilm Healthcare Europe, Dusseldorf, Germany). MRI images were anonymized and 
evaluated in random order by two radiologists (V.T. and S.B.), with 4 and 8 years of experience in 
thoracic MRI scoring respectively. Both radiologists were blinded to any clinical information and to 
each other’s MRI assessment.
Morphological scoring system: CF-MRI scoring system
Morphological images BLADE and TrueFISP were scored with the Cystic Fibrosis MRI scoring system 
(CF-MRI), a scoring system derived from the Brody scoring system and adapted to MRI [4,5]. This 
scoring system evaluates the five lung lobes and lingula as the sixth lobe. The CF-MRI scores assess the 
following components: bronchiectasis, mucus plug, parenchymal changes (atelectasis, consolidation, 
ground-glass), trapped air. Differently from CT, air wall thickening is combined with bronchiectasis 
in the CF-MRI, because of the lower spatial resolution of MRI [4]. For the same reason, the pattern 
of trapped air is not scored in CF-MRI, as this has previously been shown to be unreliable [4]. A 
composite score for each component is calculated and expressed as a percentage of a maximum score, 
on a 0-100 scale. The higher the score the more severe the disease.
Diffusion Weighted Imaging (DWI) Analysis
DW images and Apparent Diffusion Coefficient (ADC) maps: qualitative and 
quantitative analysis
The sensitivity of the DWI technique to water motion depends on scanner’s parameters, which 
are summarized by the b-value, expressed as sec/mm [6,7]. Water molecules with a large degree of 
motion (i.e. fluid) will have a fast DWI signal decay with high b-values. Conversely, slow-moving 
water molecules show a lower DWI signal decay with large b-values. DWI is typically performed 
using at least two b values to enable meaningful interpretation [8]. The interpretation of the relative 
attenuation of DWI signal intensity on images obtained at different b values, allows the analysis of 
different tissue components. For instance, in a tumor with cystic and solid components, the cystic 
portion will show greater signal decay on high b-value images because water diffusion is less restricted. 
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By contrast, the more cellular solid portion will show relatively high signal intensity at high b-value 
[8]. Therefore, in case of tumors and inflammation high DWI signal (bright) can be visually assessed at 
high b-values. However, this qualitative visual assessment is limited by the T2 shine-through artefact, 
where tissues with long T2-relaxation time have high DWI signal at high b-value, despite normal 
water diffusion [7]. This potential source of error can be eliminated by using an apparent diffusion 
coefficient ADC map, which is an average image obtained by DWI signal at different b-values. Areas 
of restricted diffusion in highly cellular tissue have low ADC values compared with less cellular areas 
that return higher ADC values. It is important to notice that areas of restricted diffusion will appear 
as low-signal intensity areas (dark) on ADC map, and as high-signal intensity areas (bright,) on DW 
images (opposite to ADC maps). Hence, ADC maps are complementary to DW images for a correct 
interpretation of DWI signal.
Table E2. DW imaging analysis.
Parameter Score
Presence of hotspot  – Score 1: presence of hotspots greater than 5% of lobe volume
 – Score 0: no hotspot
Extension  – Score 1: hotspots occupying a volume smaller than 33% of the lobe
 – Score 2: hotspots occupying a volume between 33% and 67% of the 
lobe
 – Score 3: hotspots occupying a volume greater than 67% of the lobe
Signal Intensity (SI) dominant hotspot  – Score 1: SI hotspots greater than SI cord spine
 – Score 0: SI hotspots smaller than SI cord spine
Mean signal intensity (SImean)  – Score 1: mean SI hotspots within a lobe is greater than SI of cord spine
 – Score 0: mean SI hotspots within a lobe is smaller than SI of cord 
spine
Sub-score A  – A=(E + SI)
Sub-score B  – B=(E + SImean)
Total DWI score (DWI)  – DWI=P+A+B
DW images were scored using a semi-quantitative scoring system which assesses each lobe using the following parameters: presence of 
hotspot (P), extension of hotspot (E), signal intensity of the dominant hotspot (SI) and average signal intensity of the hotspots within 
a lobe (SImean). For each lobe, we obtained two sub-scores: A=(E + SI) and B=(E + SImean). The total DWI score is the sum of P + A + B, 
and the maximum possible score is 54. The DW images with the highest b-value (b= 800mm/sec2) were scored. 
In this study, we combined a semi-quantitative scoring system to score DW images and quantitative 
measurement performed on ADC maps. The DWI scoring system presented in table E2 describes 
how the lesions with high-signal intensity on DW images with high b value, defined as hotspots, were 
quantified. This method proved to be reliable in previous studies, with high sensitivity and specificity 
[9-12].
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ADC map were used to objectively quantify diffusion in those dominant pulmonary lesions, which 
showed restricted diffusion at high b-values [13]. A region-of-interest (ROI) of the same size and 
location was positioned in these dominant lesions with restricted diffusion on ADC maps, on both 
baseline and follow-up MRI. Adjacent vessels and areas with susceptibility artifact caused by air-tissue 
interface were excluded from image analysis.
Results
Score reliability
Figure E3. Inter-observer agreement for total DWI score. Bland-Altman plot of inter-observer agreement (observer 
1 versus observer (2) at (a) baseline and (b) follow-up MRI. Note that mean differences are close to zero and that all 
observations are around the mean.
Figure E4. Intra-observer agreement for total DWI score. Bland-Altman plot of intra-observer agreement (observer 
1, one month time gap between scores) at (a) baseline and (b) follow-up MRI. Note that mean differences are close 
to zero and that all observations are around the mean.
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Abstract 
Objectives: To compare trapped air (TA) on MRI (MRITA) to TA on chest CT in the year before 
(CTTA-pre) and after (CTTA-post) the MRI, and to regions of hypoperfusion (HP) on contrast-enhanced 
chest MRI (CEMRIHP) and to pulmonary function tests (PFT). 
Methods: During their annual examination patients with CF underwent MRI, CEMRI spirometry 
and plethysmography. CEMRI was scored for TA and HP and CT for TA using CF-MRI and CF-CT 
scoring systems. Descriptive statistics were used to compute the extent of TA and HP and Pearson test 
to assess association between TA, HP and PFT parameters.
Results: Twenty-six patients were enrolled (mean 14 years, range 8-18, 11 female). TA and HP were 
observed in 12/24 (50%) and 17/24 (71%) patients respectively. MRITA correlated with CTTA-pre, 
(r=0.54, p=0.008), CEMRIHP (r=0.66, p<0.0001), and FEF75 (r=-0.54, p=0.006). MRITA was smaller 
compared to CTTA-pre, and CTTA-post (z=-3.52; p<0.0001). MRITA was not significant different from TA 
as established by plethysmography (z=-1.154; p=0.24). CEMRIHP was significantly larger than MRITA 
(p=0.008).
Conclusions: TA as observed on CT and MRI is a mix of TA and HP. For CT the term TA can be 
better replaced by low-attenuation region (LAR) and for MRI by low-intensity region (LIR).
Keywords: magnetic resonance imaging, perfusion magnetic resonance imaging, pulmonary function 
tests, trapped air, hypoperfusion, mosaic pattern.
Key points 
1. Hypoperfusion is more frequent and significantly larger than trapped air 
2. For CT and MRI the term trapped air is a misnomer
3. ‘Trapped air’ on CT can better be named low-Attenuation Region (LAR) 
4. ‘Trapped air’ on MRI can better be named Low-Intensity Regions (LIR)
5. LAR on expiratory CT is larger than LIR on expiratory MRI
6. The role of HP and potential therapies should be further investigated
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Introduction
Regions of low attenuation as detected on chest computed tomography (CT) scans are a common 
finding of cystic fibrosis (CF) lung disease [1]. These regions are present in early stage CF lung disease 
and often match areas of structural changes [2]. Radiologists described these regions with the term 
mosaic pattern, which can represent either trapped air (TA) or hypoperfusion (HP) due to hypoxic 
vasoconstriction [3]. It is also recognized that low attenuation regions can be a mix of HP with or 
without TA [4]. 
Traditionally, TA has been quantified using pulmonary function tests (PFT) using body 
plethysmography and helium dilution tests. Unfortunately, these techniques have not been well 
validated [5,6]. Clearly, PFT are not able to detect HP. Using chest CT in combination with a contrast 
agent, we can measure the contribution of TA and HP to the observed regions of low attenuation. 
However, contrast agent is not routinely administered by those CF centers, which have included chest 
CT as a routine examination in the annual CF follow-up [7]. The main reason for this is the 1.5 times 
higher radiation exposure needed for a perfusion CT study compared to a standard chest-CT [8] as 
well as the risk to adverse reaction to contrast agents [9]. Over the last decades, chest MRI has been 
developed as alternative technique to assess CF lung disease [10]. By administration of gadolinium-
based contrast agents, perfusion can be assessed with contrast-enhanced magnetic resonance imaging 
(CEMRI) techniques [11]. In addition, MRI can also be used to detect TA, by using expiratory scans 
with short or ultra-short echo-time (TE) sequences [12,13]. Therefore, MRI allows to visualize both 
TA and HP in a single session without the use of ionizing radiation [14]. A disadvantage of using 
gadolinium-based contrast agents for routine chest MRI protocol in CF, is that it introduces a small 
risk related to the use of the contrast agent [15]. The importance of acquiring both ventilation and 
perfusion information in CF lung disease has recently been highlighted as a novel biomarker to assess 
therapy efficacy of respiratory tract exacerbations [16]. Before CEMRI can be recommended, the 
diagnostic advantage over PFT and CT should be further investigated. To date, no study has directly 
correlated PFT estimates of TA to CT and MRI estimates of TA and to HP as assessed by CEMRI 
[4,16-18]. 
The main aims of this study were: 1) to compare TA on expiratory MRI (MRITA) to TA on chest 
CT performed in the year before (CTTA-pre) and after (CTTA-post) the MRI, and 2) to establish the 
contribution of HP using CEMRI (CEMRIHP) to regions of MRITA and 3) to compare MRITA and 
CEMRIHP regions to PFT parameters of TA and small airways disease.
Materials and Methods
This cross-sectional prospective single centre study was approved by the ethical committee of the 
Erasmus MC (MEC 2007-289). Patients with CF in the Erasmus MC Sophia Children’s Hospital 
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have a biennial chest CT starting at the age of 1 year and a biennial chest MRI starting at the age 
of 8 years. Those patients, who were scheduled for their annual examination that included a routine 
biennial MRI, were informed about the study at least three weeks before the annual examination, and 
informed consent was obtained the day of the visit. For this study, CEMRI was added to the routine 
MRI protocol. Inclusion and exclusion criteria are presented as online supplement material in Table 
1E. 
Physical examination, blood sample, and PFT
On the day of the annual visit, each patient underwent physical examination, weight and height 
measurements, PFT, microbiology, and blood withdrawal for blood chemistry and hematology. For 
the purpose of the study the blood withdrawal was executed using an indwelling peripheral intravenous 
catheter that was left in place after the withdrawal for later contrast agent infusion. 
Before the MRI, each study patient performed spirometry test according to “ATS/ERS guidelines 
[19] during sitting and supine positions using a spirometer (Masterscope, CareFusion, Houten, The 
Netherlands). Each patient was instructed on how to perform the breathing manoeuvres needed during 
the scans. The following forced expiratory flows and volumes were recorded: forced vital capacity 
(FVC), forced expiratory volume in 1 second % predicted (FEV1), forced expiratory flow at 75% 
(FEF75). Additionally, Total Lung Capacity (TLC) was measured using whole body plethysmography 
(TLCbb,) and helium dilution (TLCHe) [20]. Using these techniques we computed TABB-He using the 
formula TLCBB-TLCHe/TLCBB. The PFT protocol took approximately 30 minutes. 
MRI, CEMRI and CT protocols
MR images were acquired in a 1.5 T Signa Hdxt MRI (General Electric Healthcare, Milwaukee, WI, 
USA) using the whole body coil for radiofrequency excitation and an eight-channel torso coil for 
signal reception. The protocol consisted of unenhanced and Gd-enhanced images with administration 
of gadopentetate dimeglumine (Magnevist, Bayer Schering Pharma, Berlin, Germany), 0.2 mL/kg at 
2 ml/sec followed by 20 ml saline flush. Non-contrast images included 2D steady-state free precession 
(SSFP) sequences at end-inspiration and end-expiration in the axial, coronal and sagittal planes. Scan 
parameters have been previously reported [21]. 
CEMRI consisted of end-expiratory 3D spoiled gradient echo (SPGR) sequence with time 
resolved imaging of contrast kinetics (TRICKS) platform and the following scan parameters: 
TR/TR/α=2.1ms/1ms/12°, bandwidth=63.84 MHz, averages=0.5, in plane resolution=1.4x2.3 mm, 
slice thickness=5 mm, and average temporal resolution of 1.5 sec per phase (40 phases in 60 sec). The 
MRI protocol lasted about 35 minutes.
CT volumetric inspiratory and expiratory images were acquired using a 6-slice multi-detector CT 
scanner (Somaton Emotion, Siemens Medical Solutions, Erlangen, Germany). CT scan parameters 
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are described in Table 2E of the online supplement. CT scans were performed with spirometry control 
[22].
Imaging Analysis
All MR and CT images were anonymized and scored in random order in the Advantage Windows 
Server (General Electric Healthcare, Milwaukee, WI, USA) imaging platform. For the purpose of 
this study we used two scoring systems. The first observer, with 7 years of experience in chest scoring, 
scored separately MRI and CEMRI scans using the CF-MRI scoring system, which is an adapted 
version of the CF-CT scoring system that was used in previous studies [23,24]. The use of the CF-MRI 
scoring system allows comparing CF related findings between the CT and MRI images. 
To compare the extent of TA and HP between MRI and CT, the first observer scored TA on CT images 
obtained in the year prior (CTTA-pre) and after (CTTA-post) the MRI using the CF-CT scoring system 
[25,26]. It is well recognized that the total volume of TA on chest CT does not change significantly 
over a two-year interval [27]. However, the pattern of TA can change of this time interval. For the 
purpose of this study, we scored only the extent of TA on expiratory CTs (CTTA) to match the CF-MRI 
TA sub-score (MRITA) [27]. CTTA was scored in 8 mm axial reformats, to match slice thickness of MR 
images, using sharp kernel (B70s) and standard window setting: window width=1500 Hounsfield Unit 
(HU) and window length=-450 HU. All score and sub-scores were expressed as a percentage of the 
maximum possible score, ranging from 0 (no pathological findings) to 100 % (maximum severity).
A second observer, with 3 years of experience in chest scoring, scored simultaneously MRI and 
CEMRI scans using the newly developed PatteRn OverlaPping Rotterdam (PROPeR) scoring system 
to determine if HP as depicted by CEMRI was larger, equal or smaller than TA as depicted by MRI. 
In short, the PROPeR scoring system overlaps the end-expiratory MRI with CEMRI by using 
imaging registration techniques, which allow scoring per lobe of the differences between TA and HP 
(TA/HPlobe). For instance, when the extent of HP is 0-25 % larger than the extent of TA a score of 1 
is assigned; vice versa a score of -1 is assigned when TA is 0-25% larger than HP. When HP overlaps 
TA, a score of zero is assigned.
The first and second scorers were blinded for each other’s scores. A more detailed description of both 
MRI scoring systems is available in the online supplement (Table 3E-4E and Figure 1E-3E).
Statistics
Descriptive statistics were used for patient characteristics and to describe the extent of MRITA, CTTA 
and CEMRIHP. Intra-observer variability of the MRITA and CEMRIHP were evaluated with Intraclass 
Correlation Coefficient (ICC) and Bland-Altman plots. ICC values of <0.20, 0.21-0.40, 0.41-0.60, 
0.61-0.80 and 0.81-1 are generally considered to represent poor, fair, moderate, good and very good 
observer variability, respectively [28]. The MRITA was compared to CEMRIHP using Wilcoxon test for 
paired samples. In addition, the observer evaluated independently using the PROPeR scoring system, 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
120
Chapter 6
pairs of CT and MRI scans without patient identifiers to evaluate whether CTTA was more, the same 
or less relative to MRITA and CEMRIHP. 
Finally, Spearman test was used to correlate MRITA, CTTA, CEMRIHP, and PFT parameters. According 
to Cohen’s criteria correlations with an r between 0.10 and 0.29 are considered weak, between 0.30 
and 0.49 moderate and above 0.50 as strong [29]. Statistical analyses were performed using SPSS 
version 20.0 for windows. Continuous variables are displayed as mean (±Standard Deviations) or 
median (interquartile range) depending on data distribution. P-values less than 0.05 (two tailed) were 
considered statistically significant. Multiple correlations were adjusted using Bonferroni correction.
Results
Fifty-nine patients with CF were asked to participate in the study. Thirty-three declined to participate 
in the study primarily because of the required contrast injection. Twenty-six consecutive patients 
were enrolled in the study (mean 14 years, range 8-18 years, 11 female). Two patients were excluded 
for incomplete MRI data (no contrast administration), and 3 patients for incomplete CT data (no 
expiratory CT), so eventually twenty-one patients with CF were included for data analysis (median 
age 14 years, range 8-17 years, 9 females). Patients’ PFT, MRI, CEMRI and CT scores are summarized 
in Table 1.
Table 1. Patients’ characteristics and MRI, CEMRI and CT sub-scores.
Parameters Value
FVC 92.35% (81.7-108.7)
FEV1 89.65% (74.4-101.5)
FEF25-75 51.4% (35.5-70.1)
TLCbb-TLChe 0.14±0.7
TLCbb-TLChe/TLCbb 3.81±15.88 %
MRITA 2.78 (0-23.6) %
CEMRIHP 6.9 (0-33.3) %
CTTA-pre 22.2 (16.6-55.5) %
CTTA-post 33.3 (16.6-50) %
All data are presented as mean±2SD or median (interquartile range) according data distribution. FVC=Forced vital capacity 
percentage of predicted; FEV1=Forced Expiratory Volume in 1 sec percentage of predicted; FEF75=Forced expiratory Flow at 75 % 
percentage of predicted; TLCbb=Total lung capacity measured with body-box technique; TLChe=TLC measured with helium-dilution 
technique; MRITA=Magnetic Resonance Imaging trapped air score, CEMRIHP= Contrast Enhanced MRI hypoperfusion score; 
CTTA-pre=Computed Tomography TA score of CT performed 1 year before MRI, CT TA-post=CT-TA score of CT performed 1 after 
MRI. MRI and CT scores are all presented as percentage of the maximum score, ranging from 0 (no TA or HP) to 100 (TA or HP).
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Extent of Trapped Air and Hypoperfusion on MRI, CT and PFT
MRITA was detected in 12/24 (50%) patients, while CEMRIHP in 17/24 (71%). CTTA-pre was detected 
in 17/23 patients (74%), and CTTA-post in 20/23 (87%). The first observer showed that the median 
CEMRIHP score was two-times higher compared to MRITA, however this difference was not statistically 
significant (z=-0.44; p=0.6). Also the second observer showed that HP was larger than TA, with a 
median TA/HPlobe score of 1 (IQR -1; 2), which was statistically significant (p= 0.008). MRITA scores 
were 16.7 % lower relative to CTTA-pre (z=-3.29; p<0.001) and 22.2 % lower relative to CTTA-post 
(z=-3.51; p<0.0001). The mean not significant (p=0.17) difference between CTTA-pre and CTTA-post was 
5%. MRITA was not significant different from TABB-He (z=-1.15; p=0.25). TABB-He was significant lower 
relative to CTTA-pre (z=-3.243; p=0.001) and CTTA-post (z=-3.527; p<0.0001).
Correlation between trapped air, hypoperfusion and pulmonary function test
After Bonferroni correction, the p-value for multiple correlations was set to p=0.00625. A strong 
positive correlation was found between MRITA and CTTA-pre (r=0.6; p=0.004), CTTA-post (r=0.59, 
p=0.005), and CEMRIHP (r=0.58, p=0.006). MRITA had a negative correlation with FVC (r=-0.572, 
p=0.007; not significant after Bonferroni) FEV1 (r=-0.6, p=0.004), and FEF75 (r=-0.64, p=0.002). 
CEMRIHP has a strong negative correlation with FEF75 (r=-0.65, p=0.001), but weak correlations with 
CT-TApre (r=0. 57, p=0.007), and CTTA-post (r=0.55, p=0.009). CTTA-pre had negative correlation with, 
FEV1 (r=-0.59, p=0.004), and FEF75(r=-0.59, p=0.004), but not with FVC (r=-0.52, p=0.01). TABB-He 
did not correlate significantly with any tested parameters.
Score reliability
Intra-observer variability for MRITA and CEMRIHP was very good (ICC= 0.85) and good (ICC=0.72) 
respectively. Bland-Altman plots showed no systematic errors both for MRITA and CEMRIHP (Figure 
4E, online supplement)
Discussion
In this study we compared the ability to detect trapped air by MRI with that of CT and of PFT. In 
addition, we investigated how far the severity of trapped air as established by MRI overlapped regions 
of hypoperfusion. 
The first important finding of our study is that we are able to detect TA with proton MRI. MRITA 
had a strong positive correlation with CTTA-pre and CTTA-post, and a strong negative correlation with 
PFT parameters of airway obstruction. These results were somewhat unexpected, because the SSFP 
sequence had shown previously poor performance for TA assessment [23,30]. However in our 
protocol, we standardized image acquisition by extensive training of the patient prior to the MRI to 
perform adequate breath-hold maneuvers. Patient’s training allowed to acquire expiratory images at 
nearly residual lung volume, with a optimal characterization of TA due to higher contrast with the 
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surrounding normal and hyperperfused lung tissue [22]. Moreover, we noticed that patient’s training 
improved image quality by reducing motion artefacts (Figure 1).
Figure 1. 2D Steady State Free Precession (SSFP) scans at (A) end-inspiration (Total Lung Capacity) and (B) 
end-expiration (Residual Volume). Note sharp definition of low intensity region (LIR) in the end-expiratory image 
(arrows in B) and no evidence of motion artifacts.
The second important finding of our study is that there was dissociation between MRITA and CEMRIHP. 
Previous study have demonstrated that HP is an early and common feature of CF lung disease [4,16] 
2 m; median age 16 years. In our cohort study, we not only confirmed that HP is a common feature of 
CF lung disease, but also significantly larger than TA (Figure 2). We also found that the CEMRIHP was 
strongly correlated to PFT parameters of airways obstruction. These findings suggest that HP is not 
only the result of hypoxic pulmonary vasoconstriction due to airway obstruction, where regions of TA 
overlap HP; but there are also regions of HP that do not match TA and that might result from other 
CF-related factors, such as chronic lung inflammation, in the absence of obstructive airway disease 
[31]. A second option is that the hypoxic pulmonary vasoconstriction is reducing perfusion to a larger 
area than the hypo ventilated lung region. A third possible explanation is that CEMRIHP also detects 
areas of “micro-hypoventilation”, which are not detectable by proton MRI and PFT. This would make 
of HP a high sensitivity biomarker to detect ventilation impairment in CF lung disease. 
A third finding of our study is that the extent of MRITA was not significant different from TABB-He. 
Differently, the CTTA (pre and post) were both significantly higher compared to TABB-He and MRITA 
(Figure 3). These differences in TA assessment between MRI and CT might be attributed to the lower 
sensitivity of MRI for air [32]. However, our results suggest that the regions of low attenuation as 
observed on chest CT might reflect a mix of TA and HP (Figure 4), being MRITA significantly smaller 
than CEMRIHP. Low attenuation on CT can be caused by TA as well as by HP, while MRITA reflects just 
low signal intensity caused by incomplete deflation of the lung. In a non-contrast CT, radiologist can 
only define HP indirectly, as in case of concordant low-density regions in inspiration and expiration. 
Conversely, CEMRI gives a direct evaluation of HP and when combined with MRITA assessment on 
expiratory MRI allows differentiating between TA and HP. Hence, from our study it becomes clear 
that the term TA for regions of low attenuation on expiratory chest CT is not appropriate and should 
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be avoided as these regions are likely to be the result of a combination of TA and HP. We suggest that 
a more appropriate term for TA is low-attenuation region (LAR) for CT and low-intensity region 
(LIR) for MRI. For the clarity of this discussion section we will however continue to use the term TA 
in this paper.
Figure 2. Trapped Air (TA) and Hypoperfusion (HP). (A) end-expiratory coronal 2D Steady-State Free Precession 
(SSFP) proton-MRI and (B) coronal end-expiratory reformat 3D Spoiled Gradient Echo (SPGR) with TRICKS 
contrast-enhanced MRI. Note that HP areas often match areas of structural changes as in right upper (open arrows) 
and lower lobes (close arrows), but that there are also clearly HP on the CEMRI that are apparently free of disease 
on proton-MRI (arrowheads).
Figure 3. Comparison between MRITA and CEMRIHP. (A) End-expiratory axial 2D Steady-State Free Precession 
(SSFP) proton-MRI, (B) axial end-expiratory reformat 3D Spoiled Gradient Echo (SPGR) with TRICKS contrast-
enhanced MRI (CEMRI), and (C) Fusion Image CEMRI overlaid on MRI. Note that the hypoperfusion area in the 
left upper lobe (dotted area, in image B) is larger than the trapped air areas (dashed lines in A).
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Figure 4. Comparison between CT, MRI and CEMRI. (A) End-expiratory axial CT, (B) end-expiratory axial 2D 
Steady-State Free Precession (SSFP) proton-MRI and (C) axial end-expiratory reformat 3D Spoiled Gradient Echo 
(SPGR) with TRICKS contrast-enhanced MRI. Note that the hypodense area in image A (dotted area) is larger than 
the hypointense area in B (dashed line), and similar to the hypointense area in C (double line).
Our findings support HP as a relevant independent biomarker of CF lung disease in addition to TA to 
monitor and target therapy [31]. When studying lung perfusion this justifies the use of contrast agent 
with chest MRI. However, there are MRI techniques in development to assess lung perfusion without 
the need for a contrast agent, such as Fourier Decomposition and arterial spin labelling [11,33]. This 
would avoid the possible risks related to the use of Gadolinium, such as deposition of Gd in the brain, 
as recently highlighted by the literature [15]. Hence, our study supports further development and 
validation of these non-contrast MRI techniques and to establish their sensitivity relative to CEMRI 
to detect HP.
Finally, we acknowledge some limitations to this study. Firstly, we assessed TA and HP using semi-
quantitative scoring systems. We did so in order to reduce variability as it allowed us using for CT 
and MRI the same scoring strategy for TA and for MRI and CEMRI the same scoring strategy for TA 
and HP. Moreover, this scoring system was already successfully used by our group and similar to single 
morphologic-functional MRI scoring system proposed in the literature [34]. 
Secondly, for the comparison of the extent of TA with that of HP, we used two scoring systems, 
which were executed by two independent observers. The new PROPeR scoring system was especially 
developed to allow a sensitive comparison between the extent of HP with that of TA. Our approach 
confirmed the results of the first independent observer, who showed that the median CEMRIHP score 
was a factor two higher compared to MRITA, although not significant. Importantly, intra-observer 
variability with the CF-MRI scoring system was good with ICCs being 0.81 [35].
Finally, there was a 1-year time gap between CTTA-pre and MRITA and between MRITA and CTTA-post. This 
comparison was justified as not much change in CTTA over a two-year period can be expected. Loeve et 
al, did not find a significant change in CTTA over a two year time period using a sensitive quantitative 
image analysis system [27]. Similarly, we did not find a significant difference between CTTA-pre than 
CTTA-post. However, we showed a consistent higher median score of CTTA-pre and of CTTA-post relative to 
MRITA.
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Conclusions
By comparing MRI, CT and PFT, we showed that CEMRIHP is more frequent and its extent larger 
than of MRITA and that MRITA was similar to TA as quantified by PFT. Furthermore, we showed 
that CTTA is substantially larger than MRITA. Our findings show that HP contributes importantly to 
regions often described in radiology reports as ”trapped air” or as “mosaic pattern” on CT. Therefore, 
we propose that these terms can be better replaced by low-attenuation region (LAR) for CT and low-
intensity region (LIR) for MRI respectively. Finally, the findings of our study highlight the importance 
of HP in CF lung disease as independent outcome measure in addition to TA to monitor and target 
therapy. Further studies using CEMRI or non-contrast perfusion MRI techniques are needed to 
investigate the role of HP and potential therapies.
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Supplement
Table 1E. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
 – Age between 6 and 18 years old (age range for MRI in 
our institution)
 – Diagnosis of CF confirmed by sweat-test and/or DNA 
analysis and/or electro physiology testing 
 – Stable condition defined as: no requirement for i.v. 
antibiotics at the time of the annual check-up
 – Ability to perform pulmonary function tests 
 – Ability to do breath-hold manoeuvres 
 – CT scan made in the year before and after the MRI
 – Signed written informed consent
 – Able to comply with protocol requirements.
 – Inability to follow instructions of the investigator
 – Current respiratory tract infection requiring i.v. 
antibiotics
 – Pulmonary complications that might put the patient at 
risk to participate in the study
 – Claustrophobia
 – History of anaphylactic reaction on contrast agent
 – Any clinical condition which, according to the treating 
physician, might put the patient at risk
 – Severe asthma and/or severe allergies as determined by 
physician
 – Ferro-magnetic implants
Table 2E
Inspiratory
kV mAs Rotation  
time (sec)
Collimation 
(mm)
Pitch Kernels MPR
110 (80#) 20 CD4D 0.6 6*2 1.50 B60s, B30s 1, 5, 8 mm axial
3 mm coronal and sagittal
Recon increment 1.2 mm
Expiratory
110 (80#) 10 eff mAs 0.6 6*2 1.50
CD4D=CareDose; MPR=multiplanar reformats. (#) kV voltages for children below 25 kg.
Imaging Analysis
To set the best Contrast-to-Noise (CNR) between high and low density lung structure for MRI, we 
used an approach similar to chest CT using the standard lung window. Due to the lack of defined 
window setting for proton Magnetic Resonance Imaging (MRI) and Contrast Enhanced MRI 
(CEMRI), we set for each patient the window level above the background noise level and the window 
width approximately two-folds higher than the window level [17]. This method supplies the best 
CNR between high and low density lung structures, similar to Computed Tomography (CT) using 
the standard lung window. The level of ambient (background) lighting was kept constant during all 
viewing sessions to ensure consistent viewing conditions. The contrast enhanced phase of CEMRI 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
129
CEMRI in CF
6
scan that was selected for HP scoring was that of the first pass of the contrast in the lung and that 
with the highest CNR. First, the end-expiratory MRI and CEMRI scans were anonymized and scored 
in random order by the first observer using the Cystic Fibrosis (CF) MRI scoring system (CF-MRI). 
CF-MRI scoring system
For the CF-MRI scoring system the following items are scored: bronchiectasis, air wall thickening, 
mucus plugging, parenchyma score (including bullae, cysts, atelectasis, consolidation and ground glass 
opacity) and trapped air (TA). Hypoperfusion (HP) is not routinely scored with CF-MRI [22,23]. 
To score HP, the same categories used to score TA are used in order to enable the comparison. The 
extent of TA and HP is defined per lobe according the categories shown in Table E3. The total score 
per patient for TA (or HP) is calculated by summing up the scores of the five lobes and lingula as sixth 
lobe, with higher scores indicating more TA (or HP). The maximum possible absolute score for TA 
as well as for HP is 18. For the purpose of this study only TA and HP were scored with the CF-MRI.
Table 3E. Cystic Fibrosis Magnetic Resonance Imaging (CF-MRI) scoring system for trapped air and hypoperfusion.
Extent Score
No TA (or HP) 0
TA (or HP) less than 33% lobe volume 1
TA (or HP) between 33% and 67% lobe volume 2
TA (or HP) more than 67% lobe volume 3
TA=Trapped air, HP=hypoperfusion.
PatteRn OverlaPping Rotterdam (PROPeR) scoring system
A second observer, blinded to the assessment of the first observer, who scored with the CF-MRI 
scoring system, scored MRI and CEMRI scans using the PatteRn OverlaPping Rotterdam (PROPeR) 
scoring system. This PROPeR score is performed for each lobe separately, with the lingula considered 
as sixth lobe. First, the observer compares simultaneously slice by slice the end-expiratory proton-MRI 
and the CEMRI scans of the same patient in order to determine if HP is greater, equal or smaller 
than TA. Next, end-expiratory MRI and CEMRI are merged using the imaging registration tools of 
Advantage Windows Server (General Electric Healthcare, Milwaukee, WI, USA) imaging platform. 
This tool overlaps the end-expiratory MRI with the CEMRI scans, and superimposed the signal of the 
CEMRI to the end-expiratory MRI. This allows scoring per lobe the different extent between TA and 
HP (TA/HPlobe). Differences in extent between TA and HP are scored as shown in Table 4E.
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Table 4E. Comparison of Contrast Enhanced Magnetic Resonance Imaging (CEMRI) and MRI scans.
PatteRn OverlaPping Rotterdam (PROPeR) score Scoring
HP>TA HP=TA HP<TA
Extent Score Extent Score Extent Score
HP greater than TA of 0-25% 1 HP equal to TA 0 HP smaller than TA of 0-25% -1
HP greater than TA of 26-50% 2 HP greater than TA of 51-75%
HP greater than TA of 76-100%
HP greater than TA of 26-50% -2
HP greater than TA of 51-75% 3 -3
HP greater than TA of 76-100% 4 -4
HP=hypoperfusion; TA=Trapped Air. 
For instance, when the extent of HP is 0-25 % larger than the extent of TA a score of 1 is assigned 
(Figure 1E), vice versa a score of -1 is assigned when TA is 0-25% larger than HP (Figure 2E). When 
HP overlaps TA or there is homogenous signal both in MRI and CEMRI a score of zero is assigned 
(Figure 3E).
Figure 1E. Comparison between MRITA and CEMRIHP by the second observer using the PROPER scoring 
system. (A and D) axial end-expiratory reformat 3D Spoiled Gradient Echo (SPGR) with TRICKS contrast-
enhanced MRI (CEMRI); (B and E) end-expiratory axial 2D Steady-State Free Precession (SSFP) proton-MRI; and 
C and F) Fusion Image CEMRI overlaid on MRI. Note areas of hypoperfusion in both lungs in image D (black line 
areas) and areas of trapped air in image E (white line areas). When compared on fusion image F, hypoperfusion is 
larger than the trapped air areas (line pattern areas in F). Hence, for these lobes (right middle and left lower lobes) a 
score of 1 is given.
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Figure 2E. Comparison between MRITA and CEMRIHP by the second observer using the PROPER scoring 
system. (A and D) end-expiratory axial 2D Steady-State Free Precession (SSFP) proton-MRI; (B and E) axial end-
expiratory reformat 3D Spoiled Gradient Echo (SPGR) with TRICKS contrast-enhanced MRI, and C and F) Fusion 
Image CEMRI overlaid on MRI. Note homogeneous signal both in end-expiratory MRI (white line areas in D) and 
CEMRI (black line areas in image E). When compared, no differences are seen in the fusion image (image F). Hence, 
in this case a score of 0 is given.
Figure 3E. Comparison between MRITA and CEMRIHP by an observer using the PROPER scoring system. (A 
and D) end-expiratory axial 2D Steady-State Free Precession (SSFP) proton-MRI, (B and E) axial end-expiratory 
reformat 3D Spoiled Gradient Echo (SPGR) with TRICKS contrast-enhanced MRI (CEMRI), and C and F) Fusion 
Image CEMRI overlaid on MRI. Note that area trapped air in right upper lobe in image D (white line area) and 
area of hypoperfusion in image E (black line area). When compared on fusion image F, trapped air is larger than the 
hypoperfusion (line pattern area in F). Hence, for this lobe a score of -1 is given.
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Figure 4E. Intra-observer variability trapped air and hypoperfusion assessment. Bland-Altman plot of intra-
observer agreement (observer 1, one month time gap between scores) for (A) Magnetic Resonance Imaging Trapped 
Air (MRITA) score and (B) Contrast enhanced MRI Hypoperfusion (CEMRIHP) score. Note that mean differences are 
close to zero and that all observations are around the mean.
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Abstract 
Purpose: to evaluate feasibility of 3D-Fourier Decomposition (FD) lung ventilation MRI with highly 
time-resolved 4D MRI on a 3T system. 
Methods: five volunteers and four patients with Cystic Fibrosis (CF) were enrolled in the study. MRI 
protocol consisted of breath-hold 3D-SPGR (SPGRbh) and two free-breathing multiphase 3D-SPGR 
with different temporal resolutions: conventional 3D-SPGR (1sec/volume) and 3D DIfferential 
Subsampling with Cartesian Ordering (DISCO) (343 ms/volume). 3D-FD ventilation maps were 
obtained with in-house developed software. The 4D sequences were scored for image quality and 
signal-to-noise ratio (SNR). Trapped-air (TA) was assessed using the CF-MRI scoring system in 
end-expiratory SPGRbh (TAbh) and in the 3D-FD ventilation maps (TAFD). Statistics included t-test, 
Intraclass-Correlation Coefficient (ICC) and Pearson correlation coefficient (r).
Results: median age of volunteers and patients were 30 and 23 years respectively. Image quality (p=0.2) 
and SNR (p=0.79) were similar between both conventional SPGR and DISCO. Both sequences enabled 
3D-FD ventilation maps. Good agreement (ICC=0.875) and high correlation (r=0.877, p<0.001) 
were found between TAFD and TAbh. 3D-FD ventilation maps facilitated TA scoring (p<0.0001).
Conclusion
Both conventional SPGR and DISCO sequences enable 3D-FD ventilation maps. 3D-FD facilitates 
TA assessment compared to conventional SPGRbh. 3D-FD techniques enable a faster and more 
comprehensive assessment of TA compared to 2D-FD techniques. 
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Introduction
Several obstructive lung diseases cause ventilation impairment, frequently secondary to structural 
changes such as bronchial wall thickening, mucus plugs and bronchiectasis [1]. Computed 
tomography (CT) and Magnetic Resonance Imaging (MRI) allow for detection and quantification 
of ventilation impairment. Current quantitative assessment mostly consists of measuring trapped air 
(TA), hypoperfusion (HP) or a combination of both [2]. Quantification of TA and HP are relevant for 
several lung diseases, such as asthma and cystic fibrosis (CF) [3,4]. Recent evidence confirmed that TA 
and HP are important disease biomarkers to assess treatment efficiency [5,6]. For this reason, imaging 
has been increasingly used in clinical practice to monitor TA and HP [7]. To date CT has been the 
preferred method, being recognized as the most sensitive technique to monitor structural lung changes 
[8]. TA with CT can be assessed indirectly through visualization of low attenuation regions on end-
expiratory CT scans, which adds extra radiation dose to the CT protocol. Similarly, HP assessment 
requires intra venous contrast administration and additional radiation exposure. Cumulative dose 
is thus the major disadvantage of CT, which restricts its use and disqualifies CT as the first choice 
for the detection and monitoring of functional information [9]. To reduce radiation exposure, MRI 
techniques have been introduced [10]. TA can be visualized on conventional short TE gradient-echo 
sequences (TE~0.4-0.7ms), but they have limited sensitivity to detect TA, because they suffer of fast 
signal decay due to T2* effects or SNR [11]. The reduced sensitivity to assess TA on end-expiratory 
MRI scans has promoted the development of new MRI techniques to improve TA quantification. 
One of those techniques is the extraction of ventilation maps using two-dimensional (2D) Fourier 
Decomposition (FD). 2D FD is a free-breathing gradient-echo technique that have been shown useful 
for the assessment of TA and HP without the need for intravenous or gaseous contrast agents [12]. 
Ventilation and perfusion maps obtained with 2D FD have been validated in healthy volunteers and 
in patients with CF, lung cancer and pulmonary embolism using mostly 2D steady state free precession 
(SSFP) [13-16]. However, despite the good temporal resolution (3-4 images/sec), this 2D FD has been 
limited by relatively lengthy scan time, poor spatial resolution and Specific Absorption Ratio (SAR) 
limitations at 3T [12]. The introduction of highly time resolved three-dimensional (3D) FD variants 
has not yet been reported using 3D Spoiled Gradient echo (SPGR) techniques. The challenge is to 
develop 3D sequences with sufficient temporal and spatial resolution in order to compute FD maps. 
Optimally In order to separate signals contributing from respiratory and cardiac cycles, a minimal 
temporal resolution of at least double the frequency of the highest frequency signal component (i.e. 
heart rate) is required according to the Nyquist criterion [12]. To achieve this with 3D, we included 
highly accelerated 3D SPGR sequences and special view shared variant called DIfferential Sub-
sampling with Cartesian Ordering (DISCO) in order to achieve similar temporal resolution of 2D 
FD [17]. High parallel imaging acceleration is possible with 3D scanning, and the view sharing of 
the DISCO sequence enables even higher temporal resolution than conventional cartesian 3D SPGR 
acquisition scheme [17]. 
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In this pilot study, we aimed to evaluate the feasibility of 3D FD lung MRI using conventional 3D 
SPGR (SPGRC) and DISCO data acquisition schemes in a group of healthy volunteers and patients 
with CF. In particular we compared image quality and signal-to-noise ratio (SNR) of SPGRC and 
DISCO. Then we compared TA assessment using 3D SPGR breath-hold end-expiratory scans (SPGRbh) 
and the 3D FD ventilation maps obtained with the aforementioned 3D multiphase sampling schemes.
Methods
MRI experiments with healthy volunteers were conducted following institutional review board 
approval and informed consent (MEC-2014-096). Patients with CF were included from a clinical 
study which tested a new administration device for inhaled antibiotics (MEC-2014-260) and which 
MRI protocol included the required sequences. Exclusion and inclusion criteria for volunteers and 
patients are displayed in Table 1.
Breathing maneuvers
Subjects were trained to perform breathing maneuvers by a lung function technician prior the MRI. 
Breathing maneuvers were repeated in supine position on a stretcher using a custom made MRI-
compatible spirometer (Masterscope, CareFusion, Houten, The Netherlands). Aims of the training 
were to monitor and standardize breathing maneuvers during the MRI by using spirometer volume 
data during the MRI. For the static MRI acquisitions subjects were trained to obtain a maximal breath 
hold time of 15 seconds at ≥95% of the inspiratory vital capacity (IVC) and at ≥90% expiratory vital 
capacity (EVC). For the dynamic maneuvers subjects were instructed to have a regular breathing pace 
(5-7 seconds per respiratory cycle).
MRI protocol
MRI scans were performed at 3.0T (Discovery MR750, GE Healthcare, Milwaukee, WI, USA) using 
a 32 channels phased-array receiver only torso-coil and with the whole body coil for transmission. 
The MRI protocol included spirometer controlled breath-hold end-inspiratory and end-expiratory 
accelerated 3D SPGR scans covering the entire lung volume: TR/TE/α=1.1 ms/0.5ms/2°; 
voxel resolution 3 mm3 isotropic. Eight to ten seconds breath-hold time were achieved using the 
Autocalibrating Reconstruction for Cartesian (ARC) parallel imaging with factors ranging between 
1-2. Then two 4D SPGR scans were performed during tidal breathing for an acquisition time of around 
1 minute with different data collection strategies at maximum ARC acceleration (ARC=6). The first 
4D SPGR (SPGRC) scan used a TR/TE/α=1 ms/0.4ms/1°; actual voxel resolution of 7.5x7.5x4 mm
3 
for a temporal resolution of 1.13 sec/volume. The DISCO scan used TR/TE/α=1.1/0.4/1°, actual 
voxel resolution of 6x6x6 mm3 with a predefined A region fraction of 0.5 with a number of B regions 
of 6, providing an effective temporal resolution of 343 ms/volume. A and B regions were predefined 
based on prior phantom and volunteer testing regarding ghosting artifacts in the anterior- posterior 
direction.
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Table 1. Inclusion and Exclusion criteria volunteers and patients.
Volunteers
Inclusion criteria Exclusion criteria
 – Healthy subject defined as a volunteer who is not 
referred to the hospital with signs and symptoms of 
disease;
 – Age ≥18 years old;
 – Signed informed consent.
 – Any contra-indication to an MRI (i.e. metal implants)
 – Woman who are pregnant or lactating;
 – Physical or mental status that interferes with the 
informed consent procedure;
 – Participation in another clinical study.
CF Patients
Inclusion criteria Exclusion criteria
 – Age ≥8 years; 
 – Clinical diagnosis of CF by a positive sweat test or two 
CF-related mutations; 
 – Chronic Pseudomonas Aeruginosa (Pa) colonization 
requiring maintenance therapy with inhaled 
tobramycin, defined according to the Leeds criteria 
(>50% Pa positive airway cultures over last 12 months); 
 – Small airways obstruction present on spirometry defined 
as follows: dissociation between FVC and FEF75 values 
(i.e. FEF75 at least 20% (absolute percent predicted) less 
than FVC); 
 – Ability to breathe through a mouthpiece and to use the 
inhaler;
 – Ability to perform lung function tests;
 – Written informed consent. 
 – Severe acute exacerbation of pulmonary infection 
(requiring intravenous treatment with antibiotics) 
within one month prior to start or during the study; 
 – Known impaired kidney function (estimated creatinine 
clearance <60 ml/min); 
 – Known aminoglycoside hypersensitivity;
 – Start of nephrotoxic or ototoxic drugs, e.g. 
aminoglycosides, within 1 month prior to start or 
during the study; 
 – Therapy (e.g. furosemide) or disease which may 
complicate evaluation of the study protocol, as judged 
by the investigator; 
 – Participation in another drug-investigating clinical study 
at the start or within 1 month prior to the start; 
 – Inability to follow instructions of the investigator;
 – Use of Tobramycin Inhalation Powder as part of the 
maintenance therapy.
Image analysis
All images were anonymized and analyzed in random order by a single observer (A.B.) on 3D Slicer 
(http://www.slicer.org). Ventilations maps were obtained using in-house developed software. Then, 
image analysis was conducted in three steps: image quality, SNR and TA assessment.
Fourier Decomposition ventilation maps
The computation of the FD ventilation map was performed in 5 steps. First, in order to facilitate 
the alignment of all acquired volumes in the dynamic sequence, this was processed to remove the 
characteristic bias field of MR images using N4ITK [18]. The shrink factor was four, and the B-spline 
fitting was set to two elements in each spatial dimension. Second, the Elastix image registration 
framework [19] was used to align the 3D time frames using a group wise deformable registration 
by minimizing the variance of intensity over time. Similarly to Mogalle et al [20], the 4D free-form 
B-spline that provides smoothness in the three spatial dimensions and in the time dimension had 
a resolution of 20 mm in space and 1 frame in time. Registration was achieved using a stochastic, 
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adaptive gradient descent optimizer and a multi-resolution scheme with four resolution levels. After 
successful registration, each voxel v(x,y,z,t) will correspond to the same anatomical position in the patient, 
independent of t. Third, the intensity profile (Figure 1, top) along time, t, of each voxel v(x,y,z) is analyzed 
using the Fourier transformation, which decomposes the signal into the frequencies that make it up 
(Figure 1, middle). The first and last five frames of each sequence were discarded for this step, to 
ensure that the analyzed portion of the sequence contained only the instructed breathing maneuver. 
Fourth, all Fourier decomposition vectors are averaged for the entire sequence and the mode in the 
frequency domain is automatically detected as the breathing frequency (Figure 1, bottom). For each 
voxel position, the response around the detected peak is integrated within a window of 8/60 Hz, to 
allow variations in the breathing frequency, resulting in a single value per voxel that corresponds to the 
amount of ventilation at that location. Finally, the ventilation maps are normalized by linear scaling, 
such that the 5th and 95th percentile of the entire 3D ventilation map are set to 0 and 1, respectively 
and values outside that range are clipped.
Figure 1. Top: Intensity value along time for a fixed point in the lung after registration and bias correction, where the 
breathing pattern can be seen (conventional SPGR multiphase, temporal resolution around 1 sec/ image). Middle: 
Fourier decomposition of the intensity profile. Bottom: Averaged results of the Fourier decomposition for all voxels. 
A clear peek at 0.14Hz can be seen, corresponding to a slow breathing frequency of around 7 seconds per cycle. Values 
between the purple lines are integrated to produce the ventilation maps.
Image Quality analysis
Image quality of SPGRC and DISCO sequences was scored regarding blurring and ghosting using a 
5 points scale ranging from 1=severe to 5=imperceptible. Imperceptible was defined when the signal 
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in the lung parenchyma was less than 20% of the max signal of the anterior chest wall at a point 
a maximum chest wall displacement. Similarly, image quality was scored with a five point scale in 
SPGRbh scans and the 3D FD regarding ability to define region of TA, ranging from 1=non-diagnostic, 
TA region non identifiable to 5=no noise of motion artifact interfering with assessment of TA region. 
SNR measurement
SNR was computed in SPGRC and DISCO images. SNR was computed according to the formula: 
[mean Signal Intensity (SI)/Standard Deviation (SD) of noise]. SI of the lung was recorded as mean 
pixel intensity value of a region of interest (ROI) manually positioned in the lung parenchyma without 
including major blood vessels. To take into account variation in SI between anterior and posterior 
lung parenchyma due to effect of gravity on blood distribution, ROIs were positioned at three levels: 
anterior, mid and posterior lung parenchyma (Figure 2). ROIs were positioned in the slices passing 
at the level of the carina bifurcation and in both right and left lung. The ROIs to measure SD of the 
noise were positioned in the background air outside of the chest in an area without ghosting artefacts. 
This procedure was repeated in three representative inspiratory and three expiratory phases for each 
dynamic scan in order to take SI variation related to breathing cycle into account. For each dynamic 
scan were therefore positioned 42 ROIs.
Figure 2. Signal-to-noise ratio analysis. Example slice of region of interest (ROI) positioning for signal-to-noise 
ratio (SNR) measurements. Six ROIs are positioned in the lung parenchyma: 1=right anterior, 2=left anterior, 3=mid-
right, 4=mid-left, 5=right posterior and 6=left posterior. ROI number 7 is positioned in the air outside of the body 
to measure image noise. 
Trapped air quantification
TA was quantified using the CF-MRI scoring system [21]. This scoring system evaluates the five lung 
lobes and lingula as the sixth lobe. CF-MRI quantifies the extent of TA in 4 categories per lobe: 
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0=absent, 1=TA<33% lobe volume; 2=TA between 33-67% lobe volume; 3=TA>67% of the lobe 
volume(21). TA was scored on breath-hold end-expiratory SPGR (TAbh) and on the FD ventilation 
maps (TAFD). On 3D FD maps, TA was detected when large color scale variations were present outside 
the major blood vessels. TA scores were expressed as a percentage of the maximum possible score, on a 
0-100 scale. The observer was also asked to judge if ventilation maps were useful to detect TA relative 
to breath-hold scans according to a five point scale (Utility score): 1=disagree strongly; 2=disagree; 
3=neither agree nor disagree; 4=agree; 5=strongly agree.
Statistics
Descriptive statistics were used. T-test was used to assess differences for repeated measurement of SNR, 
image quality, and TA. Strength of association between TA score on breath-hold images (TAbh) and 
on FD ventilation maps (TAFD) was computed with the Pearson test. Finally, Intra-Class Correlation 
Coefficient test was used to assess agreement on TA score between TAbh and TAFD. Statistical analyses 
were performed using SPSS version 20.0 for windows. Continuous variables are displayed as mean 
(±Standard Deviations) or median (interquartile range) depending on data distribution. P-values less 
than 0.05 (two tailed) were considered statistically significant. 
Results
Five healthy volunteers (median age 30 years, age range 27-35 years, 2 female) and four patients (mean 
age 23 years, age range 10-43 years, no female) were enrolled in the study. All subjects successfully 
completed the MRI protocol.
Image quality
Image quality, SNR and TA data are summarized in table 1. There were no significant differences 
in image quality between SPGRC and DISCO regarding ghosting and motion artifacts (p=0.2). 
Similarly there were no significant differences on image quality for scoring TA between SPGRbh and 
FD ventilation maps (p=0.16).
SNR
There were no significant differences in SNR between SPGRC and DISCO (p=0.79). Differences 
in SNR were found between ventral and mid lung portions (t=4.1, p<0.001; 95% C.I. 4.7-13.8), 
between ventral and dorsal lung portions (t=-4.62, p<0.001; 95% C.I. -23.2- -9.2), and between mid 
and dorsal lung portions (t=-8.2, p<0.001; 95% C.I. -31.7- -19.2) (Figure 3). SNR was significantly 
lower in inspiration than in expiration (t=3.53, p<0.01; 95% C.I. 3.6-12.7), while there were no 
significant differences in SNR between right and left lung (p=0.38).
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Trapped air assessment
There were no significant differences between TAbh and TAFD (p=0.44). Good agreement between TAbh 
and TAFD was also confirmed by ICC analysis (ICC=0.875). Bland-Altman and identity plots did not 
show systematic errors, although TAFD was slightly higher than TAbh (Figure 4). The observer agreed 
on judging FD ventilation maps useful to detect TA (p<0.0001). High correlation between TAbh and 
TAFD was found (r=0.877; p<0.001).
Table 1. Image quality, signal-to-noise ratio and trapped air.
Parameter Value
Image quality SPGRbh 4.55±1.04
Image quality SPGRC 4.44±1.05
Image quality DISCO 4±1.15
SNRSPGRC 32±33.87
SNRDISCO 31.4±29.3
TAbh 21.7±38.3 %
TAFD 24.2±43.1 %
Utility score FD 4±1.5
SPGRbh=3D Spoiled Gradient echo breath-hold; SPGRC=conventional SPGR multi-phase; DISCO=DIfferential Sub-sampling with 
Cartesian Ordering; SNRSPGRC=Signal-to-noise ratio SPGRC; TAbh=Trapped Air scored on breath-hold SPGR; TAF=TA scored on 
Fourier Decomposition ventilation maps. Data are presented as mean ±2 Standard Deviations
Figure 3.
Y-axis=Mean Signal-to-Noise Ratio (SNR). X-axis=positions of region of interest (ROI) on lung parenchyma: 1=right anterior, 2=left 
anterior, 3=mid-right, 4=mid-left, 5=right posterior and 6=left posterior. Note significant differences in SNR between anterior and 
mid, anterior and dorsal, and between mid and dorsal lung portions (all p<0.001).
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Figure 4. Bland-Altman and identity plots. (A) Bland-Altman plot of trapped air (TA) assessment between Fourier 
Decomposition (FD) ventilation maps (TAFD) and Spoiled Gradient echo (SPGR) end-expiratory breath-hold scans 
(TAbh). Solid line=mean difference TAFD vs TAbh, dotted line=±2 SD. (B) Identity plots between TAFD and TAbh; solid 
line =correlation line, dotted line= identity line (y=1*x+0). Note that TAFD is slightly higher than TAbh.
Discussion
In this study, we evaluated feasibility of 3D FD lung MRI using SPGRC and DISCO scans. We also 
compared image quality, SNR and TA assessment using SPGRbh, against the 3D FD ventilation maps.
 
Firstly, we showed that both SPGRC and DISCO allowed obtaining 3D FD ventilation maps with 
similar quality despite different temporal resolution. For perfusion imaging, the temporal resolution 
of SPGRC was not able to detect changes in perfusion because was similar to the heart rate. While 
faster scan rate (>5 Hz) could lead to FD analysis with two spectral peaks, one for ventilation and 
one for perfusion, the acquisition speed of our DISCO implementation could not detect reliably the 
perfusion peak. This might be explained by the lack of in-flow effect in the 3D technique compared 
to the 2D scanning approaches. Scan rate might also be increased by enabling higher ARC parallel 
imaging accelerator factors up to 12 or higher [11] for perfusion peak detection. Compressing sensing 
(CS) could be also used to increase the scan rate more effectively and allow a better detection of the 
perfusion peak [22]. In our institution CS was not available at the time of the study, therefore we could 
not evaluate it.
Secondly, we observed that similar image quality and SNR were achieved with SPGRC and DISCO 
because similar imaging parameters were used. DISCO may introduce more ghosting and blurring 
artifact derived from the view sharing but in our study it was not critical for imaging registration and 
3D FD imaging. SNR analysis also confirmed heterogeneity of SNR in lung parenchyma due to the 
known effect of gravity on blood distribution and due to the respiratory cycle [23]. 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
143
3D-FD in CF
7
Finally, we showed that TA assessed on breath-hold scan and FD ventilation maps was equivalent 
(Figure 5). Despite slightly higher values for TAFD compared to TAbh, this was not significant and good 
agreement between the methods was seen. Interestingly, the observer considered the FD ventilation 
maps easier to score TA because the color scale facilitated the detection. In our protocol, the use of 
a MRI compatible spirometer also improved detection of TA on SPGRbh but with limited SNR and 
spatial resolution than a typical CT scan [23]. This problem may be overcome using ultra-short TE 
(UTE) sequences in the future. Nonetheless UTE scans are characterized by long free-breathing scans 
(e.g. 5-7 min) and may be prone to respiratory artifact hampering TA detection [24]. Our 3D FD 
method allows obtaining similar information about TA, but with shorter acquisition times that might 
be critical in severely ill or non-compliant patients.
Figure 5. Coronal and axial 3D SPGR breath-hold (a-b-e-f ) and 3D Fourier Decomposition ventilation maps 
(c-d-g-h) in a patient with CF (a-d) and a healthy volunteer (e-h). Note the signal void in the upper lobes in an 
area of severe trapped air (black arrows in a and white arrow in d) and homogeneous signal in the volunteer (black 
arrows in e and white arrows in h).
There are some limitations that might have reduced agreement between TAbh and TAFD. The first 
limitation of our study is that TA was compared in images acquired using different breathing 
conditions. As discussed, FD ventilation maps were acquired near functional residual volume level 
(FRC) using free breathing acquisition, while SPGRbh was acquired after a deep expiration at residual 
volume (RV). It has been shown that CT scans acquired near FRC overestimate TA relative to scans 
acquired near RV [26]. This coincides with our findings that TAFD was slightly higher than TAbh, 
although still not significantly different.
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The second limitation of our study is that we did not compare SNR and image quality of 2D FD versus 
our 3D FD ventilation maps. We did not add 2D FD because of time constraint and ethical board 
approval. However, we aimed to demonstrate feasibility of 3D FD against breath-hold expiratory 
scans.
The third limitation of our study was that it was a single center study in a small number of subjects, 
which limits external validity of our findings. Further improvement of MRI protocol will allow us to 
apply this method in a larger cohort study and to compare TA assessment with 3D FD with other 
established techniques for measuring TA (i.e. plethysmography or hyperpolarized-noble gases MRI). 
Conclusions
We have shown that both 3D SPGRC and DISCO acquisition schemes enable 3D FD ventilation 
maps of similar quality despite different temporal resolutions. 3D FD ventilation maps were as good 
as end-expiratory breath-hold scan to quantify TA, but the observer judged 3D FD easier to interpret. 
3D FD enables a more comprehensive assessment of TA compared to 2D FD techniques and it is 
more amenable for patient comfort. This method might be applied in critically ill or non-collaborative 
patients to perform ventilation imaging with MRI.
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Abstract
Tracheobronchomalacia (TBM) is defined as an excessive collapse of the intrathoracic trachea. 
Bronchoscopy is the gold standard for diagnosing TBM; however it has major disadvantages, such as 
general anaesthesia. Cine computed tomography (CT) is a noninvasive alternative used to diagnose 
TBM, but its use in children is restricted by ionising radiation. Our aim was to evaluate the feasibility 
of spirometer-controlled cine magnetic resonance imaging (MRI) as an alternative to cine-CT in a 
retrospective study.
12 children with a mean age (range) of 12 years (7-17 years), suspected of having TBM, underwent 
cine-MRI. Static scans were acquired at end-inspiration and expiration covering the thorax using a 
three-dimensional spoiled gradient echo sequence. Three-dimensional dynamic scans were performed 
covering only the central airways. TBM was defined as a decrease of the trachea or bronchi diameter 
>50% at end-expiration in the static and dynamic scans.
The success rate of the cine-MRI protocol was 92%. Cine-MRI was compared with bronchoscopy or 
chest CT in seven subjects. TBM was diagnosed by cine-MRI in seven (58%) out of 12 children and 
was confirmed by bronchoscopy or CT. In four patients, cine-MRI demonstrated tracheal narrowing 
that was not present in the static scans.
Spirometer controlled cine-MRI is a promising technique to assess TBM in children and has the 
potential to replace bronchoscopy.
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Introduction
Tracheobronchomalacia (TBM) is defined as an excessive collapse of the intrathoracic part of the trachea 
and/or main bronchi during expiration [1]. When TBM is suspected, a diagnostic bronchoscopy, 
which is the current gold standard, is used to confirm the diagnosis [1,2]. In paediatric populations, 
bronchoscopy has the disadvantage that it is invasive and requires general anaesthesia, while the 
child maintains spontaneous breathing [1]. In addition, relevant daily life breathing manoeuvres, 
such as forced expiration and coughing, cannot be routinely performed during the procedure [3-4]. 
Bronchoscopy using conscious sedation, which preserves spontaneous ventilation for the evaluation of 
TBM, is used in adults [4]. However, this technique in children is, in general, not feasible due to a lack 
of cooperation [4]. Finally, bronchoscopy does not provide exact measurements of airway dimensions 
comparable to that provided by imaging techniques [3-5].
For these reasons an alternative to bronchoscopy, cine computed tomography (CT), has been used 
to assess TBM [6]. An advantage of this technique is that the collapsibility of trachea and mainstem 
bronchi can be evaluated during static and dynamic conditions [7-9]. However cine-CT to detect 
TBM exposes the patient to ionising radiation [1], which is a more significant problem for children 
than adults because they are more susceptible to the harmful effects of ionising radiation [10-14]. 
Cine-magnetic resonance imaging (MRI) might be an attractive, radiation-free alternative to cine-CT 
to diagnose TBM [15-19]. Recent improvements in MR technology (ultrafast imaging) allow dynamic 
evaluations of the central airway dimensions (cine-MRI) [15]. Ideally, breathing manoeuvres during 
cine-MRI should be standardised using cine-MRI spirometry. A MRI compatible spirometer was 
recently developed and tested [20]. To our knowledge, spirometer controlled cine-MRI has not been 
applied before in TBM assessment [16,18].
We have previously demonstrated feasibility of the spirometer-controlled cine-MRI protocol in healthy 
adult volunteers [21]. The aim of this study was to retrospectively evaluate the diagnostic feasibility 
of this protocol in a group of children, who needed a chest MRI for various indications and in whom 
the treating clinician requested assessment of TBM to be included in the evaluation. In this paper 
we describe our methodology and the results of a retrospective image analysis of static and dynamic 
changes in central airway dimensions in 12 patients.
Materials and Methods
MRI
The cine-MRI protocol for the diagnosis of TBM was developed in 10 healthy adult volunteers mean 
age (range) 31 years (30-33 years) for which approval was obtained from our institutional ethics 
committee [21]. Scanning was performed using a 1.5T Signa Hdxt MRI (General Electric Healthcare, 
Milwaukee, WI, USA) and using the whole body coil for radiofrequency excitation and an eight-
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channel torso coil for signal reception. The protocol consisted of static and dynamic acquisitions. Three-
dimensional (3D) “static” images at total lung capacity and residual volume were acquired by two 13-s 
breath-holds covering the complete thoracic region at end-inspiration and end-expiration using a 3D 
radiofrequency-spoiled gradient echo sequence (SPGR) with repetition time /echo time=1.4/0.6 ms, 
flip angle 2°, sagittal volume acquisition with a true isotropic 3.0×3.0×3.0 mm3 voxels. 3D cine-MRI 
acquisitions were acquired with the same imaging parameters and voxel resolution, but only covering 
the trachea and mainstem bronchi (12 cm sagitally). This was used to measure their dimensions and to 
monitor, in pseudo-real time, the airway dimensions to detect dynamic TBM during forced expiration 
and cough. The temporal resolution of 400 ms per volume was achieved using the temporally resolved 
imaging of contrast kinetics scan platform with accelerated imaging options [22]. 48 volumes were 
collected in 19 s. Overall the acquisition time per patient, including localisers, adjustments, breathing 
instructions and executing all scans, was ∼15 min (range 9-20 min). The videos of the dynamic 
acquisitions are provided in the online supplementary material.
Bronchoscopy
Bronchoscopies in six out of the 11 patients were carried out by a paediatric pulmonologist as part of 
diagnostic workup in routine patient care, using a flexible bronchoscope, external diameter 3.5 mm 
or 5.5 mm (Olympus; Tokyo, Japan), during general anaesthesia while maintaining spontaneous 
breathing. Airway malacia was diagnosed by visual inspection of the airway shape and dynamics during 
spontaneous breathing without positive end-expiratory pressure, and during spontaneous coughing 
in case this occurred. Malacia was defined as collapse of at ≥50% of the airway lumen, during the 
expiration phase while spontaneous breathing or while the patient was coughing [2].
Breathing instructions
Paediatric patients, who needed a chest MRI for various clinical indications and in whom the treating 
clinician requested assessment of TBM, based on their clinical presentation, were scheduled for a 
spirometer controlled cine-MRI. Half an hour before the MRI all children did a routine upright 
spirometry, coached by a lung function technician. Next, the required breathing manoeuvres were 
repeated in the supine position on a stretcher using an MRI-compatible spirometer (custom made 
Masterscope MRI; CareFusion, Houten, The Netherlands). The purpose of the training was: 1) to 
monitor and standardise breathing manoeuvres by using spirometer volume data during the MRI; 
2) to reduce anxiety related to MRI investigations; and 3) to increase the number of successful MRI 
investigations. For the static MRI acquisitions, children were trained to obtain a maximal breath-
hold time of 15 s at ≥95% of the inspired vital capacity (VC) and at ≥90% of the expired VC. For 
the dynamic cine-MRI sequences, patients were asked to perform two expiration manoeuvres, both 
starting at ≥95% of the inspired VC. The first dynamic manoeuvre was a full forced expiration, which 
was done as follows. From tidal breathing, patients were asked: 1) to take a deep breath and reach 
≥95% of inspired VC; 2) to hold their breath for a few seconds; 3) to perform a forced expiration and 
reach ≥90% of the expired VC; 4) to hold their breath for a few seconds; and 5) to breathe quietly i.e. 
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tidal volume breathing. The second dynamic manoeuvre was a full expiration manoeuvre while the 
patient produced a series of repeated coughs starting at ≥95% of inspired VC ≥90% of the expired VC.
After the training session, the patient was transferred to the MRI scanner. Breathing instructions 
during the MRI were given by the same lung function technician that performed the training, using 
the MRI compatible built-in patient audio system. During the MRI investigation, the lung technician 
sitting next to the MRI technician monitored the inspired and expired volumes and dynamic flows 
on the computer screen of the MRI-compatible spirometer set-up (Figure 1). Based on the spirometer 
data, the lung function technician instructed the MRI technician on when to start or stop the scans 
in case of patient error.
Figure 1. Magnetic resonance imaging (MRI) spirometer set-up. (a) Metal-free plastic tripod, mouthpiece and the 
MRI compatible spirometer in the lung function room where the breathing manoeuvres were trained. (b) In the MRI 
suite, the spirometer is connected to the computer by long plastic tubing, which is introduced into the Faraday cage, 
to measure differential pressure for computation of flow.
Image analysis
The first post-processing step for the lung and central airway images was performed on the scanner 
console and consisted of equalising the inhomogeneity/signal attenuation of the receiver array coil by 
using a surface coil correction intensity algorithm and adaptive filtering to enhance the signal-to-noise 
ratio. Image quality criteria were defined for both static and dynamic scans. Static scans were repeated 
if blurring of structures and ghosting were observed. Dynamic scans were repeated when excessive 
blurring and ghosting of the chest wall was observed. The latter was indicative of a lack of temporal 
resolution or due to a suboptimal breath-hold, as shown on the spirometer screen.
The image data were then transferred to an Advantage windows workstation, or onto the Advantage 
Windows Server (General Electric Healthcare) to perform cine multi-planar reformats (MPR) from the 
3D cine-MRI data collected. The MRIs were jointly evaluated by two radiologists (P. Ciet and M.H. 
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Lequin) and a standard report was written. For the retrospective analysis, all images were assessed by a 
radiologist (P. Ciet) blinded to all clinical data using manual tracing as described below.
The manual assessment started by analysing both the end-inspiration and end-expiration static volumes 
in the four-dimensional (4D) MPR platform. Reformats were performed to measure the diameters of 
the trachea and main stem bronchi using a window and magnification setting (zoom factor 3.0). 
Windowing was performed by setting the window level at one half of the maximum signal recorded 
around the trachea with a window width of 0. First, the narrowest section of the trachea in expiration 
was determined using a two-dimensional (2D) calliper to measure the anteroposterior diameter in a 
view perpendicular to the trachea midline (Figure 2). To compare the degree of narrowing, a similar 
section, angled according to the main tracheal axis, was reformatted using the surrounding anatomical 
structures as spatial reference and the distance to the carina. Next, the dynamic acquisitions (both 
forced expiration and coughing) were evaluated in cine-mode on the 4D reconstruction platform both 
in longitudinal and perpendicular views of the trachea to determine which one of the 48 volumes 
showed the greatest tracheal collapse (Figure 3). Having selected the “most collapsed” volume, the 
same distance measurements were performed as described for the breath-hold acquisitions.
Figure 2. Image analysis of dimensions for the trachea in patient B. (a-c) Reformats of three-dimensional 
radiofrequency-spoiled gradient echo sequence breath-hold during inspiration. In part a) blue line and in part (c) the 
orange line indicates the correct orientation along the midline of the trachea. (d) Shows the anteroposterior diameter 
in reformatted axial view (double oblique) and with the window set at full-width half-maximum image.
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Figure 3. Dynamic magnetic resonance imaging (a-e), respiratory waveform (f ) and bronchoscopy 
images (g, h) in patient C. (a-d) Three-dimensional volume rendering at different time points during 
the forced expiration manoeuvre. Note the trachea impression above the carina (d) indicated by a 
white arrow. (e) Sagittal view with green region of interest to assess signal intensity changes according 
to the breathing cycle. (f ) Correspondent signal intensity changes (approximate respiratory waveform) 
over time, where y-axis represents signal intensity and x-axis the time. Note the inverted relationship 
between volume of air in the lungs and signal intensity. The patient started the forced expiratory 
manoeuvre from maximum inspiration, which showed the lowest signal intensity, until maximum 
expiration, which had the greatest signal intensity. (g,h) Screen shots of the bronchoscopy evaluation 
in the same patient show bulging of the pars membranacea (black arrows) in addition to the anterior 
impression (h) just above the carina caused by the innominate artery, which corresponds to the tracheal 
impression as shown on image (d).
TBM was defined as a reduction in airway anteroposterior diameter of the trachea of >50% between 
static end-inspiration and end-expiration scans or between end-inspiration and dynamic scans as 
routinely used in the bronchoscopy assessment of TBM [17]. This definition was used to compare 
the diagnosis of TBM using cine-MRI with the subjective diagnosis made by the physician for those 
patients in whom a bronchoscopy was performed.
Comparison between MRI and bronchoscopy or CT
In six subjects bronchoscopy reports were available, which were compared to 3D cine-MRI. Since, 
using bronchoscopy, TBM is diagnosed by visual assessment and not by exact measurements of airway 
dimensions, bronchoscopy reports were used to verify the 3D cine-MRI findings. In one subject, only 
a spirometer controlled CT was available for confirmation of the diagnosis of TBM. For this patient, 
chest CT images were compared to cine-MRI findings.
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Results
Our retrospective analysis included 12 paediatric patients (Table 1), who all had a cine-MRI made 
for various clinical diagnostic reasons. Informed consent was obtained from the parents of the patient 
for anonymous analysis of the data and registered in the electronic patient record. Approval for this 
retrospective study was obtained from the institutional review board.
The success rate of the MRI protocol was 92%, only one participant was not able to successfully 
complete all required breathing manoeuvres, because of fear induced by the noise in the MRI scanner. 
Images were of diagnostic quality for analysis in all subjects, except for the patient mentioned above. 
Airway dimensions measured by the manual assessment are displayed in Table 1. TBM was diagnosed 
in seven children (58%): patient B, C, D, F, L, M and N (Table 1). In patients B and C, TBM was 
visible on the static and dynamic MRI images, whereas in patients D, F, L, M and N, TBM was visible 
only in the dynamic MRI acquisitions. Patient B and N had severe TBM, which involved the trachea 
at the level of the carina and the left main bronchus.
In patient B, who declined bronchoscopy, a follow-up chest CT scan confirmed the diagnosis of TBM. 
Patient C had TBM 1 cm above the carina, confirmed by bronchoscopy (Figure 3). Patient D had 
complete collapse of the left, main bronchus during forced expiration, which was defined as “isolated 
distal narrowing” by bronchoscopy. Patient F had a severe TBM, just above the carina, clearly visible 
during forced expiration, which was confirmed by bronchoscopy evaluation (Figures 4 and 5). 
Figure 4. Tracheobronchomalacia in patient F. Breath-hold (BH) inspiration (a), dynamic forced expiration 
manoeuvre (b) and BH expiration (c). Note the trachea lumen in the dynamic acquisition is smaller than the breath-
hold expiration acquisition (white oval).
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Figure 5. Axial reformatted images of patient F. (a) Breath-hold magnetic resonance image at end inspiration 
showing a normal round configuration of the trachea. (b) Breath-hold at end expiration at the same level, note that 
the pars membranacea is bulging into the lumen (white arrow). (c) Shows the same location as a) and b) during 
bronchoscopy evaluation during tidal volume breathing, which confirms tracheomalacia caused by an abnormal 
configuration of cartilage rings (black arrow) combined with bulging of the pars membranacea (*).
Patients L and M had TBM ∼1.5 cm above the carina bifurcation. Patients H and I had negative results 
for TBM both on MRI and bronchoscopy assessments. Patients A, E, and G were negative for TBM to 
cine-MRI assessment and no further diagnostic procedures were felt necessary by the treating physician. 
Patients L and M had positive results for TBM by cine-MRI assessment, and further assessment by 
bronchoscopy was proposed by the treating physician but declined by the parents. Hence, for all seven 
patients with available bronchoscopy and/or CT, cine-MRI was in concordance with bronchoscopy 
and/or CT for the presence or absence of TBM. For four patients this could not be evaluated.
Discussion
Our retrospective study shows that spirometer controlled 3D cine-MRI is a promising technique in 
children for the static and dynamic evaluation of central airway dimensions and could potentially 
replace bronchoscopy for the evaluation of TBM.
Cine-MRI versus bronchoscopy
The most important advantage of 3D cine-MRI was that airway dimensions could be studied during 
standardised static and dynamic breathing manoeuvres, such as forced expiration and cough. The use 
of a MRI compatible spirometer allowed us to monitor inspiratory and expiratory flows and volume 
during the MRI acquisitions [20]. By acquiring simultaneous functional and morphological data, the 
severity of the TBM can be established in a standardised fashion.
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
159
Cine-MRI for pediatric TBM
8
To evaluate airway dimensions using bronchoscopy in a child, general anaesthesia is frequently needed. 
The challenge for the anaesthesiologist is to control the level of anaesthetic in such a way that the child 
continues to breathe spontaneously. In instances where the anaesthesia is not deep enough, the patient 
begins to move and often coughs, a situation that the anaesthesiologist tries to avoid. In cases where the 
anaesthesia is too deep or when a muscle relaxant is used, spontaneous breathing stops and positive-
pressure ventilation is needed, which can obscure TBM due to the positive trans-pulmonary pressure. 
Conscious sedation enables controlled breathing manoeuvres during flexible bronchoscopy to be 
attempted. However, in children, this technique is not used routinely since it is highly dependent on 
cooperation, which is considered challenging for most children [4]. Hence, cine-MRI in children aged 
≥8 years is an attractive alternative for bronchoscopy to study airway dimensions using standardised 
breathing manoeuvres.
The second advantage of cine-MRI is that it allowed us to obtain objective airway dimensions using 
post-processing image analysis tools. This is complicated to do with bronchoscopy and, therefore, not 
routinely performed [5]. Despite developments in bronchoscopy optics, the image remains essentially 
2D and distorted [5]. Hence, the diagnosis of malacia using bronchoscopy is mostly subjective and not 
very reproducible [5]. Importantly MRI has multiplanar imaging capabilities, so 3D data sets can be 
reconstructed providing measurements in every possible plane and cross-section [16,18].
The third advantage of 3D cine-MRI is that the procedure is less invasive, relative to bronchoscopy, 
since it does not require general anaesthesia and anaesthesia related risks can be avoided. Bronchoscopy 
under general anaesthesia introduces a small risk of complications, such as respiratory depression, 
oxygen desaturation, apnoea, bradycardia, epistaxis, airway bleeding, excessive cough, transient 
laryngospasm, procedure induced atelectasis, pneumothorax and in rare cases, even fatalities [3-4].
Cine-MRI versus cine-CT
The most important advantage of cine-MRI compared with cine-CT was that it did not expose the 
children to ionising, which is a greater risk for children than adults [10-14]. Since cine-MRI does 
not require ionising radiation, all required breathing manoeuvres can be tested without concerns for 
radiation exposure. In addition, the procedure can be repeated when not executed correctly. In our 
group of patients, we had to repeat at least one acquisition per examination in 50% of tested children. 
Hence, this could be done without adding risks for the child.
Feasibility of spirometer controlled cine-MRI
Cine-MRI also has a number of limitations, the most important of which is the need for optimal 
cooperation by the patient. This is a clear challenge, especially in young children. Most children are able 
to do spirometry from the age of ≥6 years, however, having a child enter the bore of the MRI covered 
by a body-coil, with a spirometer in their mouth (Figure 1c), followed by the requested breathing 
manoeuvres, requires careful preparation and coaching. In general we consider our spirometer 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
160
Chapter 8
controlled cine-MRI feasible for children aged ≥8 years. In our small series we only had one child, 
aged 11 years, who could not complete the intended manoeuvres.
The second limitation of our cine-MRI protocol was the low spatial resolution. Clearly, the resolution 
of the MRI images is inferior to that of CT [9]. In our MRI protocol we obtained an isotropic voxel 
of 3.0 mm3, which is inferior to the submillimetric voxels that can be achieved with CT [9]. However, 
this resolution was sufficient to detect the reduction of the airway lumen of the large airways, with 
diameters ranging from 1 to 2 cm in children 6-18 years [23]. For smaller airways and dynamic images 
a higher spatial resolution will be needed. We expect that by using parallel imaging, a dedicated torso 
coil and a higher field strength, the spatial and temporal resolution can be further improved in the 
near future.
Further validation
A major limitation of our retrospective study is that we evaluated a small selected group of patients. 
However, the main aim of our study was to test the feasibility of the method for later use on a larger 
scale with a more heterogeneous group of patients [24]. Therefore, further validation of cine-MRI as 
a diagnostic method for TBM is required using a prospective study. We aim to do this comparing the 
diagnostic performance of bronchoscopy to spirometer controlled 3D cine-MRI.
Conclusions
This retrospective study showed that spirometer controlled 3D cine-MRI is a promising method to 
assess static and dynamic changes of central airway dimensions when TBM is suspected. Cine-MRI 
may be a more sensitive, faster and safer alternative for the diagnosis of static and dynamic TBM 
in cooperative children than bronchoscopy or cine-CT. Further prospective validation studies are 
required comparing the sensitivity and specificity of cine-MRI versus bronchoscopy and/or CT to 
diagnose TBM.
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Abstract
Bronchoscopy and multi-Detector Computed Tomography (MDCT) are routinely used to assess 
tracheobronchomalacia (TBM). Recently, dynamic Magnetic Resonance Imaging (cine-MRI) has 
been proposed as a radiation-free alternative to MDCT. To date, cine-MRI has not been directly 
compared to MDCT to assess TBM. In this study, we tested cine-MRI assessment of airway dynamics 
during various breathing conditions and compared cine-MRI and MDCT measurements in healthy 
volunteers and patients with suspected TBM.
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Introduction
Multi-Detector Computed Tomography (MDCT) is routinely used to assess tracheobronchomalacia 
(TBM) [1]. MDCT has comparable sensitivity to bronchoscopy for diagnosing TBM [2], but is 
limited by radiation exposure. Recently, dynamic Magnetic Resonance Imaging (cine-MRI) has been 
proposed as radiation-free alternative to MDCT [3]. Cine-MRI enables repeated imaging during a 
variety of breathing conditions [3]. To date, cine-MRI has not been directly compared to MDCT 
to assess TBM, nor has its feasibility been determined for assessing airway dynamics during a wide 
range of breathing maneuvers. The aims of this study are two-fold: 1) to develop and test a protocol 
for cine-MRI assessment of central airway dynamics during different breathing conditions; and 2) to 
compare cine-MRI measurements with MDCT in a group of healthy volunteers and COPD patients.
Material and Methods
Detailed description of the technique is provided in the online supplement.
Following informed consent (IRB Protocol number: 2013P000286), healthy volunteers and COPD 
patients with suspected TBM underwent cine-MRI and MDCT on the same day. Inclusion and 
exclusion criteria are displayed in the online supplement (OLS) (Table 1E). 
MRI
We used a cine-MRI protocol developed for pediatric patients to assess central airway dynamics while 
employing an expanded series of breathing maneuvers in both healthy volunteers and several patients 
with COPD [3]. Scanning was performed using a 1.5T Signa Hdxt MRI (General Electric Healthcare, 
Milwaukee, WI, USA) scanner and an eight-channel torso coil for signal reception. The protocol 
consisted of static end-inspiratory and expiratory scans, and three dynamic maneuvers: forced vital 
capacity (FVC), tidal breathing (TB) and hyperventilation (HV). All maneuvers were performed 
through active respiratory coaching by a respiratory physiologist. The protocol lasted 25-30 minutes. 
Videos of each dynamic scan are provided in the OLS.
CT
All CT examinations were performed using a 64-detector row scanner in the craniocaudal direction 
for both end-inspiratory and 1 dynamic mid expiratory scan. For healthy volunteers, a validated low-
dose protocol was employed [4]. For COPD patients, MDCT consisted of a validated protocol [5], as 
described in the OLS.
Imaging analysis
MRI and CT images were analyzed by an experienced thoracic radiologist. Patients’ identifications 
were coded, scans were reviewed in randomized order, CT and MRI scans were reviewed on different 
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dates. Images were analyzed using Myriam (Intrasense, Montpellier, France). Cross-sectional area 
(CSA), anterior-posterior (AP) and left-right (LR) diameters were recorded at 7 levels: 1 cm (T1), 
2 cm (T2), 3 cm (T3), 4 cm (T4), 5 cm (T5) above the carina in the trachea and 1 cm below the carina 
in the right (RMB) and left (LMB) main bronchus. CSA and AP/LR diameters were measured with a 
hand-tracing tool on axial reformat perpendicular to the trachea centerline. %Collapse was calculated: 
%CSA=100x[1 – CSAFVC/CSAi] where CSAi and CSAFVC are the CSA of the airway lumen at end-
inspiration and during FVC, respectively. The % variation for AP (%AP) and LR (%LR) diameters 
between inspiration and expiration were calculated with the same formula. The observer repeated 50% 
of the MRI and CT measurements one month apart to determine intra-observer variability. 
Statistics
Descriptive statistics were used to summarize central airways measurements between volunteers and 
patients. Intra-Class Correlation coefficient (ICC) and Bland-Altman plots were used to assess inter-
modality (MRI versus CT) and intra-observer agreements (MRI versus MRI and CT versus CT). 
Finally, using mixed-effects models analysis, we assessed the contribution of %AP and %LR to %CSA. 
Moreover, we assessed %CSA between the breathing maneuvers and the central airways positions 
(T1-T5 and RMB-LMB). Differences were statistically significant if p<0.05. 
Results
The MRI and CT data of twelve participants (median 64.5 years, range 45-77 years, 7 female) including 
nine volunteers and three COPD patients, were compared. All MRI and MDCT examinations were 
technically successful. 
Inter-modality and intra-observer agreement
Table 1 shows ICC for inter-modality and inter-observer agreements. Bland-Altman plots are presented 
in OLS (Figure 2E-8E). Inter-modality agreement was very good (ICC>0.81) for end-inspiratory 
images, and good (ICC>0.61) for dynamic expiratory images. Intra-observer agreement for MRI 
measurements was good to very good (ICC 0.77-0.99) for all breathing maneuvers and very good 
(ICC. 0.98) for CT measurements. 
Central airways dynamics in different breathing conditions
Central airways %collapse for the static and dynamic scans for volunteers and patients are summarized 
in Table 2. Cine-MRI showed an increasing tracheal %collapse according to the respiratory effort 
required by the breathing maneuvers. In volunteers, the greatest tracheal %collapse was for the FVC 
maneuver, followed by BH, HV and TB. In COPD patients, tracheal %collapse was higher during 
HV than BH. Main bronchi %collapse followed the same decreasing order of the tracheal %collapse 
in volunteers, but not in patients that showed increased airways changes during TB.
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Central airways dynamics for volunteers and patients
All three COPD patients had “saber-sheath” tracheas as diagnosed by CT, with excessive collapse of the 
LR diameter. COPD patients showed higher tracheal changes during dynamic breathing maneuvers 
compared to healthy volunteers (Table 2). Tracheal %collapse was 1.5 times higher in COPD patients 
than healthy volunteers for all three dynamic maneuvers, except BH maneuvers. Tracheal %AP was 
greater in COPD patients during FVC and HV maneuvers. Tracheal %LR was 1.4 (FVC maneuver) 
and 7 (TB maneuver) times greater in COPD patients than volunteers. Main stem bronchi also 
showed larger dynamic changes in patients than in volunteers.
Central airways %collapse per position between volunteers and patients is presented in OLS (Tables 
2E-5E). %CSA per position was homogenous in the group of volunteers, while larger variability was 
seen in 3 COPD patients. 
Mixed-model analysis
Mixed model analysis showed that %AP and %LR equally contributed to %CSA (Table 3). There were 
significant differences in CSA changes between BH (used as reference) and TB, but not between FVC 
and HV. Changes of CSA were significantly different between T2 (used as reference), and T4 and T5, 
but not for T1, T3, RMB and LMB (Table 4).
Table 1. Inter-modality (MRI versus CT) and intra-observer agreement for MRI and CT measurements.
Inter-modality agreement (MRI vs. CT)
End-Inspiratory Dynamic expiratory
CSA 0.928 0.81 
AP 0.884 0.616
LR 0.815 0.670
Intra-observer agreement MRI
BH FVC TB HV
CSA 0.987 0.992 0.985 0.897
AP 0.944 0.939 0.946 0.774
LR 0.928 0.958 0.948 0.825
Intra-observer agreement CT
CSA 0.996
AP 0.991
LR 0.981
BH=breath-hold maneuver; FVC=forced vital capacity maneuver; TB=tidal breathing maneuver; HV=hyperventilation maneuver; 
CSA=cross-sectional area; AP=anterior-posterior diameter; LR=left-right diameter. ICC values between 0.40-0.60; 0.60-0.80; and 
≥0.80 are considered to represent moderate, good, and very good agreement, respectively.
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Table 3. Effect table for %CSA outcomes based on the mixed-effects models analysis.
Outcome: CSA (%)
Estimate effect SE p-value
Intercept 9.5019 1.5993 p<0.0001*
AP (%) 0.6141 0.0419 p<0.0001*
LR (%) 0.5938 0.0522 p<0.0001*
TB -3.1546 1.4439 0.0289*
FVC 2.5527 2.0474 0.2125
HV -2.7399 1.4367 0.0565
T1 -0.1041 1.3715 0.9395
T3 -1.9429 1.3365 0.1460
T4 -3.8882 1.4036 0.0056*
T5 -2.6775 1.2745 0.0357*
RMB -1.3526 1.9216 0.4815
LMB 1.1488 1.8268 0.5294
AP=Anterior-posterior diameter; LR=left-right diameter; %CSA=cross-sectional area changes in %;%AP=anterior-posterior dimeter 
changes in %, LR%=left-right diameter changes in %, TB=tidal breathing maneuver; FVC=Forced Vital Capacity maneuver; 
HV=hyperventilation maneuver; T1, T3, T4, T5=tracheal points at 1 cm, 3 cm, 4 cm and 5 cm from carina respectively; RMB=1 
cm below the carina in the right main bronchus, LMB=1 cm below the carina in the left main bronchus; SE=Standard Error. To 
compare airways changes during dynamic maneuvers, BH maneuver was used as reference because representing the most standardized 
procedure. To compare airways changes between the central airways positions, T2 was used as reference instead of T1 to exclude the 
area next to the carina, which usually shows the largest changes. Note that %AP and %LR have similar estimate effect on %CSA. 
For example, when comparing two patients with equal %LR, a change of 1% of %AP determined a change of 0.61 % of CSA. 
Similarly in two patients with equal %AP, a change of 1% of %LR determined a change of 0.59 % of CSA. Significant differences 
are indicated by star (*). 
Discussion
Our study is the first to compare cine-MRI to MDCT in the assessment of central airway dynamics. 
We found that cine-MRI offered potential advantages to MDCT, most notably in terms of its enhanced 
capability to capture the maximal degree of expiratory collapse. 
The higher %collapse for cine-MRI compared to MDCT resulted in lower inter-modality ICCs for 
the dynamic expiratory measurements than the end-inspiratory. This was because cine-MRI enabled 
to acquire multiple images during dynamic expiration and to select the time point where the trachea 
showed the greatest collapse (Figure 1). Conversely, MDCT only provided a single “snapshot” of the 
expiratory phase. Therefore, cine-MRI has the potential to avoid underestimation of TBM.
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Figure 1. Static and dynamic MRI and CT scans in a patient with saber-sheath tracheobronchomalacia (TBM). 
Breath-hold end-inspiratory (A) and dynamic-expiratory (B) axial CT reformats. Forced vital capacity (FVC) 
inspiratory (C) and maximum dynamic expiratory (D) axial MRI reformats. Note severe lateral tracheal collapse 
during FVC maneuver both with CT (arrowhead) and with cine-MRI (arrow). 
Secondly, we showed that cine-MRI allows comparing airways dynamics in different breathing 
conditions between volunteers and COPD patients. All COPD patients with TBM had greater 
%collapse than volunteers in the dynamic maneuvers but not during the breath hold maneuvers 
(Figure 2), confirming the importance of the dynamic scans to assess TBM [6].
Thirdly, for COPD patients, we found that AP and LR diameters equally contribute to CSA changes. 
Previous studies had shown that AP diameter contributes more than LR diameter to CSA changes 
[4]. This discrepancy might derive from the wider range of airways dynamics tested in our study 
(BH, FVC, TB and HV) compared to the BH and FVC maneuvers previously investigated. This 
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technique may improve our understanding of the relative contributions of AP and LR movement to 
tracheal collapse. This can facilitate selection of those patients who are most likely to benefit from 
tracheobronchoplasty to reinforce the posterior tracheal wall from those who may benefit from more 
conservative measures such as Continuous Positive Airway Pressure [7]. 
We acknowledge that the small number of participants enrolled in this pilot study is a major limitation. 
Although sufficient to demonstrate the feasibility and promise of these methods, a future larger study 
of COPD patients is needed to validate our findings and to determine their clinical utility in predicting 
treatment options.
Figure 2. Forced vital capacity (FVC) maneuver, 48 phases (3D volumes) are acquired in 19 seconds. Axial 
reformats of phase 1 (A), phase 13 (B), phase 21 (C) and phase 29 (D). Note that phase 13 (image B) shows the 
smallest tracheal lumen (“most collapsed”). 
Conclusions
Cine-MRI is a technically feasible alternative to MDCT for assessing central airways dynamics while 
avoiding potentially unnecessary radiation exposure. Future studies are needed to determine its role in 
predicting the optimal therapeutic intervention for COPD patients with TBM. 
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Supplement
Material and Methods
Participants’ selection
From September 2013 to April 2015, fifteen participants were recruited in the study according the 
inclusion and exclusion criteria shown in table 1E. Two subjects were consented but not scanned, the 
first one for a contraindication to MRI namely ferromagnetic osteosynthesis material) and the second 
subject for sickness on the day of the MRI. MR images of one participant could not be accessed on 
Myriam platform and therefore excluded. The MRI and CT data of nine healthy volunteers (median 
age 60 years, range 45-72 years, 6 female) and three COPD patients (median age 72 years, range 70-77 
years, 1 female) were compared.
Table 1E. Inclusion and exclusion criteria for volunteers and patients with TBM.
Volunteers
Inclusion criteria Exclusion criteria
 – Between the ages of 45-75 years. 
 – Non-smoker.
 – No known history of respiratory disease.
 – No recent hospitalizations that required 
intubation.
 – Ability to give written informed consent and 
willing to comply with the protocol requirements.
 – Willing to undergo a research MRI and a research 
CT on the same day.
 – Pregnant or lactating females. 
 – Moderate-to-severe renal impairment defined as glomerual 
filtration rate (GFR)/eGFR ≤ 45 mL/min.
 – History of respiratory illness or taking any medications for 
respiratory issues.
 – Unable to hold their breath for longer than 15 seconds or are 
unable to follow breathing instructions.
 – Movement disorder.
 – Known allergy to one or more of the ingredients in the 
investigational products, or have a history of hypersensitivity 
to any metals.
 – Have any contraindications to MRI such as a pace-maker, 
magnetic material (i.e., surgical clips) or any other conditions 
that would preclude proximity to a strong magnetic field.
 – Severe claustrophobia.
 – Diabetic.
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Patients
Inclusion criteria Exclusion criteria
 – Between the ages of 45-75 years. 
 – Able to give written informed consent and are 
willing to comply with the protocol requirements.
 – Meet the GOLD Stage II-IV criteria for COPD.
 – Referred at BIDMC for MDCT assessment 
of the trachea for known or suspected 
tracheobronchomalacia.
 – Willing to undergo an MRI in addition to their 
clinically scheduled MDCT.
 – Pregnant or lactating females. 
 – Moderate-to-severe renal impairment, defined as a glomerual 
filtration rate (GFR)/eGFR ≤ 45 mL/min.
 – History of acute respiratory illness requiring antibiotics, 
hospitalization, or an emergency room visit in the past 2 
months.
 – Unstable cardiac disease or myocardial infarction in the past 
6 months.
 – History of tracheal surgery, including tracheostomy.
 – History of prior therapeutic radiation to chest or neck.
 – History of prolonged intubation beyond 7 days.
 – Unable to hold their breath for longer than 15 seconds or are 
unable to follow breathing instructions.
 – Movement disorder.
 – Known allergy to one or more of the ingredients in the 
investigational products, or have a history of hypersensitivity 
to any metals.
 – Any contraindications to MRI such as a pace-maker, magnetic 
material (i.e., surgical clips) or any other conditions that 
would preclude proximity to a strong magnetic field.
 – Severe claustrophobia.
 – Unwilling to undergo both the MDCT and an MRI on the 
same day.
Breathing maneuvers
Subjects were asked to perform three dynamic maneuvers: forced vital capacity (FVC), tidal breathing 
(TB) and hyperventilation (HV). In the FVC maneuver, subjects were asked while tidal breathing,: 1) 
to take a deep breath and reach Total Lung capacity (TLC); 2) to hold their breath for a few seconds; 
3) to perform a forced expiration and reach residual volume (RV); 4) to hold their breath for a few 
seconds; and 5) to breathe quietly [1]. In the TB maneuver, subjects were asked to breath-quietly, 
while in the HV maneuver patients increased their respiratory frequency with a respiratory cycle every 
2 seconds. All static and dynamic maneuvers were performed through active spirometric monitoring 
by a respiratory physiologist, who ensured that maneuver was correctly performed, using a dry-seal 
volume displacement spirometer (Eagle II Survey spirometer; Collins Sensormedics, Yorba Linda, CA, 
USA).
MRI 
The cine-MRI protocol consisted of three-dimensional (3D) “static” images at TLC and RV were 
acquired by two 12-s breath-holds covering the complete thoracic region at end-inspiration and end-
expiration. 3D cine-MRI acquisitions were acquired with the same imaging parameters and voxel 
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resolution of the static scans, but only covering the trachea and main stem bronchi (12 cm sagitally). In 
the cine-MRI scan, 48 volumes were collected in 19 seconds achieving a temporal resolution of 400 ms 
per volume (2)such as general anaesthesia. Cine computed tomography (CT. Videos of the dynamic 
scans are provided as Graphics Interchange Format (GIF) files A-C.
CT
CT scans were performed using a 64-MDCT scanner (Light Speed VCT; General Electric Medical 
Systems, Milwaukee, WI, USA). Low-dose CT protocol for volunteers had the following imaging 
parameters: 120 kVp, 40 mA, 0.625 mm collimation, 0.5 second gantry rotation, pitch of 1.375, and 
10 cm field of view. To reduce radiation exposure, helical scanning was performed in the craniocaudal 
direction from 2 cm above the aortic arch to 2-3 cm below the carina, corresponding to a length of 
approximately 8-9 cm [3]. Standard clinical protocol for COPD patients had the following parameters: 
80 mA, 120 kVp, 0.625 mm detector collimation, and 0.5 s gantry rotation time. The scan length 
included the entire lungs [4]. All images were acquired at end-inspiration (TLC) and during forced 
expiration (SVC).
Imaging Analysis
MRI and CT images were anonymized and analyzed in random order by thoracic radiologist with 7 
year of experience in MRI. Images were analyzed using the “airways stent planning tool” on Myriam 
platform (Intrasense, Montepellier, France). This tool allows drawing a centerline in the trachea and 
main stem bronchi both on CT and MR images. Cross-sectional area (CSA), anterior-posterior (AP) 
and left-right (LR) diameters were taken in seven different positions: 1 cm (T1), 2 cm (T2), 3 cm 
(T3), 4 cm (T4), 5 cm (T5) above the carina in the trachea and 1 cm below the carina in the right 
(RMB) and left (LMB) main stem bronchi (Figure 1E). CSA and AP/LR diameters were measured 
with a hand-tracing tool on axial reformat perpendicular to the trachea centerline. The %Collapse was 
calculated as follows: %CSA=100x[1 – CSAFVC/CSAi] where CSAi and CSAFVC are the CSAs of the 
airway lumen at end-inspiration and during FVC, respectively. The % of variation for AP (and LR) 
diameter between inspiration and expiration was calculated as follows: %AP=100x[1-APe/APi] where 
APi and APe are the APs of the airway lumen at end-inspiration and -expiration, respectively. 
A magnification setting with a zoom factor of 5 was used for central airways measurements. Window 
setting for MRI was set to obtain the best Contrast-to-Noise ratio (CNR) between tracheal wall and 
lumen by using an approach similar to chest CT with the standard lung window. Due to the lack of 
defined window setting for MRI, we set for each patient the window level above the background noise 
level and the window width approximately two-folds higher than the window level. This method 
supplies the best CNR between high and low density lung structures, similar to CT using the standard 
lung window [5]. Window setting for CT were: window length -500 and width 1600. The level of 
ambient (background) lighting was kept constant during all viewing sessions to ensure consistent 
viewing conditions.
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For the FVC maneuver, the narrowest section of the trachea in forced expiration was determined using 
the cine-mode tool on the Advantage Windows Server (AWS) imaging platform (General Electric 
Healthcare, Milwaukee, WI, USA). This cine-mode tool displays longitudinal and perpendicular views 
of the trachea on a 4D reconstruction platform that allows selecting which one of the 48 volumes 
showed the greatest tracheal collapse (Figure 2). This “most collapsed” volume was used to draw the 
measurements previously described with Myrian. For TB and HV maneuvers, the observer used the 
cine-mode tool to determine all end-inspiratory and end-expiratory phases during these dynamic 
maneuvers. Then, these multiple end-inspiratory and end-expiratory phases of the TB and HV 
maneuvers were analyzed with Myrian. In the TB scans, a median of 6 inspiratory (interquartile range, 
IQR, 4.25-7 phases) and 6 expiratory phases (IQR 4.25-6.75) was recorded and analyzed. In the HV 
scans, a median of 9 inspiratory (IQR 7.25-11) and 9 expiratory phases (IQR 8-11) was recorded and 
analyzed. Half of the MRI (MRI1 vs. MRI2) and CT (CT1 vs. CT2) data were analyzed twice 1 month 
apart for intra-observer variability assessment.
Mixed model analysis
Data were analyzed using a mixed-effects models to investigate whether there was an association 
between specific covariates and the outcomes of interest, while accounting for the correlation within 
the same patients [6]. With the mixed model analysis, we wanted to assess the contribution of %AP 
and %LR to %CSA.
The outcome for this model was %CSA, while the covariates were: %AP, %LR, the maneuvers (FVC, 
TB and HV) and the central airways positions (from T1-T5 and RMB-LMB). To compare airways 
changes during dynamic maneuvers, BH maneuver was used as reference because representing the 
most standardized procedure. To compare airways changes between the central airways positions, T2 
was used as reference instead of T1 to exclude the area next to the carina, which usually shows the 
largest changes. Statistical analysis was performed with SPSS (version 20.0, SPSS, Chicago, IL, USA) 
and R (version 3.1.3, the R foundation for statistical computing, Vienna, Austria).
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Figure 1E. Central airways measurements. 
Cross-sectional area (CSA), anterior-posterior (AP) and left-right (LR) diameters were measured at 1 cm (T1), 2 cm (T2), 3 cm 
(T3), 4 cm (T4) and 5 cm (T5) from carina bifurcation. CSA, AP and LR were also measured at 1 cm below the carina in the right 
(RMB) and left main bronchus (LMB). 
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Chapter 10
Abstract
Background: Pompe disease is a progressive metabolic myopathy. Involvement of respiratory muscles 
leads to progressive pulmonary dysfunction, particularly in supine position. Diaphragmatic weakness 
is considered to be the most important component. Standard spirometry is to some extent indicative 
but provides too little insight into diaphragmatic dynamics. We used lung MRI to study diaphragmatic 
and chest-wall movements in Pompe disease.
Methods: In ten adult Pompe patients and six volunteers, we acquired two static spirometer-controlled 
MRI scans during maximum inspiration and expiration. Images were manually segmented. After 
normalization for lung size, changes in lung dimensions between inspiration and expiration were 
used for analysis; normalization was based on the cranial-caudal length ratio (representing vertical 
diaphragmatic displacement), and the anterior-posterior and left-right length ratios (representing 
chest-wall movements due to thoracic muscles).
Results: We observed striking dysfunction of the diaphragm in Pompe patients; in some patients 
the diaphragm did not show any displacement. Patients had smaller cranial-caudal length ratios than 
volunteers (p<0.001), indicating diaphragmatic weakness. This variable strongly correlated with forced 
vital capacity in supine position (r=0.88) and postural drop (r=0.89). While anterior-posterior length 
ratios also differed between patients and volunteers (p=0.04), left-right length ratios did not (p=0.1).
Conclusions: MRI is an innovative tool to visualize diaphragmatic dynamics in Pompe patients and to 
study chest-walland diaphragmatic movements in more detail. Our data indicate that diaphragmatic 
displacement may be severely disturbed in patients with Pompe disease.
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Background
Pompe disease (OMIM 232300: acid maltase deficiency or glycogen storage disease type II) is an 
inherited progressive metabolic myopathy caused by acid D-glucosidase deficiency due to mutations 
in the acid D-glucosidase (GAA) gene (OMIM 606800) [1,2]. Pulmonary dysfunction caused by 
progressive weakness of the respiratory muscles is a characteristic feature of the disease [1,3,4]. In 
patients with the classic infantile form cardiorespiratory failure leads to death within the first year of 
life [5,6]. In patients with late-onset or non-classic Pompe disease pulmonary dysfunction progresses 
more slowly. The first sign of respiratory involvement in these patients is decreased pulmonary function 
in supine position, eventually necessitating respiratory support during sleep. Patients in the end-stage 
of the disease require continuous respiratory support [7-9]. Weakness of the diaphragm–the main 
respiratory muscle – is considered to be the major cause of respiratory dysfunction in Pompe disease 
[3,10]. Although pulmonary function tests (PFTs) may be indicative of diaphragmatic weakness by 
showing a difference between forced vital capacity (FVC) in sitting and supine position – i.e. postural 
drop – or by a decreased mean inspiratory pressure (MIP), they provide too little insight in dynamics 
of the diaphragm [11]. More insight in the function of the diaphragm has become extra relevant 
since enzyme replacement therapy (ERT) has been available for Pompe disease. While several studies 
have shown that ERT has positive effects on skeletal muscle function by showing stabilization or 
improvement of muscle strength or the distance walked in six minutes, the effects on lung function 
especially in supine position seem to be less pronounced [7,12-16]. In an earlier study that compared 
the effects of ERT on pulmonary function in sitting and supine positions, we found that 15% of 
patients were therapy resistant when pulmonary function was measured in sitting position, and that 
35% were therapy resistant when it was measured in supine position [13]. Recent MRI sequences and 
image analysis techniques make it possible to directly assess the individual contribution of respiratory 
muscles – including the diaphragm – during the breathing cycle [17-22].
The aim of the current study was to determine whether MRI could be used as an innovative tool to 
gain greater insight into the function of the diaphragm in Pompe disease, and to correlate these data 
with the results of PFTs.
Methods
Study population
All patients with Pompe disease in the Netherlands are referred to Erasmus MC University Medical 
Centre Rotterdam. For this cross-sectional pilot study we selected ten adult patients with various 
degrees of respiratory dysfunction. As controls we included six age- and gender-matched volunteers. 
Informed consent was obtained from all participants. The study protocol was approved by the Medical 
Ethical Committee at our hospital (Amendment 7 to protocol MEC-2007-103).
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An MRI-compatible spirometer was used to standardize lung volumes and breathing movements 
during the MRI (MasterSceen Pneumo spirometer, CareFusion, Houten, the Netherlands). Before 
MRI, FVC and forced expiratory volume in one second (FEV1) were measured according to ATS/
ERS standards [23,24]. Spirometry parameters are expressed in percentages predicted. Postural drop 
(ΔFVC) was calculated as (FVCsitting-FVCsupine)/FVCsitting *100%. An ΔFVC of more than 
25% is thought to reflect diaphragmatic weakness [11,25]. Before MRI, a Dwyer pressure gauge was 
used according to ATS/ERS standards to measure maximum static inspiratory (MIP) and expiratory 
pressures (MEP) [26]. Results are expressed in kilopascal (kPa). The carbon dioxide (CO2) fraction in 
the expired gas was measured with a capnograph (ms-capno, Viasys Healthcare, Wurzberg, Germany) 
at maximum expiration. In the absence of ventilation irregularities, the expiratory CO2 approximates 
the arterial CO2 pressure. A daytime expiratory CO2 over 6.0 kPa suggests hypercapnia and chronic 
alveolar hypoventilation [27].
MRI and imaging analysis
Scanning was performed with a 3T GE Signa 750 MRI (General Electric Healthcare, Milwaukee, 
USA) using the whole-body coil for radio-frequency excitation and a 32-channel torso coil for signal 
reception. First, a 3-plane localizer was performed during a maximum inspiratory movement (i.e. a 
five-second breath-hold scan); all subsequent volumes imaged were based on this localizer. Second, 
shimming was performed on this localizer, and shim settings were maintained throughout scanning. 
To evaluate changes in lung shape and volume, two static scans were acquired. These use two 
12-second breath-hold scans covering the entire thoracic region acquired at end-inspiration and end-
expiration in a 3D RF-spoiled gradient echo sequence with TR/TE=1/0.5 ms, flip angle 2°, sagittal 
volume acquisition with 3 mm slice thickness, 1.5 mm slice separation between slices and planar pixel 
resolution between 1.4x1.4 and 1.5x1.5 mm2. Overall acquisition time per patient was 20 minutes.
Each lung was segmented manually at inspiration and expiration using 3D Slicer (http://www. 
slicer. org), with segmentation being performed every second slice in the axial plane [28]. A full 3D 
segmentation was reconstructed by interpolating the individual segmentation slices in the cranial-
caudal axis. Using the 3D lung segmentations, the length and volume of each independent lung was 
estimated along the main axes of the MRI acquisition (cranial-caudal, anterior-posterior and left-right). 
To cope for variations in lung size due to inter-subject anatomical variations, each length at maximum 
inspiration was divided by the corresponding length at maximum expiration. Therefore the normalised 
value is a rate of length increase compared with the expiration point (e.g. a ratio of 1.2 would mean an 
increase of 20% in length). Because of the assumption that the chest-wall is responsible for changes in 
volume in the anterior-posterior and left-right directions, and the diaphragm expands the lung in the 
cranial-caudal directions, it is possible to study the contributions to volume changes of the chest-wall 
and the diaphragm individually.
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Statistical analysis
Data were analyzed using SPSS version 21 (SPSS, Chicago, IL, USA) and are presented as medians 
with ranges, or as numbers with percentages. The Mann-Whitney test was used to analyze differences in 
PFT results and MRI findings between patients and volunteers. The Spearman’s correlation coefficient 
(r) was used to calculate the relationship between PFT outcomes and MRI results in Pompe patients. 
A p-value <0.05 was considered statistically significant.
Results
Study population
Table 1 shows the characteristics of the Pompe patients and the volunteers. All Pompe patients had 
an acid alpha-glucosidase deficiency and all patients carried the common mutation c.-32-13T>G in 
one GAA allele and a second pathogenic mutation in the second allele. In five patients this second 
pathogenic mutation was c.525delT, in two patients c.1548G > A, and the other three patients carried 
a different second mutation. None of the patients was currently smoking and two patients had smoked 
in the past. None of the patients or volunteers had co-morbidities that could influence the function 
of the diaphragm.
Table 1. Patient characteristics and PFT results in patients and volunteers. 
Patients Volunteers P-value
Age (years) 46 (32-66) 43 (27-55) 0.25
Gender, (% males) 5 (50) 3 (50) 1.0
Height (cm) 178 (154-196) 177 (175-190) 0.39
Weight (kg) 73 (61-88) 85 (65-94) 0.13
BMI (kg/m2) 23.4 (20.6-25.4) 24.9 (21-25.7) 0.18
Duration of the disease (years) 16 (9-30) - -
Duration of ERT (years) 5.5 (0-7) - -
Wheelchair-dependent (%) 1 (10) 0 (0) 0.79
Ventilator-dependent (%) 3 (30) 0 (0) 0.37
Pulmonary function test
FVCsitting (%) 60 (45-84) 102 (92-111) 0.001
FVCsupine (%) 43 (27-70) 102 (87-113) 0.001
ΔFVC (%)a 33 (11-44) 0 (0-10) 0.001
FEV1 sitting (l/s) 59 (42-80) 98 (85-117) 0.001
FEV1 supine (l/s) 40 (30-63) 91 (76-112) 0.001
MIP (kPa) 6.9 (3.9-8.3) 8.6 (6.4-11.8) 0.07
MEP (kPa) 10.0 (6.4-11.8) 12.5 (10.3-14.2) 0.02
Continuous variables are expressed as median and range, categorical variables as number and percentage. BMI=body mass index, 
ERT=enzyme replacement therapy, FVC=forced vital capacity, FEV1=forced expiratory volume in one second, MIP=maximum static 
inspiratory pressure, MEP=maximum static expiratory pressure. aΔFVC is calculated as (FVCsitting-FVCsupine)/FVCsitting x100%. 
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Table 1 shows PFT in sitting and supine positions. In both these positions, patients had lower median 
values for FVC and FEV1 than healthy volunteers did (p=0.001). The median ΔFVC was higher in 
Pompe patients (p=0.001). The median MEP was lower in patients (10.0 kPa) than in volunteers 
(12.5 kPa, p=0.02). The median MIP showed a trend towards a lower median value for the patients 
(6.9 kPa) relative to the healthy volunteers (8.6 kPa, p=0.07). Three patients had a expiratory CO2 
fraction over 6.0 kPa and two of these patients were ventilator-dependent.
MRI
Figure 1 shows the line-up during the MRI. Participants were placed in supine position with the MRI-
compatible spirometer positioned above them. Figure 2 shows coronal slices through the carina for the 
breath-hold scans with the corresponding color plots of a Pompe patient and a volunteer. In the Pompe 
patient there was hardly any displacement of the diaphragm. Additional file 1 in the online data 
supplement shows the color plots of each individual subject and Additional files 2 and 3 demonstrate 
two examples of dynamic MRI scans in a healthy volunteer and a patient with Pompe disease.
Figure 1. Line-up during the MRI Patients were placed in supine position in the MRI scanner with an MRI-
compatible spirometer positioned just above the head.
Figure 3 shows the changes per individual in the three chest-cage directions between inspiration and 
expiration. In volunteers, the main contributor to the changes in lung volume was the diaphragm 
(white bars). In most Pompe patients, these changes were due mainly to the thoracic muscles (grey and 
black bars), but, as Figure 3 shows, these patients had a large variety in diaphragmatic and chest-wall 
movements. The median cranial-caudal length change, representing diaphragmatic displacement before 
normalization for lung size, was 82 mm (range 46-90 mm) in volunteers and 28 mm (range 5-49 mm) 
in patients (p=0.002). The median anterior-posterior length change was 37 mm in volunteers (range 
25-42 mm) and 18 mm (range 13-31 mm) in patients (p=0.006); the median left-right length change 
was 24 mm in volunteers (range 21-34 mm) and 17 mm (10-26 mm) in patients (p=0.02).
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Figure 2. MR images and color maps at maximum inspiration and expiration MR images during 12-second 
breath-holds in inspiration and expiration in a patient with Pompe disease and a healthy volunteer. The color 
maps represent the thickness of the segmentation in the anterior-posterior axis (red being the thickest and blue being 
the thinnest). Note the limited increase in vertical length in the Pompe patient relative to the increase in the healthy 
volunteer.
Figure 3. Ratios between inspiration and expiration in three directions for patients and volunteers measured 
with MRI. The length ratios between inspiration and expiration in the cranial-caudal direction (white bars), anterior-
posterior direction (black bars) and left-right direction (grey bars) are shown for individual patients and volunteers. 
Volunteers are numbered 1 to 6 and patients 7 to 16. The length ratios are calculated by dividing the median length 
during inspiration by the median length during expiration for each axis.
Figure 4 shows the different length ratios after normalization for lung size. The cranial-caudal length 
ratio between inspiration and expiration (representing diaphragmatic displacement) was lower in 
Pompe patients (median 1.35, range 1.07-1.64) than in volunteers (median 1.82, range 1.66-2.08) 
(p=0.001). While the anterior-posterior length ratio was also lower in patients (median 1.40, range 
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1.20-1.58) than in volunteers (median 1.59, range 1.42-1.71) (p=0.04), the left-right length ratio did 
not differ significantly between patients (median 1.35, range 1.20-1.56) and volunteers (median 1.41, 
range 1.36-1.58) (p=0.1). In the three Pompe patients who were ventilator-dependent the cranial-
caudal length ratio was lower than in the other Pompe patients (median 1.22 versus 1.43, p=0.02). 
These ventilator-dependent patients had a longer duration of the disease (median 29 years versus 15 
years). There was no correlation between the cranial-caudal length ratio and the duration of ERT.
Figure 4. Median ratios between inspiration and expiration in three directions for both groups. This figure 
shows the same ratios as Figure 2, but now for the groups of Pompe patients and volunteers. The box plots represent 
the median with the range. The Mann-Whitney test was used to calculate the difference in each direction between 
patients and volunteers.
Correlation between PFT and MRI
As Figure 5 shows, ΔFVC and FVC supine were strongly correlated with the cranial-caudal length ratio 
(r=0.89 and r=0.88, p<0.001) in Pompe patients, but there were no correlation between MIP and the 
cranial-caudal length ratio (r=0.32, p=0.37), MEP and cranial-caudal length ratio (r=0.23, p=0.53), 
or FVC sitting and cranial-caudal length ratio (r=0.46, p=0.18). The only significant correlation 
regarding the anterior-posterior length ratio was with FVC supine (r=0.74, p=0.02).
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Figure 5. Correlation between cranial-caudal length ratios and FVC supine (A), postural drop (B) and MIP (C). 
The dots represent patients and the triangles volunteers. Spearman’s correlation coefficient (r) was used to calculate 
the correlation between the cranial-caudal length ratio versus FVC in supine position, the postural drop (ΔFVC) 
and MIP. As these calculations were performed only in the Pompe patients, the volunteers were excluded for these 
analyses. FVC=forced vital capacity, MIP=maximum static inspiratory pressure.
Discussion
Our study shows that MRI can be used as an innovative tool to gain greater insight into involvement 
of the diaphragm in Pompe disease. It was demonstrated that the diaphragmatic function is severely 
impaired and in some patients there was even hardly any displacement of the diaphragm. To a lesser 
extent, movement of the anterior chest-wall was reduced. Our results suggest that diaphragmatic 
displacement measured with MRI is strongly correlated with the postural drop and FVC in supine 
position measured with common spirometry.
Decreased pulmonary function is an important feature of Pompe disease. Ten or 15 years after onset, 
half of the adult patients with Pompe disease require ventilator assistance. The main cause of death 
in this group of patients is respiratory failure, a process in which dysfunction of the diaphragm is 
considered to play an important role [8,9,29]. Our MRI study suggests that the function of the 
diaphragm in Pompe disease is more impaired than that of the thoracic musculature. It is not clear 
how and why the diaphragm muscles are more severely affected than the other respiratory muscles. 
Our study supports a recent study describing atrophy of the diaphragm and reduced lung height 
on static MRI and computed tomography scans in patients with Pompe disease. In this latter study 
semi-quantitative scoring scales were used, and computed tomography was used to measure lung 
height in one direction [30]. In our study MRI was performed under spirometry control and lung-
shape variations were quantified in three directions. This enabled us to show that the cranial-caudal 
movement related to diaphragmatic function in patients with Pompe disease is impaired more than 
the anterior-posterior motions of the anterior chest-wall. Similarly, the correlation we found between 
ΔFVC and FVC in supine position and our MRI results suggest that both these parameters might be 
used as an indirect tool for determining diaphragmatic function, with the advantage that MRI also 
visualizes diaphragmatic and chest-wall movements.
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A striking finding in our study was that displacement of the diaphragm was extremely impaired in 
some of the patients, while still residual pulmonary function in supine position was measurable. This 
could have important consequences when therapy comes in place and might explain why pulmonary 
function, particularly in supine position, responds poorly to ERT in some of the Pompe patients. 
Therefore, more studies are required to investigate at what stage the diaphragm and other respiratory 
muscles become affected in Pompe disease; especially since it has been shown that response to ERT 
is better in patients who are less severely affected [3,13,31]. Another intriguing question is how MIP 
and MEP relate to diaphragmatic weakness. It has been hypothesized that these parameters might be 
better predictors for diaphragmatic weakness than FVC in supine position [30]. Our study implied 
a weak correlation between MIP or MEP and diaphragmatic displacement. A possible explanation 
could be that MIP reflects both the strength of the diaphragm and other inspiratory muscles, while 
the cranial-caudal length ratio only reflects diaphragmatic displacement. In an earlier study we found a 
positive correlation between FVC in upright position and MIP an MEP [3]. Larger studies are required 
to explore this relationship in more depth. Comparison of diaphragmatic involvement in patients with 
Pompe disease to those with other neuromuscular disorders such as Duchenne Muscular Dystrophy 
might provide insight whether onset and the extend of diaphragmatic involvement is disease specific.
A limitation of our pilot study is that we selected a relatively small number of adult Pompe patients with 
variable degrees of respiratory dysfunction (FVC in supine position: 27 to 70% of normal). This subset 
of patients may not be fully representative for the total group of Pompe patients. In subsequent studies 
also patients with normal or close to normal respiratory function need to be studied to get more insight 
at what stage of the disease the diaphragm becomes affected. The use of MRI to evaluate diaphragmatic 
and chest-wall movements has some limitations. Contraindications such as metal implants, invasive 
ventilation and claustrophobia make it impossible to scan certain patients. Moreover, patients need to 
be able to perform spirometry in supine position. In next studies it might also be considered to include 
other techniques to measure lung and respiratory muscle function in addition to spirometry such as 
sniff nasal inspiratory pressures, transdiaphragmatic pressures or transdiaphragmatic twitch pressures 
[32]. Prigent et al showed that transdiaphragmatic pressures and transdiaphragmatic twitch pressures 
correlated well with all spirometry volumes and non-invasive maximal pressures in adult patients with 
Pompe disease [33]. Whether transdiaphragmatic pressure measurements show a better correlation 
with the cranial-caudal length ratio measured with lung MRI than with spirometry data needs further 
investigation.
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Conclusions
MRI appears to be an innovative tool to visualize diaphragmatic dynamics in Pompe patients and to 
study chest-wall and diaphragmatic movements in more detail. Our data indicate that diaphragmatic 
displacement can be very severely impaired in patients with Pompe disease and might explain why 
FVC responds poorly to ERT in some of the patients. As MRI adds detailed dynamic and structural 
information to data obtained by pulmonary function tests, particularly of the diaphragm, it may serve 
as a valuable tool in providing new insights in when the diaphragm starts to be involved in the disease 
process and on its responsiveness to therapy. It may also serve as a prognostic tool. More research is 
warranted to explore these topics.
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In this thesis, we aimed to use chest Magnetic Resonance Imaging (MRI) as a new technique for 
thoracic imaging. The core of the thesis consists of the application and development of new MRI 
protocols for Cystic Fibrosis (CF) lung disease. We also developed innovative applications of chest 
MRI for the dynamic evaluation of airways and the diaphragm. In this chapter, we discuss the main 
findings of our studies in the context of the current literature, their implications and the possible 
future research directions.
Chest MRI for Morphological Imaging
As described in chapter 2, chest MRI is intrinsically limited by several technical factors which affect 
image quality [1]. These limitations make comparison with computed tomography (CT) regarding 
morphological imaging somewhat biased. CT has undoubtedly higher spatial resolution than MRI 
and shorter acquisition times, which makes it the first choice for thoracic imaging [2]. In addition 
the long track record of chest CT has made it the current gold standard in clinical practice both as 
diagnostic and monitoring tool [3-5]. 
Conversely, chest MRI has been in development for only two decades, after the introduction of new 
techniques, which allowed to obtain reasonable image quality in acceptable scan time [6]. The major 
driving force to develop chest MRI is its application for lung diseases requiring repeated imaging and 
where cumulative radiation dose related to the use of chest CT is considered an important limitation 
[7,8]. One of these lung diseases is CF, the most common hereditary disorder in Caucasians [9]. 
Patients with CF suffer of chronic lung infection and inflammation that starts in early childhood 
[10]. Repeated imaging is needed to efficiently monitor and to direct therapy in CF lung disease 
[11]. Several studies have shown that CT is more sensitive than pulmonary function tests to detect 
disease progression in CF [12]. At the same time, it is clear that although small, the risk related 
to repeated scans cannot be ignored [8]. Some studies in large cohort populations have shown an 
increased incidence of radiation-induced cancers related to the use of CT imaging [13]. Even though 
the range of radiation dose registered in these cohort studies is clearly higher than those used in chest 
CT imaging for CF, the risk cannot be totally eliminated by reducing the dose, due to the stochastic 
nature of the damage caused by ionizing radiation [8]. Moreover, this risk is even higher in young 
children, who have higher radiation sensitivity than adults [14].
For these reasons, almost ten years ago the first studies were conducted comparing image quality of 
chest MRI to CT. In a cross sectional study of Puderbach et al, an MRI protocol using Half-Fourier 
single-shot turbo spin-echo” (HASTE@Siemens) sequence showed good comparability with CT 
to detect specific CF lung disease related to morphological findings, such as bronchiectasis, mucus 
plugging, bullae/cysts, and collapse/consolidation [15]. However, HASTE showed lower ability to 
correctly classify the severity of bronchiectasis, bronchial wall thickening and trapped air [15]. In a 
second study conducted by our group using a steady state free precession (SSFP@General Electric) 
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MRI protocol, similar results were shown [16]. In particular it became clear that there was a systematic 
underestimation of the severity of lung damage by MRI relative to CT due to poor visualization of 
peripheral bronchiectasis [16]. Similarly MRI was less sensitive to detect trapped air relative to CT 
[16]. Rajaram et al showed that SSFP MRI was inferior to CT in imaging parenchymal lung disease 
[17]. One limitation of these studies was the conventional Cartesian k-space acquisition scheme used 
[18]. Cartesian k-space acquisition schemes are more sensitive to breathing and cardiac artifacts than 
non-Cartesian (i.e. helicoidal, radial, etc.) acquisition [19]. Non-Cartesian k-space sequences, such 
as radial (STARVIBE@Siemens) and helical (PROPELLER@General Electric) are characterized by 
greatly reduced sensitivity to motion compared to previous fast spin-echo and gradient-echo sequences 
[20]. 
To test if this new type of sequences are superior to conventional MRI sequences, in the study 
described in chapter 3, we compared PROPELLER (Periodically Rotated Overlapping ParallEL Lines 
with Enhanced Reconstruction; BLADE@Siemens) sequence to CT [21]. PROPELLER is a free-
breathing Turbo Spin-Echo sequence with non-Cartesian k-space acquisition scheme (helicoidal) [22]. 
The main finding of our study was that despite this lower sensitivity to motion; PROPELLER MRI 
was still inferior to CT [23]. In particular, we found that compared to CT, PROPELLR MRI tended 
to underestimate CF findings for mild CF disease and to overestimate for severe CF disease [23]. 
A second important positive finding of our study was the high specificity of MRI for CF findings, 
which justifies its use for short or long term monitoring of specific CF lung disease alteration, such as 
consolidation, mucus plugs, etc [23].
Recently a multi-sequence MRI protocol including HASTE, BLADE, volumetric interpolated breath-
hold examination (VIBE) and time-resolved angiography with stochastic trajectories (TWIST) was 
compared to CT [24]. This cross sectional study showed good agreement between CT and MRI, 
although scoring was performed in consensus, and therefore intra- and inter-reader variability were 
not assessed [24]. 
To date all the sequences tested so far for CF lung imaging were limited by low signal to noise ratio 
(SNR) because of long echo times (TE) [1]. To overcome this limitation, ultra-short or zero-TE (UTE/
ZTE) sequences (microsecond μs instead of millisecond ms) have been recently developed and tested 
in CF disease, showing better results compared to conventional sequences [25,26]. Unfortunately, 
these UTE/ZTE sequences require long acquisitions times, because they are performed under free-
breathing conditions; hence reproducibility is affected by patient performance. 
It is important to note that, all the aforementioned studies were based on a single center experience. 
The primary and most obvious limitation of single-center studies is their potentially limited external 
validity. Especially the clinical value of MRI single centers studies is limited as standardization across 
MRI vendors and centers is difficult [27]. This lack of standardization still remains the main limitation 
in the implementation of chest MRI as a tool for routine clinical care [27]. To date no multi-vendor 
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studies have been published, mostly because of the large variability in MRI performance among vendors 
or even between similar scanners of the same vendor. In a recent study presented at the International 
Society of Magnetic Resonance in Medicine (ISMRM), variation up to 40% were registered in SNR 
for the same sequence (same scan parameters) performed in different scanners [28]. 
In summary, the continous development of high performance morphological MR sequences for chest 
MRI has reduced the diagnostic gap to CT. However, to close this gap, a large effort in MRI protocol 
standardization is needed allowing large cohort multi-centers studies [21]. 
Beyond morphological imaging
One of the major advantages of MR over CT is its multi-parametric imaging capability and superior 
tissue characterization. Different tissue weighting provides a variety of information facilitating lesion 
characterization [1]. For instance T2-weighted sequences are important to identify fluid-containing 
structures, such as cysts or pleural effusions, while PD-weighted sequences are appropriate for airway 
imaging and trapped air assessment [1]. MR allows to obtain important functional information 
without exposing patients to ionizing radiation. Several MRI techniques can be used to obtain VIPS, 
i.e. functional information about Ventilation, Inflammation, Perfusion, and Structure [21]. The 
application of these MRI techniques to obtain VIPS information in patients with CF is described in 
chapters 4-7 of this thesis.
Assessment of Inflammation with MRI
In chapter 4 and 5, we described the use of Diffusion-Weighted MRI to assess inflammation in patients 
with CF [29]. Inflammation is a major component of CF lung disease leading to progressive damage 
of lung structure [30]. The vicious cycle of infection, inflammation and damage determines those 
structural changes (i.e. bronchiectasis), which facilitate chronicity of infection [31]. CF patients face 
a state of chronic inflammation that increases during respiratory tract exacerbation (RTE). Different 
methods to assess lung inflammation have been evaluated so far. Several blood markers have been 
proposed, but they have shown low sensitivity and low clinical utility. Among pulmonary function 
tests, Lung Clearance Index (LCI) and Fractional exhaled nitric oxide (FeNO) have been used to assess 
inflammation [32,33]. However both LCI and FeNO showed high variability and limited ability to 
provide regional information on inflammation [34,35]. Regarding imaging, PET-CT has been also 
used to show persistent foci of inflammation in patients with CF, but its use is restricted by high 
radiation exposure [36]. Therefore, to date no radiation-free techniques were available to quantify and 
localize lung inflammation.
For the first time, we proposed DW-MRI as possible technique to localize and quantify inflammation 
in patient with CF [29]. In the first study on DW-MRI (chapter 4), we explored the feasibility of this 
technique in patients with CF [29]. The major finding of this cross-sectional study performed in a 
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
213
Discussion
11
group of stable patients with CF was that DW-MRI showed foci of high signal intensity (“hotspots”) 
which only in part overlapped with structural lung changes on morphological CT or MRI [29]. We also 
observed that DW-MRI had a strong correlation with radiological and clinical parameters indicating 
of CF lung disease severity [29]. In addition, there were significant differences in PFT parameters 
between patients with and without DW-MRI hotspots [29].
Based on these results, we decided to validate DW-MRI in a cohort of CF patients with and without 
RTE (chapter 5). The most interesting observation of this study was that DW-MRI could track 
inflammatory changes over the course of RTE treatment. In patients with RTE, DWI signal at 
high b values showed an overall significant reduction following antibiotic treatment, while in the 
control group no significant differences in DWI signal between baseline and follow-up were observed. 
Interestingly, the morphological score (CF-MRI) was significantly different between the RTE and 
control groups both at baseline and follow-up. Therefore CF-MRI score was not able to detect patients 
with RTE. The other important finding was the fair to good accuracy of DW-MRI to differentiate 
patients with CF treated for a RTE. The final important finding of this study was the low intra- and 
inter-observer variability of DW-MRI, which supports the robustness of this method in clinical trials 
focused on RTE treatment.
In these two studies we have shown that DW-MRI could be a useful tool to efficiently localize and 
quantify inflammation during RTE. The final step to validate our method would be to compare areas 
with and without DWI signal using broncho-alveolar lavage (BAL) in order to clarify the nature of 
DWI hotspots. 
Assessment of Perfusion with MRI
In chapter 6, we studied perfusion in a group of patients with CF. It is well known that structural 
changes affecting lung ventilation determine a reduction of lung perfusion according to the hypoxic-
vasoconstriction reflex. This principle was demonstrated a decade ago by Eichinger et al, showing 
that areas of hypoperfusion matched areas of structural changes using contrast-enhanced MRI 
(CEMRI). Despite this study, CEMRI was not widely introduced in clinical practice. This likely 
happened because the technique at that time was not robust. Large variability between observers was a 
common problem, and only highly trained radiologists could provide reproducible results. Moreover 
no automated software tools for lung segmentation or perfusion quantification were available. Finally 
the risk related to contrast administration further reduced the enthusiasm to implement CEMRI in 
the CF population. 
A recent study renewed interest on CEMRI. Wielpütz et al showed that hypoperfusion is a common 
entity in mild CF disease, and that it can be reversed after treatment for RTE exacerbation [37]. The 
findings of this study supported the use of CEMRI as an imaging biomarker in CF patients. In our 
CEMRI study in chapter 6, we aimed firstly to study the relationship between hypoperfusion (HP) 
and trapped air (TA). In addition we evaluated the relation between TA assessed by CEMRI and CT 
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and PFT. The main finding of our study was that HP was more frequent and severe than TA in patient 
with early CF disease. We also confirmed that expiratory CT detects more TA than expiratory MRI. 
From our study it became clear that the term TA is a misnomer, and that hypodense regions on CT 
and hypo-intense regions on MRI would be better described by the terms low-density region (LDR) 
and low-intensity region (LIR) respectively. 
The higher prevalence of HP compared to TA in CF patients suggests that other factors play a role 
in addition to the hypoxic-vasoconstriction reflex. One of these factors might be inflammation, as 
suggested by the findings of Wielpütz et al, that lung perfusion improved after RTE treatment [37]. 
It would be also interesting to investigate whether reversibility of TA/HP is restricted only to mild 
CF patients or it would occur in more advanced disease as well. These interesting questions will be 
addressed by studies using CEMRI only after further validation of the technique. A multi-vendor 
platform as VIPS MRI might help to make CEMRI an important imaging biomarker for CF lung 
disease [21]. Moreover other non-contrast techniques such as Fourier Decomposition (FD) or Arterial 
Spin Labeling (ASL) might be further developed in order to obtain information about perfusion 
without contrast administration [38,39].
Assessment of Ventilation with MRI
Ventilation imaging with MR can be performed with several techniques. The most studied technique 
for ventilation imaging is that with hyperpolarized gas MRI [40]. Hyperpolarized gas MRI uses gaseous 
contrasts based on helium (3He) and xenon (129Xe) to provide high resolution images of pulmonary 
ventilation, microstructure and gas exchange [40]. Despite the great potential of this technique, its 
high complexity and cost of the noble gasses and the need of dedicated hardware limits its application 
in clinical practice [41]. A more feasible and promising technique is Oxygen-enhanced MRI, which 
uses the paramagnetic effect of oxygen to shorten T1 relaxation times obtaining maps of the oxygen 
distribution in the lung [42,43]. Oxygen-enhanced MRI has been already used and tested in patients 
with asthma and chronic obstructive pulmonary disease [43,44]. Despite that the technique is cheaper 
and more available than hyperpolarized gases MRI, it has been not yet transferred in clinical practice 
because of its long acquisition times (5-30 min) [40]. The most promising technique for ventilation 
MRI is a non-contrast SSFP-based sequence that provides ventilation and perfusion maps [45]. This 
technique for ventilation MR imaging technique is FD, a free-breathing technique that does not 
use gaseous or intravenous contrast agents. FD has been already validated in healthy volunteers and 
patient with CF [38,46].
In chapter 7 we describe the use of a three-dimensional (3D) version of FD that we developed using 
the DIfferential Sub-sampling with Cartesian Ordering (DISCO) sequence [47]. The standard FD is 
based on a bi-dimensional (2D) SSFP sequence [45]. This entails that for covering the entire lung it 
is necessary to set a multi-slab acquisition, which can last from 3-10 minutes depending on the slab 
thickness. In our study, we demonstrate that 3D FD with DISCO is feasible and it facilitates the 
assessment of TA compared to conventional breath-hold expiratory scans. After further optimization 
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and validation, our 3D FD MRI might be a feasible method to implement in clinical practice for the 
assessment of lung ventilation.
MRI to assess central airways mechanics
In chapter 8, we describe a MRI protocol that we developed to assess central airways dynamics [48]. 
Cine computed tomography (CT. Central airways are routinely assessed with bronchoscopy, but 
this technique has some disadvantages [49]. Bronchoscopy in children usually requires anesthesia, 
therefore relevant breathing maneuvers (i.e. forced expiration and coughing) cannot be performed and 
exact measurements of airway dimensions are difficult [49]. Dynamic evaluation can be performed 
using computed tomography (CT), but MRI has the advantage to avoid ionizing radiation, which is 
particularly important for pediatric patients or for those patients who require repeated imaging [50].
In the study described in chapter 8, we showed that cine-MRI is a feasible technique in pediatric 
patients [48]. By using an MRI compatible spirometer we were able to perform specific breathing 
maneuvers, such as peak flow or coughing that helped to diagnose tracheomalacia [48]. We think that 
spirometer controlled cine-MRI has great potential to replace bronchoscopy or cine-CT. To validate 
this technique, we are currently conducting a study where we will compare sensitivity and specificity of 
our spirometry-controlled cine-MRI protocols to bronchoscopy for diagnosing tracheomalacia.
In chapter 9, we applied a similar cine-MRI protocol to a cohort of healthy volunteers and patients 
with COPD to quantify tracheal collapse in different dynamic conditions. We proved that the cine-
MRI protocol allows exact measurement of the tracheal collapse in different breathing conditions. 
Interestingly we found that tracheal collapse in adults varies from 23% in breath-hold condition, to 
53% during peak flow expiration, to 12% in free-breathing and to 14 % during hyperventilation. 
To further optimize this technique, automated segmentation software tool is needed in order to 
reduce time-consuming post-processing. Moreover, this cine-MRI protocol might be combined with 
other MRI techniques to characterize airway lesions. By using a multi-parametric MRI protocol with 
contrast it might be possible to differentiate between benign and malignant airway lesions, avoiding 
unnecessary diagnostic bronchoscopy and facilitating surgical planning.
MRI to assess diaphragm mechanics 
In chapter 10, we describe the use of MRI to assess diaphragmatic motion [51]. The assessment of 
the function of the diaphragm is highly relevant for several diseases [52]. Neurological diseases, such 
as muscular dystrophy or metabolic degenerative disease, can affect diaphragmatic function [53]. 
Diaphragm is the main inspiratory muscle; therefore its dysfunction leads to respiratory insufficiency 
[53]. To date, the gold standard to assess diaphragmatic motion has been lung function tests, which 
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– as previusoly mentioned – are limited by low sensitivity and high variability [54]. Regarding 
imaging, ultrasound (US) has been the most used technique to assess diaphragmatic motion [55]. In 
fact compared to MRI, US is cheaper and faster, although it lacks cross-sectional capabilities and it 
has large variability due to the operator dependency [52,55]. MRI has a great potential to provide a 
sensitive imaging biomarker of diaphragm motility [56,57]. 
In our study, we applied a spirometry controlled cine-MRI protocol to assess diaphragm motility in 
patients with Pompe disease and in a group of healthy volunteers [51]. Pompe disease is a hereditary 
genetic metabolic disorder, characterized by accumulation of glycogen in the muscles and nerves [58]. 
This results in progressive muscle weakness, hypotonia, recurrent chest infections and eventually 
respiratory insufficiency [58]. The enzyme replacement therapy for this disease costs around 23K€ 
a month [59]. A sensitive tool to assess therapy efficacy on the function of the diaphragm and other 
respiratory muscles was missing. PFT can be indicative of diaphragmatic weakness by showing a 
difference between forced vital capacity (FVC) in sitting and supine position or by a decreased mean 
inspiratory pressure (MIP), but it provides only indirect information on diaphragm mechanics. In 
our study, we showed that MRI could be a sensitive tool to assess diaphragm mechanics [51]. We 
demonstrate that the diaphragmatic displacement can be severely impaired in patients with Pompe 
disease [51]. The second important finding of our study was that Pompe patients could be stratified 
according the displacement of the diaphragm, which was extremely impaired in some of the patients, 
while in others some residual function of the diaphragm in supine position was measurable [51]. The 
main advantage of MRI compared to ultrasound is the superior detailed anatomical information in 
3D that can be obtained in dynamic and static conditions. Our MRI protocol has also the advantage 
that it is combined with the use of the spirometer, enabling to correlate pulmonary function with MRI 
parameters related to the diaphragm. Combining these parameters may provide new insights in the 
disease process and on its response to therapy. This method has been recently improved by automated 
software tools analyzing the motion of the diaphragm and other respiratory muscles. This technique 
will be used in a longitudinal study where we aim to compare diaphragm and chest wall musculature 
mechanics in patients with Pompe disease with healthy volunteers. In this study, we will also compare 
MRI with ultrasound of the diaphragm. 
When validated, this technique is likely to become an important diagnostic tool for other diseases, such 
as congenital diaphragmatic hernia, diaphragm paralysis and other causes of limb-girdle weakness.
Other directions for future research
In addition to the findings and possible future research directions based on the studies of this 
thesis, there are several opportunities to further improve the role of thoracic MRI as diagnostic and 
monitoring tool.
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MRI protocol standardization
As discussed previously, the main reason of the limited use of chest MRI in the clinic is the lack of 
standardization among MRI vendors and hospitals. Few centers have acquired sufficient experience to 
routinely introduce chest MRI in clinical practice [27]. Most of pulmonologists are not aware of chest 
MRI capabilities, and they prefer to rely on CT. Even radiologists find chest MRI difficult and time 
consuming, mostly because they are not familiar with the technique. 
However, with the technological advances achieved over the last decade, chest MRI is now mature to 
be translated in clinical practice [7,60]. Through an international collaboration, we aim to develop a 
VIPS chest MRI protocol that will supply information about Ventilation, Inflammation, Perfusion 
and Structure in one session of maximum half an hour [21]. This protocol will be harmonized among 
the main MRI vendors (General Electrics, Philips and Siemens). This VIPS platform will be firstly 
tested for monitoring CF lung disease during a pulmonary exacerbation and later for other chronic 
lung diseases.
Other applications of lung MRI in pediatrics
Different chronic lung diseases are suitable to be assessed with thoracic MRI. Bronchopulmonary 
dysplasia (BPD) is a severe chronic lung condition associated with long-term respiratory sequelae 
[61]. Chest CT has been used to assess and monitor structural lung changes in BPD [62]. Despite 
low or ultra-low dose CT protocols developed for BPD, the young age of these patients and the need 
for repeated imaging are a matter of concern regarding the risk of radiation-induced cancer. MRI as 
radiation-free technique would allow repeated imaging in BPD patients [62]. Moreover MRI will 
allow to obtain information about structural lung changes, but also about ventilation and perfusion. 
This functional information might be relevant to understand pathophysiology of BPD and why some 
patients evolve to severe obstructive airways disease. 
Other diseases that might be studied with MRI are Chronic Obstructive Pulmonary Disease (COPD) 
and asthma. For parenchymal visualization, ultrashort (UTE) and zero echo-time (ZTE) sequences 
showed better spatial resolution, signal-to-noise (SNR) and contrast-to-noise ratio (CNR) than 
conventional sequences [63,64]. Using these sequences, patients with COPD can be differentiated from 
healthy subjects and classified according disease severity [64]. In fact, with increased COPD grade, the 
parenchymal signal intensity distribution shifts toward lower signal intensities, so UTE signal can 
be used to quantify parenchymal tissue destruction and inflammation [64]. These measurements are 
highly reproducible and usable for longitudinal studies. 
Several studies have shown the utility of ventilation imaging with MRI for COPD and asthma [44,65-
67]. For example oxygen-enhanced MRI showed higher correlation to PFT and clinical parameters 
of COPD than CT, with higher potential for more accurate clinical stage classification [66]. Similar 
results were showed in patients with asthma [68]. Interestingly, to date Fourier Decomposition has not 
been tested in COPD patients. This technique would have the advantage to supply information about 
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ventilation and perfusion in a single free-breathing scan without contrast administration. Perfusion 
biomarkers might become relevant for clinical trials and using Fourier Decomposition would avoid 
Gadolinium administration, which has been recently debated after evidence of brain Gd deposition 
[69]. 
Lung perfusion in COPD and asthma has been extensively investigated with MRI [70-76]. Multiple 
quantitative and semi quantitative perfusion-derived parameters have been described to classify 
COPD severity [70-72]. Interestingly MRI appears to be more sensitive than CT in identifying early 
perfusion abnormalities among controls and mild COPD subjects [72]. Full quantitative analysis of 
pulmonary microvascular perfusion seems time-consuming and not needed [70]. There is indeed a 
close correlation between quantitative and semi quantitative perfusion parameters, therefore semi 
quantitative values may be useful as surrogate markers for regional pulmonary blood flow (PBF) in 
clinical practice and for follow-up examinations [70]. 
Development of Software tools for thoracic MRI
Another important limiting factor for the use of MRI in clinical practice has been the lack of dedicated 
software tools for automatic analysis of thoracic MRI. To date there are no automatic commercially 
available segmentation software for lung and airways on MR images. These tools are indispensable to 
move from qualitative to quantitative imaging. Physicians need to extract meaningful numbers out of 
the images that can help them to objectively determine disease progression, stability or improvement. 
Our group is aiming to develop scoring systems for several lung diseases that can be ultimately 
automated. The biomarkers derived from these software tools will be integrated in the report that 
accompanies the radiological examination. 
Summary
In this thesis we have shown the multiple capabilities of MRI for lung imaging. Chest MRI is ready 
to be converted in a unique single session imaging tool that can provide structural and functional 
information. Several chronic obstructive lung diseases might benefit from the development of the 
VIPS MRI platform, which will allow new clinical diagnostic scenarios and interventional clinical 
trials.
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Chapter 12
Chapter 1 contains a general introduction to thoracic MRI and describes the aims of the studies 
included in this thesis.
Chapter 2 is a state-of-the-art review about thoracic MRI, especially focused on children. It sets 
the stage for the studies performed in this thesis by describing the most common MRI acquisition 
techniques, their problems and the possible solutions to make chest MRI feasible in children.
The studies described from chapter 3 to chapter 7 are the core of this thesis and consist of the application 
and development of new MRI protocols for monitoring Cystic Fibrosis (CF) lung disease. CF lung 
disease requires repeated imaging in order to assess disease progression. To reduce cumulative dose 
related to CT imaging, MRI has been proposed as a safe radiation-free alternative.
In chapter 3, we describe a study comparing chest MRI to CT to monitor CF lung disease using 
PROPELLER MRI, a sequence with reduced sensitivity to motion artifacts. We found that motion 
correction in PROPELLER MRI does not improve assessment of CF lung disease compared to 
CT. However, the good inter- and intra-observer agreement and the high specificity suggest that 
PROPELLER MRI can play a role in the short-term follow-up of CF lung disease (i.e. pulmonary 
exacerbations).
In chapter 4 and 5, we describe the use of diffusion-weighted MRI (DW-MRI) as possible tool to 
monitor and quantify lung inflammation during respiratory tract exacerbation (RTE) in patients with 
CF. Chapter 4 represents a cross-sectional study where we explored the feasibility of DW-MRI to 
assess inflammatory lung changes in patients with CF. We observed that the areas of increased DW-
MRI signal (“hotspots”) only partly overlapped structural abnormalities on morphological CT or 
MRI. In addition, DW-MRI scores strongly correlated with radiological and clinical indicators of 
CF lung disease severity. Significant differences in pulmonary function (FEV1) were found between 
patients without and with DW-MRI hotspots. Finally, we found that the amount of mucus in the 
lungs of patients with CF was the best predictor of restricted diffusion.
In Chapter 5 we describe a longitudinal DW-MRI study, where we applied our DW-MRI protocol to a 
group of CF patients with and without respiratory tract exacerbation (RTE). This study demonstrated 
that DWI score and Apparent Diffusion Coefficient (ADC) detected the clinical changes of patients 
with CF treated for a RTE with fair to good accuracy. Moreover, DWI score and ADC were strongly 
correlated with symptom scores and spirometry measures in these patients.
In chapter 6 we describe the use of contrast enhanced MRI (CEMRI) in a group of CF patients to assess 
the relationship between hypoperfusion (HP) and trapped air (TA). We compared the amount of TA 
quantified by CT, MRI and pulmonary function tests (PFT) with the amount of HP quantified with 
MRI. Our study demonstrated that HP was more frequent and its volume larger than TA quantified 
by MRI. Interestingly the volume of TA measured with MRI was similar to that quantified by PFT, 
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but smaller than TA on CT. Our findings showed that HP contributes importantly to regions often 
described in radiology reports as ”trapped air” or as “mosaic pattern” on CT. Therefore, we propose 
that these terms could be better replaced by low-density region (LDR) for CT and low-intensity region 
(LIR) for MRI respectively.
In chapter 7 we describe an upgraded three-dimensional (3D) version of Fourier Decomposition (FD) 
technique, an MRI method for ventilation and perfusion imaging. We showed that both Cartesian and 
non-Cartesian K-space acquisition schemes enable 3D FD ventilation maps. Despite that the temporal 
resolution of our protocol was not sufficient to obtain 3D perfusion maps, 3D FD enabled a faster 
and more comprehensive assessment of trapped air compared to conventional 2D and 3D breath-
hold scans. This method might be applied in critically ill or non-collaborative patients to perform 
ventilation imaging with MR.
Chapters 8-10 describe the use of MRI to assess airways and diaphragm in dynamic conditions (cine-
MRI). In chapter 8, we described a new MRI protocol to assess tracheobronchomalacia (TBM) 
in pediatric patients. This feasibility study showed that cine-MRI has great potential to replace 
bronchoscopy or cine-CT in pediatric patients, so limiting the burden of invasive procedures or 
radiation exposure. In chapter 9 we used the same MRI protocol as described in chapter 8 to assess 
tracheal collapse in a group of healthy volunteers and patients with saber-sheath TBM. We showed 
that MRI allows to assess tracheal collapse in different breathing conditions, such as peak flow, tidal 
breathing and hyperventilation maneuvers. Significant differences in tracheal collapse were found 
between volunteers and TBM patients for all three breathing maneuvers. 
In chapter 10, we described the use of MRI to assess diaphragmatic impairment in a group of patients 
with Pompe disease, a glycogen storage disease that affected nerves and muscles. Using a spirometry 
controlled cine-MRI protocol we assessed diaphragm motility in patients with Pompe disease and a 
group of healthy volunteers. We demonstrated that the diaphragmatic displacement in patients with 
Pompe disease was severely impaired compared to healthy volunteers. We also demonstrated that 
Pompe patients could be stratified according the displacement of the diaphragm, which function was 
extremely impaired in some of the patients, while in others some residual function of the diaphragm 
in supine position was measurable. The higher sensitivity of our MRI method compared to PFT and 
ultrasound could provide new insights in the disease process of Pompe disease and on its response to 
therapy.
The findings of the studies included in the thesis are discussed in chapter 11 along with their 
implications and future research directions.
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Chapter 13
Hoofdstuk 1 geeft een algemene introductie over de long MRI als stralingsvrij alternatief voor de long 
CT. De doelen van de studies die in dit proefschrift staan worden beschreven.
Hoofdstuk 2 is een state-of-the-art review over long MRI, vooral voor kinderen. Deze review geeft een 
achtergrond van de studies in dit proefschrift en beschrijft de meest gebruikte MRI-technieken, hun 
problemen en de mogelijke oplossingen om long MRI bij kinderen mogelijk te maken. 
De studies beschreven in hoofdstuk 3 t/m 7 zijn de kern van dit proefschrift en beschrijven de 
ontwikkeling en het gebruik van nieuwe MRI protocollen voor Cystic Fibrosis (CF) longziekte. Voor 
CF longziekte is het belangrijk om regelmatig en met veilige en gevoelige radiologische methoden de 
voortgang van de longziekte te bewaken. 
In hoofdstuk 3 vergelijken we de gevoeligheid van PROPELLER MRI met CT om CF longziekte 
op te sporen. PROPELLER MRI zou minder gevoelig zijn voor storing door beweging. We vonden 
PROPELLER MRI in vergelijking met CT toch minder goed om CF longziekte te monitoren. Wel was 
er een goede inter- en intra-observer overeenkomst en was er een hoge specificiteit van PROPELLER 
MRI om longafwijkingen bij CF op te sporen. Dit suggereert dat MRI een rol zou kunnen spelen 
in de korte-termijn follow-up van CF longziekte, bijvoorbeeld bij toename van long problemen 
(exacerbaties).
In hoofdstuk 4 en 5 beschrijven we het gebruik van diffusie-weighted MRI (DW-MRI) als techniek voor 
het opsporen en kwantificeren van ontsteking tijdens exacerbaties bij patiënten met CF. Hoofdstuk 
4 beschrijft ons cross-sectionele onderzoek waarin we de uitvoerbaarheid van DW-MRI hebben 
onderzocht om ontsteking in de longen bij patiënten met CF op te sporen. We hebben waargenomen 
dat gebieden met een verhoogd DW-MRI signaal (“hotspots”) slechts gedeeltelijk overlappen met 
structurele afwijkingen op CT of MRI. Verder was er een duidelijke samenhang tussen de DW-
MRI scores met radiologische en klinische kenmerken van CF longziekte. Significante verschillen 
in longfunctie werden gevonden tussen patiënten zonder en met DW-MRI hotspots. Uiteindelijk 
vonden we dat de hoeveelheid slijm in de luchtwegen van patiënten met CF de beste voorspeller was 
van de ernst van de ontsteking.
Hoofdstuk 5 beschrijft ons DW-MRI vervolgonderzoek, waar we het DW-MRI protocol bij een 
groep van CF-patiënten met en zonder exacerbatie hebben getest. Deze studie toonde aan dat we met 
de DWI score en de apparent diffusie coëfficiënt (ADC) de klinische veranderingen bij patiënten met 
CF behandeld voor een exacerbatie met een redelijke tot goede nauwkeurigheid konden volgen. Verder 
kwamen de DWI score en ADC goed overeen met symptoomscores en longfunctiemetingen bij deze 
patiënten.
Processed on: 23-11-2016
506596-L-sub01-bw-Ciet
229
Samenvatting
13
In hoofdstuk 6 beschrijven we het gebruik van contrast enhanced MRI (CEMRI) bij een groep 
CF-patiënten om de relatie te bestuderen tussen longdoorbloeding en toegankelijkheid van de 
kleine luchtwegen (= Trapped air: TA). We vergeleken de hoeveelheid TA gemeten met CT, MRI 
en longfunctietesten met de longdoorbloeding gekwantificeerd met MRI. Onze MRI studie toonde 
dat het gebied met een verminderde longdoorbloeding groter was dan het trapped air gebied. De 
hoeveelheid TA gemeten met MRI kwam goed overeen met die gemeten met longfunctietesten. TA 
volume gemeten met MRI was kleiner dan dat gemeten met CT. Onze bevindingen tonen aan dat 
verminderde longdoorbloeding bijdraagt aan gebieden die in radiologierapporten worden aangeduid 
als “trapped air”of als “mozaïek patroon” op CT. Daarom stellen we voor dat deze termen beter kunnen 
worden vervangen door lage dichtheid regio (LDR) voor CT en lage intensiteit regio (LIR) voor MRI.
In hoofdstuk 7 beschrijven we een verbeterde drie-dimensionale (3D) versie van Fourier Decomposition 
(FD) techniek, een MRI methode om ventilatie en doorbloeding met MRI zichtbaar te maken. Deze 
methode kan bij ernstig zieke of niet-cooperatieve patiënten worden toegepast.
In hoofdstuk 8-10 beschrijven we het gebruik van cine-MRI voor de dynamische beoordeling van 
luchtwegen en het middenrif. In hoofdstuk 8 beschrijven we een nieuw dynamisch MRI-protocol 
voor de beoordeling van centrale luchtweg stabiliteit bij kinderen. Deze studie toonde aan dat cine-
MRI waarschijnlijk belastende kijkingrepen kan vervangen bij kinderen voor de beoordeling van 
luchtwegen. In hoofdstuk 9 gebruikten we het cine-MRI protocol om de luchtwegstabiliteit bij een 
groep gezonde vrijwilligers en bij volwassen patiënten met slappe centrale luchtwegen te beoordelen. 
Duidelijke verschillen in luchtwegstabiliteit werden gevonden tussen vrijwilligers en patiënten.
In hoofdstuk 10 beschrijven we het gebruik van MRI om de functie van het middenrif te beoordelen 
in een groep van patiënten met de ziekte van Pompe, een stofwisselingsziekte die zenuwen en spieren 
aantast. Tijdens gecontroleerde ademhalingsmanoeuvres beoordeelden wij de bewegelijkheid van het 
middenrif bij patiënten met de ziekte van Pompe en bij een groep gezonde vrijwilligers. We tonen aan 
dat de functie van het middenrif bij patiënten met de ziekte van Pompe ernstig verminderd was ten 
opzichte van de gezonde vrijwilligers. Deze methode kan ons helpen om het ziekteproces bij de ziekte 
van Pompe beter te begrijpen en om het effect van enzymtherapie beter te beoordelen.
De bevindingen van de studies in dit proefschrift worden besproken in hoofdstuk 11, samen met hun 
betekenis voor de gezondheidszorg en toekomstige onderzoeksrichtingen.
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BH = breath-hold
BMI = body mass index
BW = bandwidth
CEMRI = contrast enhanced MRI
CF = cystic fibrosis
CF-CT = cystic fibrosis computed tomography score
CF-MRI = cystic fibrosis magnetic resonance imaging score
CNR = contrast-to-noise ratio
COPD = chronic obstructive pulmonary disease
CPAM = congenital lung airway malformations
CPAP = Continuous Positive Airway Pressure
CS = compress sensing
CSA = cross-sectional area
CT = computed tomography
CT-BE = computed tomography bronchiectasis score
CT-Mucus = computed tomography mucus plugging score
CXR = chest x-ray
DCE = dynamic contrast-enhanced imaging
DISCO = DIfferential Subsampling with Cartesian Ordering
DW-MRI = diffusion weighted MRI
ECG = electro-cardiogram
EPI = echo planar imaging
ERT = enzyme replacement therapy
EVC = expiratory vital capacity
FA = flip angle
FD = Fourier decomposition
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